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1. Introduction: The molecular basis of phenotypic diversity
1.1 The genetic basis of phenotypic diversity
1.1.1 The mapping of phenotype to genotype
The collection of a living being’s observable characteristics such as morphology, biochemi-
cal and physiological properties, life cycles and behavioral patterns is defined as ”phenotype”
[1]. Example of observable phenotypes range from morphological difference between species
[2], variation between individuals of the same species [3], and variation between different cell
types within the same tissue [4, 5] (Figure 1.1).
An important goal in biology is to understand the molecular origin of phenotypic vari-
ation. This question has deep implication in a variety of different contexts, ranging from
evolution and speciation to early diagnosis and treatment of human disease. A fundamental
component underlying phenotypic variation lies in the presence of inheritance factors, collec-
tively summarized as the ”genotype” [1]. The association between genotype to a phenotype
is explored by the field of genetics. This field originated from the work of Gregor Mendel, a
19th century Austrian monk whose experiments on plant hybridization provided the basis for
classical genetics [6]. These eventually led to the discovery of ”Mendel’s law” which describe
how hereditary factors would segregate in crosses, leading to an inherited predictable phe-
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Figure 1.1. Examples of phenotypic differences
This figure shows interspecies differences in cranial morphology of Darwin’s finches (left, adapted from [2]),
intraspecies differences as shell patterning variation in the mollusk Donax varabilis (center, adapted from
http://en.wikipedia.org/wiki/Phenotype), and morphological differences between cell in different lay-
ers of the epidermic tissue (right, adapted from https://en.wikipedia.org/wiki/Epidermis_(skin)).All
three cases are examples of phenotypic variation.
notype. Hereditary or genetic factors existed in multiple forms or versions termed ”alleles”
and their combination would give rise to different phenotypic patterns.
Genetic factors, or ”genes” became an intense object of study in the early 20th century,
leading to major discoveries on their shape and organization [7].The revelation of the phys-
ical nature of genetic factors came in 1944, where the genetic material responsible for the
inheritance of the phenotype was found to be deoxyribonucleic acid, or DNA [8], a polymeric
molecule formed by single monomeric units called nucleotides [4]. This discovery marks the
beginning of the field of ”molecular genetics” and associates the concept of genetic inheri-
tance and allelelic variation to the molecular nature of DNA. Different alleles were revealed to
be changes in the sequence of nucleotides. These changes are called ”mutations” or ”genetic
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variants”, and their effects has been partially interpreted with the discovery of the ”genetic
code”, which converts the information inside the coding portion of a gene into a protein se-
quence [4]. Despite the advancements of the understanding of the nature of genetic factors,
a major difficulty lies in the fact that, in most cases, phenotypes are not easily explained by
Mendel’s laws, but rather involve the interaction and contribution of different genetic factors
and interaction with environment. This can be described as :
Genotype(G) + Environment(E)→ Phenotype(P ) (1.1)
Such phenotypes are termed ”complex traits” and are in many cases common across the
general population [9]. Understanding the genetic basis underlying complex traits remains
up to this day an important and difficult challenge.
1.1.2 The genetic basis of common traits and disease: the common and rare
variant hypotheses
A fundamental goal in biomedical research is to understand the contribution of genetic
variants toward common diseased phenotypes. The ability to predict the susceptibility of a
single individual to develop any particular disease can indeed have large implications toward
the goal of personalized medicine [10]. Two major hypotheses describing the relationship
between genetic variants and common disease emerged over time [11, 12]. The first one has
been described as the ”common disease common variant” hypothesis and it postulates that
common diseases and phenotypes are explained by one or few causative genetic variants that
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are common in the population [13] (Figure 1.2). A variant is defined to be common if present
at a frequency of 5% or greater in the general population [14]. The biggest corollary of this
model is that causative variants are few and frequent, thereby reducing the difficulty of the
problem and the number of patients required for any particular study. This hypothesis has
been shown to be true in the context of rare diseases [15].
In contrast, the second hypothesis, which is also known as the ”common disease rare
variant” hypothesis, predicts a scenario where common diseases and phenotypes are instead
explained by the presence of multiple causative variants that occur at a rare frequency in
the population [16, 17] (Figure 1.2). A variant is defined to be rare if present at a frequency
of 1% of lower in the general population [14]. In this case, the variants are multiple and
different, and they will co-occur very un-frequently in different patients displaying the same
phenotype. As a result, large groups of patients are necessary to reach adequate statistical
power.
The caveats of each model have important implications toward the design of the associa-
tion study necessary to find the underlying causative variants [18]. It is therefore important
to understand which model explains most of the phenotype.
Over the recent 5 years, by reviewing the results and conclusion of multiple association
studies performed on patients affected by common diseases, a clear trend emerged. Each
genetic variant in our genomes carries an ”effect size”, namely the ability of such variant
to produce a phenotypic effect. Common variants carried a very low effect size, if any at
all, whereas in contrast rare variants were associated to a high effect size, pointing them
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Figure 1.2. Common Disease Common Variant Vs Common Disease Rare Variant
Figure 2 | Scenarios in which DNA sequence variants distinguish cases and controls. 
The blue lines indicate genomic regions; red boxes indicate variants. a | Variants at a 
single locus with common alleles are more frequent in cases then controls. b | Multiple 
rare variations contribute to the phenotype such that the collective frequency of 
these variations is greater in cases. This would create a greater diversity of haplotypes 
or DNA sequences among the cases. c | Multiple rare variations contribute to the 
phenotype but act in a synergistic fashion, such that cases are likely to have more 
similar DNA sequences compared to controls. d | Multiple rare variations contribute 
to a phenotype but the variations contributing to the phenotype reside in specific 
genomic regions. This situation would create greater sequence diversity among the 
cases, as in part b, but only in the relevant genomic regions.
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leverage conditioning effects. In addition, not all models 
can accommodate quantitative trait analysis unless the 
phenotype is broken into quantiles and stratified analysis 
is pursued (TABLE 2).
Defining collapsing sets of rare variants through func-
tion or proximity. The collapsing strategy makes impor-
tant assumptions. First, some formulations of collapsed 
tests assume that each subject is likely to have only a 
single rare variant. This may be true given the low fre-
quency of the variants but, in theory, could be untrue if 
the variants interact with one another or large genomic 
regions are tested20,33. Second, if one collapses variants 
by counting individuals possessing rare variants, then 
if the frequency of these variants is large enough or if 
there are many of them, the percentage of individuals 
possessing any one of the variants could reach 100%. 
Therefore, ways of circumscribing the variants to be col-
lapsed, such as leveraging functional information (BOX 2; 
TABLE 2) or weighting the variants in some way34,35, are 
important. Alternatively, one could use statistics that do 
not rely on simple counting. For example, one could tally 
the number of variants in a collapsed set possessed by 
each individual33.
Although there are several ways to leverage func-
tional annotations to guide the collapsing of rare vari-
ants in association studies, their use will only be as good 
as the science behind those annotations. It is also pos-
sible that different functional levels of annotation can be 
used to define collapsed sets of rare variants. For exam-
ple, one could define a set of variants as ‘genic’ if they 
reside in the open reading frame associated with a gene; 
as ‘exonic’ if they reside in coding regions within that 
frame; as ‘non-synonymous coding variants’ if they per-
turb an encoded amino acid; and as ‘non-synonymous 
coding within an active site of the encoded protein’ if 
a variant impacts a residue within the active site of the 
encoded protein. With this in mind, one could per-
haps test hierarchies of hypotheses about collections of 
variants and their biological effect on a phenotype.
It is important to note the distinction between 
leveraging functional annotations to collapse a set of 
rare variants based on their location versus predictions 
that the variants themselves have a functional effect35 
(BOX 2). In fact, two recent papers23,36 suggest that lev-
eraging functional annotations and computational 
methods for predicting the consequences of specific 
rare variants can be highly advantageous in the iden-
tification of disease-predisposing variants, at least for 
rare monogenic conditions. Functional annotations 
for rare CNVs and other forms of structural variation 
can also be leveraged in collapsed or groupwise anal-
yses. However, many of these forms of variation are 
thought to exert or manifest their effects throughout 
the genome and not necessarily as a group of variants 
in a single region of the genome. Thus, pathway-based 
(BOX 2) and other higher-order approaches to collaps-
ing or summarizing rare CNV effects have been pro-
posed, especially in the context of neuropsychiatric 
diseases3,37.
Specific analysis models
There are several statistical analysis strategies that can 
be used to test the hypothesis that specific collections 
of rare variants are associated with a particular trait 
or disease. Some of these methods have been devel-
oped in contexts beyond human association studies, 
such as for assessing genetic differentiation between 
human geo-ethnic groups or pathogen sequences. In 
addition, some methods are more or less agnostic to 
variant frequencies. To facilitate their descriptions, we 
have grouped various methods together in three broad 
and somewhat arbitrary categories: tests based on the 
use of group summary information on variant frequen-
cies compared between, for example, case and control 
groups; tests based on the similarity or diversity of 
unique DNA sequences possessed by different indi-
viduals; and regression models that consider collapsed 
sets of variants and other factors as predictors of a 
phenotype. We consider each of these three categories 
separately below, although TABLE 3 provides brief sum-
maries of representative methods from each category. 
Each of the methods discussed can leverage functional 
annotations to define collapsed variant sets or can be 
used in a moving window setting (BOX 2).
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Figure 2 | Scenarios in which DNA sequence variants distinguish c ses a d controls. 
The blue lines indicate genomic regions; red boxes indicate var ants. a | Variants at a 
single locus with common alleles are more frequent in cas s then controls. b | Mu tiple
rare variations contribute to the phenotype such that th collective frequency of 
these variations is greater in cases. This would create a gr ate  diver ity of haplotypes 
or DNA sequences among the cases. c | Multiple rare variations contribute t  the 
phenotype but act in a synergistic fashion, such that cas s are likely to have mor  
similar DNA sequences compared to controls. d | Multiple rare variations ontribute 
to a phenotype but the variations contributing to the phenotype reside in specific 
genomic regions. This situation would create greater s quen e diversity among he 
cases, as in part b, but only in the relevant genomic region .
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Figure 2 | Scenarios in which DNA sequence variants distinguish cases and controls. 
The blue lines indicate genomic regions; red boxes indicate variants. a | Variants at a 
single locus with common alleles are more frequent in cases then controls. b | Multiple 
rare variations contribute to the phenotype such that the collective frequency of 
these variations is greater in cases. This would create a greater diversity of haplotypes 
or DNA sequences among the cases. c | Multiple rare variations contribute to the 
phenotype but act in a synergistic fashion, such that cases are likely to have more 
similar DNA sequences compared to controls. d | Multiple rare variations contribute 
to a phenotype but the variations contributing to the phenotype reside in specific 
genomic regions. This situation would create reater sequ nce diversity among the 
cases, as in part b, but only in the relevant genomic regions.
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there are many of them, the percentage of individuals 
possessing any one of the variants could reach 100%. 
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can also be leveraged in collapsed or groupwise anal-
yses. However, many of these forms of variation are 
thought to exert or manifest their effects throughout 
the genome and not necessarily as a group of variants 
in a single region of the genome. Thus, pathway-based 
(BOX 2) and other higher-order approaches to collaps-
ing or summarizing rare CNV effects have been pro-
posed, especially in the context of neuropsychiatric 
diseases3,37.
Specific analysis models
There are several statistical analysis strategies that can 
be used to test the hypothesis that specific collections 
of rare variants are associated with a particular trait 
or disease. Some of these methods have been devel-
oped in contexts beyond human association studies, 
such as for assessing genetic differentiation between 
human geo-ethnic groups or pathogen sequences. In 
addition, some methods are more or less agnostic to 
variant frequencies. To facilitate their descriptions, we 
have grouped various methods together in three broad 
and somewhat arbitrary categories: tests based on the 
use of group summary information on variant frequen-
cies compared between, for example, case and control 
groups; tests based on the similarity or diversity of 
unique DNA sequences possessed by different indi-
viduals; and regression models that consider collapsed 
sets of variants and other factors as predictors of a 
phenotype. We consider each of these three categories 
separately below, although TABLE 3 provides brief sum-
maries of representative methods from each category. 
Each of the methods discussed can leverage functional 
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used in a moving window setting (BOX 2).
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Adapted from [19], this figure presents 2 examples depicting common (left) nd rare (rig t) g ne ic vari nts
associated with a disease phenotype. Common causative variants will be one or few at most and they will
segregate mostly within the diseased cohort. Rare varia ts will be numerous a d will be m stly unique to
one r a f w pati nts.
as the likely causative v iants associat t ph noty e [12] (Figu e 1.3). Furth rm re, a
computational re-analysis of previous association tudies h nts at the p ssibility that previous
associations f c mmo variants to common phe ot pes were in f ct artificially linked du
to their covariance with underlying causative are variants [20]. This analysis sugge ts that
rare variants are a like y factor to xplain c mmon disease . Ther fore, in order to d ssect
the genetic basis underlying common ph notypes, it fundamentally importa to have the
ability to det ct rare variants.
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Figure 1.3. Rare variants carry a large effect size
family studies, and can be expected to vary across environments.
Narrow-sense heritability estimates in humans can be inflated if
family resemblance is influenced by non-additive genetic effects
(dominance and epistasis, or gene–gene interaction), shared familial
environments, and by correlations or interactions among genotypes
and environment36,37. However, heritabilities estimated from pedi-
gree studies in animals agree well with heritability estimated from
response to artificial selection, suggesting that estimates from family
studies are not necessarily inflated.
Teasing apart the contributions to heritability of environmental
factors shared among relatives will soon be possible because the
availability of genome-wide markers now provides empirical esti-
mates of identity-by-descent (IBD) allele sharing between pairs of rela-
tives. For example, full sibs share on average half their genetic com-
plement, but this proportion can vary—in one large study it ranged
from 0.37 to 0.62 (ref. 38). By relating phenotypic differences to the
observed IBD sharing fraction among sib pairs, marker data were used
to generate a heritability estimate of 0.8 for height38. This is remarkably
consistent with estimates using traditional methods but free of their
assumptions, suggesting that for height at least, heritability is not over-
estimated. Applying such estimation to distantly related or ‘unrelated’
individuals is now feasible using dense genomic scans39; given the num-
berof peoplewithdensegenotypingdata,heritability estimates couldbe
generated for a wide variety of traits free of potential confounding by
unmeasured shared environment.
Improving estimates of all contributors to heritability will facilitate
determination of the proportion of genetic variance that has been
explained. Despite imprecision in current estimates, it may still be
possible to know that ‘all the heritability’ has been explained by pre-
dicting phenotypes in a new set of individuals from trait-associated
markers, and correlating the predicted phenotypes with the actual
values. If the markers truly explain all the additive genetic variance,
the squared correlation between predicted and actual phenotype will
be equal to the heritability40. Population-based heritability estimates
thus provide a valuable metric for completeness of available genetic
risk information, but individualized disease prevention and treatment
will ultimately require identifying the variants accounting for risk in a
given individual rather than on a population basis.
Rare variants and unexplained heritability
Much of the speculation about missing heritability from GWAS has
focused on the possible contribution of variants of low minor allele
frequency (MAF), defined here as roughly 0.5%,MAF, 5%, or of
rare variants (MAF, 0.5%). Such variants are not sufficiently fre-
quent to be captured by current GWA genotyping arrays14,41, nor do
they carry sufficiently large effect sizes to be detected by classical
linkage analysis in family studies (Fig. 1). Once MAF falls below
0.5%, detection of associations becomes unlikely unless effect sizes
are very large, as in monogenic conditions. For modest effect sizes,
association testingmay require composite tests of overall ‘mutational
load’, comparing frequencies of mutations of potentially similar
functional effect in cases and controls.
Low frequency variants could have substantial effect sizes (increas-
ing disease risk two- to threefold) without demonstrating clear
Mendelian segregation, and could contribute substantially to missing
heritability42. For example, 20 variants with risk allele frequency of 1%
and allelic odds ratio (or probability of an event occurring divided by
the probability of it not occurring, compared in people with versus
without the risk allele) of three would account for most familial
aggregation of type 2 diabetes. There are relatively few examples of
such variants contributing to complex traits, possibly owing to insuf-
ficiently large sample sizes or insufficiently comprehensive arrays.
The primary technology for the detection of rare SNPs is sequen-
cing, which may target regions of interest, or may examine the whole
genome. ‘Next-generation’ sequencing technologies, which process
millions of sequence reads in parallel, provide monumental increases
in speed and volume of generated data free of the cloning biases and
arduous sample preparation characteristic of capillary sequencing43.
Detection of associations with low frequency and rare variants will be
facilitated by the comprehensive catalogue of variants with
MAF$ 1% being generated by the 1,000 Genomes Project (http://
www.1000genomes.org/page.php), which will also identify many
variants at lower allele frequencies. The pilot effort of that program
has already identifiedmore than 11million new SNPs in initially low-
depth coverage of 172 individuals44.
Current mechanisms for using sequencing to identify rare variants
underlying or co-located with GWA-defined associations include
sequencing in genomic regions defined by strong and repeatedly repli-
cated associations with common variants, and sequencing a larger frac-
tion of the genome in people with extreme phenotypes. In the absence
of GWA-defined signals, sequencing candidate genes in subjects at the
extremes of a quantitative trait (such as lipid levels or the age at onset),
can identify other associated variants, both common and rare45,46. An
important finding from these studies is thatmuch of the information is
providedbypeople at the extremesof trait distributions,who seemtobe
more likely to carry loss-of-function alleles47.
Sample sizes used for the initial identification of DNA sequence
variants have generally been modest, and sample size requirements
increase essentially linearly with 1/MAF. Much larger samples are
needed for the identification of associations with variants than those
needed for the detection of the variants themselves. They also scale
roughly linearly with 1/MAF given a fixed odds ratio and fixed degree
of linkage disequilibrium with genotyped markers. Sample size for
association detection also scales approximately quadratically with
1/j(OR2 1)j, and thus increases sharply as the odds ratio (OR)
declines. Sample size is even more strongly affected by small odds
ratios than by small MAF, so low frequency and rare variants will
need to have higher odds ratios to be detected.
Complicating matters further, numerous rare variants may be
detected in a gene or region but they may have disparate effects on
phenotype. Common variants have typically been analysed individu-
ally23,48, but with one or two carriers of each rare variant, pooling
them using specific criteria becomes attractive47,49,50. Pooling variants
of similar class increases the effectiveMAFof the class and reduces the
number of tests performed, but raises several other questions (Box 1).
Determining which of the multitude of variants carried by an
individual are responsible for a given phenotype represents a massive
task, especially if the causal alleles are relatively anonymous in terms
of known functional consequences. Because only a small proportion
will have obvious functional consequences for the resultant protein,
lesser evidence of association may suffice to implicate variants of this
sort. The best approaches for combining functional credibility and



































Figure 1 | Feasibility of identifying genetic variants by risk allele frequency
and strength of genetic effect (odds ratio). Most emphasis and interest lies
in identifying associations with characteristics shownwithin diagonal dotted
lines. Adapted from ref. 42.
NATUREjVol 461j8 October 2009 REVIEWS
749
 Macmillan Publishers Limited. All rights reserved©2009
Adapted from [12], this figure shows the value of sequencing cost per genome (left) and per base pair (right)
over time compared to the expected trend predicted by Moore’s Law.
1.1.3 The sequencing revolutio
A fundamental problem in rare variants genetics simply lies in the ability to detect them
in the first place. As rare variants occur at a frequency ower than 1%, large cohorts of
individuals have to be genotyped to detect such variants with adequate statistical power
simply due to sampling limitations. For instance, to detect a given mutation occurring at
a frequency of 1 in a 1000 in he population with a probability of 96% (i.e. to be able
to find 96% of all mutations at such frequency), it is necessary to profile 5000 patients
6
(computed directly as a result of binomial sampling). Because of this reason, the costs and
time-commitment associated with traditional genotyping strategies such a large cohort of
patients would be astronomical, making this process unfeasible. Therefore, in order to find
rare variants associated to disease, a new methodology had to be devised.
One of the largest scientific endeavors over the last 15 years was undoubtely the sequenc-
ing of the first human genome [21]. This effort was completed in 2001 and involved multiple
institutions for a cumulative costs of $100,000,000 and 10 years of time commitment. The
technology adopted by the National Human Genome Research Institute [21] and its cor-
porate competitor Celera Genomics [22] relied in both cases on ”SANGER sequencing”, a
traditional method of sequencing involving fluorescently labeled dye terminators [23]. This
method presents a major limitation, that is it can sequence only one molecular species at
a time, limiting the applicability of sequencing to small scale projects. Most of the cost
and time spent on the human genome sequencing project are a direct consequence of this
limitation.
From the late 90s to the early 2000s a series of technological advancements led to the de-
velopment of new sequencing platforms that would allow the parallel sequencing of millions
of DNA molecules at the same time [24, 25, 26, 27]. The whole range of new sequencing
technologies has been conventionally grouped under the name of ”next-generation” sequenc-
ing. These new platforms can resolve individual sequences from heterogeneous mixtures of
DNA molecules and as a result, bypass the limitations imposed by SANGER, paving the
way for a subsequent sequencing revolution. In the field of computer hardware and electri-
7
cal engineering, the Moore’s Law is often used as a reference for the rate of technological
advancement, representing the doubling rate of transistors on an integrated board [28]. As
a direct result of next-generation sequencing platforms, the cost of sequencing dropped over
time at a much faster rate predicted by Moore’s Law (Figure 1.4). At the time of writing of
this thesis, the cost of sequencing a whole human genome is already 4 orders of magnitude
lower than 2001.
Figure 1.4. Cost of DNA sequencing is dropping at a faster rate than predicted
by Moore’s Law
Adapted from http://www.genome.gov/sequencingcosts/, this figure shows the value of sequencing cost
per genome (left) and per base pair (right) over time compared to the expected trend predicted by Moore’s
Law. Note the drop in 2007 with the introduction of next-generation sequencing.
The unprecedented power of next generation sequencing offers the promise of revolu-
tionizing not just genetics but also general molecular biology research with numerous and
unexpected applications [29]. As the first part of my graduate research, I developed an ex-
8
perimentally integrated computational framework for accurately detecting rare-variants in
a cost-effective manner by leveraging the power of next-generation sequencing. This work
started as a collaboration with Todd Druley, MD-PhD who lead the initial project and it is
described in the second chapter of my dissertation.
9
1.2 When genetics fall short: epigenetic drivers of phenotype
1.2.1 Genetic factors are not sufficient to explain phenotypic variation
The promise of genetics fulfilled by the power of next-generation sequencing has indeed
the potential of revolutionizing biology and medicine by revealing the past, present, and
future of any individual from the information encoded in their genome. Or does it?
At this point in time, as we transition from the dawn of the sequencing revolution into the
world of genomic medicine, we have yet to acquire both the necessary power and knowledge to
interpret the impact of genomic variants to any relevant phenotype. A pioneering study [30]
answers this question by adopting a clever strategy to bypass our technical and theoretical
shortcomings. In this study, the authors analyzed a large cohort of monozygotic twin pairs
and looked at the incidence of a variety of different diseases within each pair.
Even by accounting for the presence of somatic mutations in the twins (genetic alter-
ations acquired in single cells within a single individual after conception [31]), it is very
safe to assume that any twin within each pair is genetically identical to their sibling. This
assumption serves as the fundamental premise for this study: if a particular disease could
be completely explained through genetics, we would expect every pair to be concordant for
that disease, i.e. if a twin developed a particular disease, their sibling would also have the
same disease, and the other way around. Following this reasoning, we can use the number
of discordant pairs to estimate what fraction of the incidence of a particular disease can be
explained solely through genetics and, most importantly, how much predictive power whole-
10
genome sequencing provides in the ideal scenario where every causative variant has been
identified and assigned to its biological function.
Despite the promise of this study, its conclusions suggested a scenario far from ideal.
Using a permissive statistical threshold that ensured at least 10% of the individuals diagnosed
as positive would effectively have the disease, the authors found that most of the patients
affected by the disease (> 50%) would have been completely disregarded as false negatives
(see Figure 1.5).
Furthermore, individuals predicted to be healthy by whole-genome sequencing (i.e. not to
have a particular disease) only carried a small reduction in relative risk of disease incidence
(see Figure 1.6) compared to the general population (with a few notable exceptions). This
suggests that even a negative result from genomic sequencing would not substantially improve
the odds of remaining healthy for most of the diseases profiled in the study.
These results indicate that even in an idealized scenario where practical and theoreti-
cal limitations are absent, whole-genome sequencing would provide only limited predictive
power restricted to a selected set of diseases. From this we can conclude that, while genetic
information is indeed important and necessary to understand and predict phenotype, it is
clearly not sufficient to do so, leaving room for other factors to come into play.
1.2.2 Epigenetic factors control phenotypes and cell-fate decisions
A second important group of factors crucial for phenotypic specification is given by
”epigenetic” factors. The adjective epigenetic has been used in different ways over the years
11
Figure 1.5. Sensitivity of whole-genome sequencing in predicting disease
We assumed that the risk alleles for these 24 diseases were independent
in these estimates; if they were not independent, then these figures rep-
resent overestimates. On the other hand, these frequencies may repre-
sent underestimates because there are a number of additional diseases
with hereditary components that have not yet been studied in mono-
zygotic twins or included in our analyses. At the very least, if we consider
only distinct disease categories whose pathogenesis is unlikely to be
shared, our analyses suggest that, in the best-case scenario, most of
the tested individuals might be alerted to a clinically meaningful risk
by whole-genome sequencing.
It was of interest to determine how the results described above var-
ied with the threshold chosen for the analysis. For example, it might
be argued that a threshold of 10% was too low for true clinical utility.
Our analyses show that the maximum fraction of affected cases testing
positive, as well as the maximum fraction of the total population that
tests positive, is not changed much when the thresholds are changed
to 20% (tables S4 and S5). With very high thresholds, however, both
these measures of sensitivity decrease significantly (tables S4 and S5).
Moreover, the maximum predictive value of a negative test drops pre-



























































































































































































































Fig. 1. The fraction of cases (that is, patients with disease) who would test positive by whole-genome sequencing. For each disease, the maximum


























































































































































































































Fig. 2. Percentage of individuals in the general population who would test positive by whole-genome sequencing. For each disease, the maximum
and minimum fraction of individuals in the population that would test positive using the thresholds defined in table S1 are plotted.
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Adapted from [30], this figure shows the sensitivity of whole-genome sequencing in correctly identifying
individuals affected by disease. For each disease, the expected maximum and minimum fraction of positive
cases are presented on the y-axis as function of the statistical threshold chosen in the study. A sensitivity
value of 100% indicates correct identification of every individual affected by the disease, whereas a sensitivity
value of 0% indicates complete failure in identifying any individual affected by the disease.
to indic te differe t e tit es and mechanisms linked by a common theme, which lies in their
non-genetic nature. The original definition of an epigenetic change states that such change
”...does not involve a mutation, but that is nevertheless inherited in the absence of the
signal (or event) that initiated the change” [32]. Epigenetic factors are important because
they integrate information from the external environment, which act as an initiating trigger,
and then maintain it over time. This process eventually translates into a phenotype.
12
Figure 1.6. Relative risk of disease in individuals testing negative by whole-
genome sequencing
DISCUSSION
The general public does not appear to be aware that, despite their very
similar height and appearance, monozygotic twins in general do not
always develop or die from the same maladies (35, 36). This basic ob-
servation, that monozygotic twins of a pair are not always afflicted by
the same maladies, combined with extensive epidemiologic studies of
twins and statistical modeling, allows us to estimate upper and lower
bounds of the predictive value of whole-genome sequencing.
On the negative side, our results show that most of the tested in-
dividuals would receive negative tests for most diseases (Fig. 2). More-
over, the predictive value of these negative tests would generally be
small, because the total risk for acquiring the disease in an individual
testing negative would be similar to that of the general population
(Fig. 3). On the positive side, our results show that, at least in the best-case
scenario, most of the patients might be alerted to a clinicallymeaning-
ful risk for at least one disease through whole-genome sequencing.
These conclusions should be compared to other models as well as
current knowledge about risk allele loci from GWAS (5–7, 37–39, and
references therein). In general, GWAS have shown that many loci can
predispose to disease and that each risk allele confers a relatively small
effect (38, 39). For example, a recent analysis of large cohorts of indi-
viduals with colorectal cancer showed that only ~1.3% of phenotypic
variance could be accounted for by the 10 loci discovered through
GWAS (40). However, it could be argued that the relatively low level
of utility that might be inferred from such studies is misleading. In
particular, it is possible that a more complete knowledge of disease-
associated variants and their epistatic relationships would be able to
reliably predict who will and who will not develop disease in the gen-
eral population. Modeling allows estimation of the maximum possible
information that could be derived from such tests.
Several of our conclusions are based on the genometype frequency
and risk distributions that would maximize the clinical utility of ge-
netic testing, that is, are best-case scenarios. The actual frequency and
risk distributions of genometypes in the population are not likely to be
distributed in this way. Indeed, other distributions are also consistent
with the monozygotic twin data on which our maxima are determined
and all other distributions yield less clinical utility than those of the
maxima. Moreover, in the real world, it is unlikely that the biomedical
correlates of every genetic variant and the epistatic relationships among
these variants will ever be completely known, or that the analytic valid-
ity of genetic testing will be perfect—as we assume in our ideal scenario.
Thus, our conclusions purposely overestimate the value of whole-
genome sequencing that will be achieved—they represent an absolute
upper bound that cannot be improved by improvements in technol-
ogy or genetic knowledge. As a practical example of this principle, we
estimate that a negative whole-genome sequencing–based test could
indicate a nearly twofold decrease in risk for prostate cancer in men
and a similar twofold decrease for urinary incontinence in women.
But this twofold decrease would only apply in a world in which the
risk alleles are distributed in a fashion that maximizes the sensitivity of
whole-genome testing (Fig. 3). In the real world, the risk alleles are not
likely to be distributed in this ideal fashion, and omniscience about
every variant is not likely to be realized. Thus, the risk of these diseases
in patients who test negative will likely be even more similar to that of
the general population. For diseases with a lower heritable component,
such as most forms of cancer, whole genome–based genetic tests will
be even less informative. Thus, our results suggest that genetic testing,
at its best, will not be the dominant determinant of patient care and
will not be a substitute for preventative medicine strategies incorporat-
ing routine checkups and risk management based on the history, phys-
ical status, and life-style of the patient.
It is important to point out that our study focused on testing rel-
atively common diseases in the general population and did not ad-
dress the use of whole-genome sequencing to identify the genetic basis



























































































































































































































Fig. 3. Relative risk of disease in individuals testing negative by whole-genome sequencing. A relative risk of 100% represents the same risk as the general
population, that is, the cohort risk. Relative risks were calculated using the genometype frequencies and genometype genetic risks that maximized or mini-
mized sensitivity for disease detection.
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Adapted from [30], this figure shows the relative risk of developing a particular disease given a negative
result by genetic testing. For each disease, the expected maximum and minimum relative risks are present d
on the y-axis as a function of the statistical threshold chosen in this study. A relative risk value of 100%
represents the same risk of developing the disease as the general population, whereas a relative risk of 0%
i dicates that the individuals in the group will not develop the disease.
One of the first observ d ex mples f an epigene ic switch consists in the regulatory
network controlling the fate of the phage λ [33]. A bacteriophage or phage is a virus that
inf cts acteri l cells. λ is a phage that infects t e bacterial species E.coli by bin ing through
the lamB or mannose receptor present on the surface of E.coli [34] and subsequently injecting
its own DNA inside the bacterial cytosol (see Figure 1.7). Once inside E.coli, λ can then
13
undergo two distinct fate decisions. In one case λ replicates itself and produces all the viral
proteins necessary for the assembly of new viral particles causing the infected E.coli cell to
undergo lysis and eventually release the new particles outside. This particular fate decision
is called ”lytic cycle”. In a second alternative scenario, the λ genome previously existing as
a separate molecule in the cytosol integrates itself into the bacterial host genome and lies
dormant. This second fate decision is called ”lysogenic cycle” (see Figure 1.7).
The choice of λ to initiate one decision over the other is controlled by a regulatory network
involving the expression and interaction of different viral proteins with the λ genome [33, 35].
The viral protein CII is the focal point of the epigenetic switch. CII is a ”transcription
factor” (TF), a DNA-binding protein that can activate or repress the expression of a target
gene by binding to its regulatory signals located upstream of the ”transcriptional start site”
(TSS) of said gene [4, 36]. The levels of CII control the switch: CII is degraded by the
activity of host proteases expressed by E.coli. When E.coli is in ideal growth conditions it
will express high levels of proteases leading to the elimination of CII from the cell. In this
scenario a TF named Cro will be expressed inducing the transcriptional program leading to
the lytic cycle.
In contrast, when E.coli is for instance ”starved” and its growth conditions are not
optimal, its proteases will be down-regulated, leading to increased levels of CII. In this
scenario CII will promote the expression of CI, another TF which will induce lysogenesis.
As depicted in Figure 1.7, the two programs are reinforced by the fact that they are mutually
14
exclusive (as one program represses the other) indicating that once the switch is activated,
a memory of the current state is then established.
Figure 1.7. Phage λ fate decision: a model for epigenetics
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Computational studies of biological networks can help to identify
components and wirings responsible for observed phenotypes.
However, studying stochastic networks controllingmany biological
processes is challenging. Similar to Schrödinger’s equation in quan-
tum mechanics, the chemical master equation (CME) provides a
basic framework for understanding stochastic networks. However,
except for simple problems, the CME cannot be solved analytically.
Here we use a method called discrete chemical master equation
(dCME) to compute directly the full steady-state probability land-
scape of the lysogenymaintenance network in phage lambda from
its CME. Results show that wild-type phage lambda can maintain a
constant level of repressor over a wide range of repressor degrada-
tion rate and is stable against UV irradiation, ensuring heritability
of the lysogenic state. Furthermore, it can switch efficiently to the
lytic state once repressor degradation increases past a high thresh-
old by a small amount. We find that beyond bistability and non-
linear dimerization, cooperativity between repressors bound to
OR1 and OR2 is required for stable and heritable epigenetic state
of lysogeny that can switch efficiently. Mutants of phage lambda
lack stability and do not possess a high threshold. Instead, they
are leaky and respond to gradual changes in degradation rate.
Our computation faithfully reproduces the hair triggers for UV-
induced lysis observed in mutants and the limitation in robustness
against mutations. The landscape approach computed from dCME
is general and can be applied to study broad issues in systems
biology.
bistable switch ∣ discrete chemical master equation ∣ epigenetic control ∣
stochasticity ∣ stochastic switch
Bacteriophage lambda is a virus that infects Escherichia colicells. It has served as a model system for studying regulatory
networks and for engineering gene circuits (1–5). Of central
importance is the molecular circuitry that controls phage lambda
to choose between two productive modes of development,
namely, the lysogenic state and the lytic state (Fig 1A). In the
lysogenic state, phage lambda represses its developmental func-
tion, integrates its DNA into the chromosome of the host E. coli
bacterium, and is replicated in cell cycles for potentially many
generations. When threatening DNA damage occurs, phage
lambda switches from the epigenetic state of lysogeny to the lytic
state and undergoes massive replications in a single cell cycle,
releases 50–100 progeny phages upon lysis of the E. coli cell. This
switching process is called prophage induction (5).
The molecular network that controls the choice between these
two different physiological states has been studied extensively
during the past 40 y (5–9). All of the major molecular compo-
nents of the network have been identified, binding constants
and reaction rates characterized, and there is a good experimen-
tal understanding of the general mechanism of the molecular
switch (5). Theoretical studies have also contributed to the illu-
mination of the central role of stochasticity (3) and the stability of
lysogen against spontaneous switching (4, 10). With the advent of
systems biology, studying the switching network of phage lambda
and lysogeny maintenance has gained added importance, because
it provides an ideal ground for developing models and algorithms
to study regulatory networks.
However, a general bottleneck problem for computational stu-
dies of regulatory networks is the limitation of existing techniques
for studying stochastic networks. Because reactions often involve
only low copy numbers of molecules and have large separations in
timescale, stochasticity has a strong influence on the behavior of
molecular networks (3, 4, 10). Deterministic models based on the
principles of mass action are often incapable of capturing the
multistable nature of the network when copy numbers are small
(11). Although the theory of the chemical master equation
(CME) provides a general framework for studying stochastic
networks (12, 13), there are no analytical solutions to the CME
except for simple toy problems (14).
One approach is to approximate the CME through various
formulations of stochastic differential equations, including the
Langevin and the Fokker–Planck formulation (12). However,
the consequences of such approximations for realistic problems
involving many molecular species and complex reactions are
unknown. Another approach is to carry out extensive stochastic
simulations. Powerful simulation tools, including the Gillespie
algorithm, have been developed (13, 15). With this approach,
many trajectories of simulated reaction events are followed,
Fig. 1. Different selection of cell fate of E. coli infected by phage lambda
and a model of the epigenetic circuit for lysogeny maintenance. (A) The
lysogenic and lytic states of phage lambda. (B) A simplified model of the
epigenetic switch for lysogeny maintenance.
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Adapted from [35], the upper part of this figure shows the life cycle of phage λ and its two fate decisions
(lytic or lysogenic) reg lated by the levels of the viral protein CII. The lower part of this figure shows a
model for the gene regulatory network of λ underlying its fate decision.
This example demonstrates how a simple regulatory circuit can control the fate of a virus
and maximize its fitness. In this case phenotypic variation (namely the pathway chosen by
λ) is drive solely by an epigenetic switch. Despite the fact that the switch itself is encoded
in the DNA, the states of the switch are not as the lytic and lysogenic viral particles are
genetically identical.
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1.2.3 Role of epigenetic factors in development and cancer
A typical and important scenario in which the establishment of radically distinct pheno-
types is observed within a clonal population can be found during the process of development
[5], where a complete organism is generated from a single cell. During the first phases of
development, a ”zygote”, the first cell resulting from fertilization of the oocyte by a single
sperm cell, gives rise to a cellular structure named the ”blastocyst”, whose inner cell mass
(ICM) consists of ”embryonic stem cells”, cells that have the potential to generate every cell
type in the adult organism. During the process of ”gastrulation”, the cells in the embryo
rearrange themselves forming three ”germ layers”, each layer carrying the capacity of gen-
erating different cell types [5]. This process becomes intrinsically more specialized, as with
each step, each intermediate cell type acquires specific functions and loses ”potency”, the
ability to differentiate into different cell types. This phenomenon has been termed ”epige-
netic landscape” by Conrad Hal Waddington [37] (Figure 1.8). This process is epigenetic
because every cell in the embryo is genetically identical and every step is associated to a
memory state. Because of this memory state, cells do move backward in development, i.e.
de-differentiate into more potent cell types.
An additional prominent example of the role of epigenetic switches can be found in
pathology, specifically in the context of cancer [38]. Using isogenic cancer cell-lines as a
model of cancer (therefore maintaining a uniform genetic background), the authors behind
this study found that the process of transformation, that is the set of phenotypic changes
that distinguish a physiologically normal cell from a tumorigenic one, was triggered by an
16
Figure 1.8. Waddington’s epigenetic landscape
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Historically, the word “epigenetics” 
was used to describe events that could 
not be explained by genetic principles. 
Conrad Waddington (1905–1975), who 
is given credit for coining the term, 
defined epigenetics as “the branch 
of biology which studies the causal 
interactions between genes and their 
products, which bring the phenotype 
into being” (Waddington, 1942). Over 
the years, numerous biological phe-
nomena, some considered bizarre and 
inexplicable, have been lumped into the 
category of epigenetics. These include 
seemingly unrelated processes, such 
as paramutation in maize (an interac-
tion between two alleles in which one 
allele causes heritable changes in the 
other allele); position effect variega-
tion in the fruit fly Drosophila (in which 
the local chromatin environment of 
a gene determines its expression); 
and imprinting of specific 
paternal or maternal loci in 
mammals. Although myster-
ies abound, the field is now 
beginning to uncover com-
mon molecular mechanisms 
underlying epigenetic phe-
nomena. We have recently 
witnessed an explosion of 
research efforts, meetings 
and symposia, international 
initiatives, internet resources, 
commercial enterprises, and 
even a recent textbook dedi-
cated to epigenetics, all of 
which lead us to this year’s 
special review issue in Cell. 
What underlies this swell 
of interest in epigenetics? 
Whether it is the enigma of 
epigenetic processes or their 
fundamental importance in 
myriad biological contexts, one thing is 
clear—the field of epigenetics is gain-
ing respect.
Epigenetics, in a broad sense, is a 
bridge between genotype and pheno-
type—a phenomenon that changes the 
final outcome of a locus or chromo-
some without changing the underly-
ing DNA sequence. For example, even 
though the vast majority of cells in a 
multicellular organism share an identi-
cal genotype, organismal development 
generates a diversity of cell types with 
disparate, yet stable, profiles of gene 
expression and distinct cellular func-
tions. Thus, cellular differentiation may 
be considered an epigenetic phenom-
enon, largely governed by changes in 
what Waddington described as the 
“epigenetic landscape” rather than 
alterations in genetic inheritance (Wad-
dington, 1957; Figure 1). More spe-
cifically, epigenetics may be defined 
as the study of any potentially stable 
and, ideally, heritable change in gene 
expression or cellular phenotype that 
occurs without changes in Watson-
Crick base-pairing of DNA.
Here, we aim to briefly introduce 
some of the core molecular actors 
that play upon the epigenetic stage 
and touch upon concepts of epige-
netic heritability and stability. Despite 
the field’s recent progress, significant 
and fundamental questions remain to 
be answered, many of which center on 
the propagation of epigenetic informa-
tion through cellular division and differ-
entiation. We highlight some of these 
questions as challenges to the emerg-
ing field. We also refer readers to the 
review articles appearing in this special 
issue, as well as a new textbook enti-
tled Epigenetics (Allis et al., 2007; see 
Book Review by Y. Shi, page 
639 of this issue).
Epigenetic Mechanisms  
at Work
Much of today’s epigenetic 
research is converging on 
the study of covalent and 
noncovalent modifications 
of DNA and histone proteins 
and the mechanisms by 
which such modifications 
influence overall chromatin 
structure. Chromatin, the 
complex of DNA and its inti-
mately associated proteins, 
provides an attractive can-
didate for shaping the fea-
tures of a cell’s epigenetic 
landscape (see Review by 
B.E. Bernstein et al., page 
669 of this issue). Diverse 
Epigenetics: A Landscape Takes Shape
Aaron D. Goldberg,1 C. David Allis,1,* and Emily Bernstein1,*
1Laboratory of Chromatin Biology, The Rockefeller University, New York, NY 10021, USA
*Correspondence: alliscd@rockefeller.edu (C.D.A.), bernste@rockefeller.edu (E.B.)
DOI 10.1016/j.cell.2007.02.006
Epigenetics has recently evolved from a collection of diverse phenomena to a defined 
and far-reaching field of study. In this Essay, we examine the epistemology of epigenetics, 
provide a brief overview of underlying molecular mechanisms, and suggest future 
 challenges for the field.
Figure 1. Waddington’s Classical Epigenetic Landscape
In 1957, Conrad Waddington proposed the concept of an epigenetic 
landscape to represent the process of cellular decision-making dur-
ing development. At various points in this dynamic visual metaphor, 
the cell (represented by a ball) can take specific permitted trajecto-
ries, leading to different outcomes or cell fates. Figure reprinted from 
Waddington, 1957.
Adapted from [37], the rolling ball indicates the fate of a single cell during the process of differentiation. The
top of the wooden table represents the most potent state in which a cell can be found, whereas the bottom
of the table represents the most differentiated state in which a cell can be found. The process of rolling down
the tabl symbolizes development. The downward steepness of the table is a refl ction of epigenetic emory
that prevents dedifferentiation under physiological conditions.
inflammatory response initiated by the protein. Scr is an oncogenic kinase [39] and it can
trigger inflammation by inactivating the transcription factor NFκB. This process initiates
a self-sustaining positive feedback (Figure 1.9). One of the steps of this feedback loop is
the generation and maintenance of Interleukin-6 (IL-6), a pro-inflammatory molecule that
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induces downstream activation of STAT3, a TF involved in tumorigenesis when constitutively
activated [40]. Finally, the authors show that the key factors mediating the epigenetic switch
are also expressed in clinical samples, suggesting that these findings may extend outside of
the model system that they adopted [38].
Figure 1.9. An epigenetic switch links inflamation to cellular transformation and
cancer
Figure 7. Positive Inflammatory Feedback Loop in Cancer Cells, Xenografts, and Cancer Patients
(A) Colony formation assay in A549 (lung), HepG2 (hepatocellular), MDA-MB-231 (breast), PC3 (prostate), and Caco2 (colon) cancer cell lines treated with 2 mg/ml
Ab-IgG (control), 2 mg/ml Ab-IL6, 80 nM siRNA control, 80 nM siRNA against Lin28B, 100 nMmicroRNA scrambled control, and 100nM let-7 microRNA for 24 hr.
The data are presented as mean ± SD of three independent experiments.
(B) Tumor growth (mean ± SD) of ER-Src cells after intraperitoneal treatment (days 15, 20, 25) with siRNA negative control, siRNA against Lin28B, BAY-117082,
Ab-IgG, and Ab-IL6. Each group consisted of five mice.
(C) Expression levels of Lin28B, let-7 and IL6 from tumors derived from the experiment described above. The data are presented as mean ± SD of three
independent experiments.
702 Cell 139, 693–706, November 13, 2009 ª2009 Elsevier Inc.
Adapted from [38], this scheme illustrates the epigenetic switch that connects inflamation to cancer. Src is
the initiating factor that triggers an inflammatory response mediated by NFκB.
These results shed light on the importance of epigenetics in disease and potentially offer
an explanation as of why the mono-zygotic twins in [30] share substantial discordance in
disease incidence.
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1.2.4 Chromatin modifications as novel and controversial epigenetic factors
The examples presented here so far depict the classical interpretation of an epigenetic
switch, namely a self-contained regulatory network where different trans-acting factors in-
teract together forming positive and negative feedback loops resulting in the initiation and
maintenance of a non-genetic memory state. In recent years, the definition of epigenetic
factors has been extended to the context of chromatin biology because of its role in mod-
ulating gene expression in a cell-type specific manner without underlying genetic changes.
Chromatin is defined as the combination of DNA and packaging proteins found in the nu-
cleus [41]. The minimal functional unit of chromatin is dictated by a small protein complex
termed ”nucleosome”, which consists of a 8 monomeric protein units named ”histones” [42].
Nucleosomes have a primary important role in packaging DNA [43] but they also serve as
important regulatory functions [44].
DNA-binding proteins such as transcription factors can modify chromatin by recruiting
catalytic domains that can covalently add or remove modifying groups to the N-terminal
tails of the histones of any given nucleosomes [45]. These groups range from small molecules
such as acetyl (COCH3) and methyl (CH3) groups to small proteins such as the Small
Ubiquitin-like MOdifier or ”SUMO” proteins. These modifications provide the basis for a
”histone code” [46] where single or multiple marks combined together can influence the level
of expression of a genes by facilitating the recruitment of protein complexes necessary for
gene expression.
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The decision of including chromatin marks as epigenetic factors has stirred controversy
among purists in the field [32, 47]. This discontent originated because chromatin marks are
not maintained across cell division due to their intrinsically fast turn-over rate [48, 49]. As
a result, they are believed to reflect transcription factor recruitment, carrying therefore a
transient and dynamic role. This behavior undermines a fundamental point in the classical
definition of epigenetics, namely the presence of a memory state that persists after the
initiating stimulus has disappeared.
1.2.5 DNA methylation is a stable chromatin modification and a classic epige-
netic factor
An important chromatin-associated factor involved in cell differentiation and development
in vertebrates is DNA methylation [50]. DNA methylation consists of the covalent addition
of a methyl group (CH3) to a cytosine nucleotide (Figure 1.10). This reaction is catalized by
a class of enzymes called ”DNA methyl transferases” (DNMTs) [51] (specifically DNMT3a
and b) (Figure 1.10) and occurs primarily (but not exclusively) in cytosines (C) followed by
a guanine (G), forming a CG di-nucleotide. Such di-nucleotide is commonly referred to as a
”CpG” and a methylated cytosine is referred to as a ”5-MethylC” or ”meC” [52].
Unlike chromatin marks, DNA methylation abides to the classic definition of epigenetic
factor as it is maintained without the presence of its initiating stimulus through a clear
molecular mechanism. DNA methylation is bound to be diluted over the course of cell
division. As new DNA is synthesized at the replication fork [53], DNA methylation is
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lost on the nascent strand because of lack of a mechanism by the DNA polymerase to
recognize and add meCs during replication. This phenomenon is biologically important and
is named ”passive demethylation” [53]. DNMT1, a member of the DNMT family of enzymes,
counteracts this problem by binding to hemi-methylated DNA at the replication fork and
subsequently restoring methylation in the newly synthesized strand [53] (Figure 1.10). This
ensures that, once DNA methylation is established in the first place, it is maintained over
the course of cell division, thereby producing an epigenetic memory state.
Figure 1.10. Establishment, maintenance, and removal of DNA methylation
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Although DNA methylation has been viewed as a 
stable epigenetic mark, studies in the past decade have 
revealed that this modification is not as static as once 
thought. In fact, loss of DNA methylation, or DNA 
demethylation, has been observed in specific contexts (see 
below) and can occur through active or passive mecha-
nisms (FIG. 1). Active DNA demethylation is the enzymatic 
process that results in the removal of the methyl group 
from 5-methyl cytosine (5meC) by breaking a carbon–
carbon bond. By contrast, passive DNA demethylation 
refers to the loss of the methyl group from 5meC when 
DNMT1 is inhibited or absent during successive rounds 
of DNA replication. Whereas passive DNA demethyla-
tion is generally understood and accepted, the subject of 
active DNA demethylation has been controversial16.
In this Review, we explore what is known about active 
DNA demethylation and the disputes that are embedded 
in this field. First, we describe the contexts in which 
DNA demethylation has been observed and discuss the 
evidence that supports an active mechanism. We then 
present the many enzymes that have been proposed 
to carry out active DNA demethylation. We conclude 
by discussing emerging themes and highlighting the 
remaining questions in this exciting field.
Evidence for active DNA demethylation
Even though DNA methylation contributes to stable, 
long-term and heritable silencing, it has become appar-
ent that in some instances DNA methylation levels 
can rapidly change by mechanisms involving active 
DNA de methylation. Genome-wide and gene-specific 
demethyl ation events have both been observed, but current 
evidence suggests that the former only occurs at specific 
times during early development, whereas the latter occurs 
in somatic cells responding to specific signals.
Genome-wide DNA demethylation of paternal pronuclei. 
Prior to fertilization, mammalian gametes are at different 
stages of the cell cycle and their genomes are organized 
differently. The egg is meiotically arrested at metaphase II, 
resulting in a diploid genome that is packaged with histones. 
Mature sperm, however, have completed meiosis, but their 
haploid genomes are packaged with protamines instead 
of histones. When a sperm penetrates the zona pellucida 
to fertilize the egg, both gametes undergo rapid changes. 
The egg completes its second meiosis resulting in the 
extrusion of one copy of the genome as the polar body; 
the sperm reorganizes its genomic DNA by replacing 
protamines with histone proteins.
Shortly after the protamine–histone exchange, the 
sperm-derived paternal pronucleus undergoes genome-
wide DNA demethylation17,18, an event that occurs quite 
rapidly within 4–8 hours post-fertilization (FIG. 2a). 
Although there are some disputes regarding the timing 
and synchrony of DNA replication in the zygote19–25, loss 
of DNA methylation is seen before the completion of 
the first cell division. Thus, it is unlikely that a passive 
demethylation mechanism is the cause for this observ-
ation. Furthermore, when zygotes were treated with 
the replication inhibitor aphidicolin, paternal genome 
demethylation was still detected17,26, further supporting 
an active demethylation mechanism.
Paternal genome demethylation has been observed in 
many mammalian organisms, including human, mouse, 
rat, bovine and pig17,18,27,28, but seems to be absent from 
others, such as sheep29. When sheep sperm are injected 
into mouse oocytes, demethylation is seen in the sheep-
derived paternal genome30, suggesting that the demethyl-
ating factor or factors are contributed by the oocyte. 
However, sheep oocytes injected with mouse sperm also 
resulted in demethylation of the mouse-derived paternal 
genome30. Although this occurs to a lesser extent com-
pared to mouse oocytes, it is likely that factors present in 
the sperm or features unique to the paternal genome also 
contribute to demethylation. Consistent with this notion, 
mouse oocytes can demethylate multiple male pronuclei31, 
but are incapable of demethylating the additional maternal 
genome in parthenogenetic, gynogenetic and digynic triploid 
zygotes32.
Although immunostaining studies suggest that 
demethylation occurs globally, bisulphite sequencing indi-
cates that some genomic regions are resistant to such a 
wave of demethylation. These genomic regions include 
imprinting control regions33, intracisternal A-particle 
(IAP) retrotransposons34 and centric and pericentric 
hetero chromatin31,35. It is not clear why these genomic 
Figure 1 | Mechanisms of DNA methylation and demethylation. During early 
development, methylation patterns are initially established by the de novo DNA 
methyltransferases DNMT3A and DNMT3B. When DNA replication and cell division 
occur, these methyl marks are maintained in daughter cells by the maintenance 
methyltransferase, DNMT1, which has a preference for hemi-methylated DNA. If DNMT1 
is inhibited or absent when the cell divides, the newly synthesized strand of DNA will not 
be methylated and successive rounds of cell division will result in passive demethylation. 
By contrast, active demethylation can occur through the enzymatic replacement of 
5-methylcytosine (5meC) with C.
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Adapted from [53], this figure displays establishment of DNA methylation by DNMT3, aintenance of
DNA methylation upon DNA replication mediated by DNMT1, and finally removal by passive (replication
dependent) and active DNA (replication independent) de-methylation.
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As with any other classic epigenetic switch, if an initiating stimulus arises, the positive
feedback can be broken and the switch can be turned. Equivalently DNA methylation can be
actively removed through chemical conversion into hydroxymethylation (CH2OH) followed
by replacement of the meC with an unmethylated C through the ”base-excision repair”
complex [54]. This process is defined as ”active demethylation”.
The function of DNA methylation consists in silencing the expression of nearby genes.
The region controlling the basal expression of a gene is called ”promoter” and it is located up-
stream the TSS of the gene. When the promoter of a particular gene becomes methylated, its
meCs can be recognized and bound by a family of proteins called ”Methyl Binding Proteins”
(MBP) [55]. Upon binding on the meCs, these proteins act as repressors of transcription,
inducing silencing of the expression of the downstream gene. Because DNA methylation is
chemically stable and it is maintained through DNA-replication, its silencing effect is stable
as well, making it a suitable epigenetic switch.
1.2.6 DNA methylation stably represses gene expression in development and
cancer
DNA methylation plays a prominent role in the context of development. Following fertil-
ization, the zygote undergoes a process of complete de-methylation termed ”erasure”, where
the pronuclei originated from the egg and sperm cells lose their methylation patterns, ef-
fectively making tabula rasa of their previous statuses [53] (Figure 1.11). This process is
followed by re-establishment of specific patterns of DNA methylation following implantation
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of the embryo, when the stem cells located in the ICM acquire a ”bimodal” methylation
state [56]. Following this process, DNA methylation mirrors the process of differentiation,
where every cell acquires specific and unique patterns across its genome.
Figure 1.11. Dynamics of DNA methylation during development
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regions are resistant to this wave of DNA demethylation, 
but one possibility is that methylation of these regions 
may be required to ensure transcriptional repression 
and chromosomal stability. Additionally, the maternal 
genome remains methylated during this time even though 
it is exposed to the same cytoplasmic factors. Insight into 
how some regions in the paternal genome are targeted for 
DNA demethylation whereas other regions are resistant 
may also provide clues as to how the maternal genome is 
protected from active demethylation (BOX 1).
The significance of zygotic paternal genome DNA 
demethylation is unclear at present. Genome-wide 
demethylation may facilitate transcriptional activation of 
the paternal genome36, which has been reported to occur 
before transcriptional activation of the maternal genome 
in some species37. Although some transposable elements 
and repeat sequences have been identified to be resistant to 
DNA demethylation, it is likely that others are still targets 
of DNA demethylation, given that these types of sequences 
account for half of the genome. Whether demethylation 
of transposable elements and repeat sequences results in 
their reactivation and, if so, what the significance of their 
reactivation is remains to be determined.
Genome-wide DNA demethylation of primordial germ 
cells. After fertilization, the one-cell zygote undergoes 
several cell divisions that ultimately lead to formation 
of the blastocyst. During this developmental period, the 
maternal genome undergoes passive DNA demethyla-
tion (FIG. 2a) — a gradual loss of DNA methylation occurs 
with each cell division38 in a replication-dependent 
manner39. Consistent with this, maternally contributed 
DNMT1 (also known as DNMT1O) is excluded from the 
nucleus40. Although passive DNA demethylation seems 
to affect a large part of the genome, imprinted genes still 
retain their methylation marks. Recent genetic studies 
indicate that maternal and zygotic DNMT1 (REF. 41) 
and the zinc finger protein ZFP57 (REF. 42) are required 
to maintain the DNA methylation imprints during 
pre-implantation development.
Figure 2 | Dynamics of DNA methylation during development. a | Active demethylation in the zygotic paternal genome. 
Shortly after a sperm fertilizes an egg, the paternal genome rapidly undergoes genome-wide active DNA demethylation 
and remains demethylated following multiple rounds of cell division. During this time, the maternal genome experiences 
gradual, passive demethylation. De novo methylation patterns are established by the DNA methyltransferases DNMT3A  
and DNMT3B during the development of the blastocyst. b | Active demethylation in primordial germ cells (PGCs). After 
implantation of the blastocyst at embryonic day 7.5 (E7.5), the extraembryonic ectoderm (ExE) and visceral endoderm (VE) 
produce signals that specify a subset of epiblast cells (Epi) to become PGCs. This process requires two key transcription 
factors, BLIMP1 (also known as PR domain zinc finger protein 1 (PRDM1)) and PDRM14, which are expressed during this 
stage of development. Following specification, PGC founder cells divide in the presence of the DNA methyltransferase 
DNMT1 and migrate towards the genital ridge. During this migration and on arrival at the genital ridge, 5-methylcytosine 
(5meC) is erased through an active mechanism. ICM, inner cell mass; TE, trophectoderm.
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Adapted from [53], this figure depicts the dynamics of DNA methylation during development. After fertiliza-
tion, DNA methylation ”erasure” of the male and female pronuclei occurs followed by denovo establishment
after implantation.
The silencing effect of DNA methylation plays a fu damental role in establishing the
epigenetic memory necessary f r development that was previously ob rved by Waddington
[37]. A notable example comes from the methylation of the gene Oct4 [57]. Oct4 is a TF
acting at the top of the transcriptional program that defines potency and stem-cell state
of a cell. Because of this reason, Oct4 is often called a ”master regulator” of pluripotency
[58]. Exogenous expression of Oct4 together with 3 other master regulators has been shown
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to dedifferentiate somatic cells back to embryonic stem cells [59]. This result indicates that
stable repression of Oct4 is a necessary epigenetic switch that in physiological conditions pre-
vents de-differentiation. The expression of Oct4 is regulated by cis-acting elements, DNA
sequences that are specifically recognized and bound by TFs [60, 61]. Methylation of these
elements is observed during differentiation and is associated to repression of Oct4 [62]. The
role of DNA methylation in the context of Oct4 is of critical importance in maintaining its
epigenetic memory. Oct4 is methylated by G9a, a histone lysine methyl-transferase that
can bind and recruit DNMT3a and b [63]. When G9a was mutated so that Oct4 would
be repressed but not methylated, it was observed that 15% of the stem-cells that under-
went differentiation could revert back to plurypotency when chemically induced to do so,
whereas cells with an intact copy of G9a fully maintained their differentiated state. Inter-
estingly, when G9a was mutated so that it would methylate Oct4 but not repress it through
chromatin marks, only 1% of the differentiated cells reverted. This finding suggests that
DNA methylation is not only necessary but also sufficient to establish epigenetic memory,
confirming its role as a true epigenetic factor.
The role of DNA methylation as a repressive epigenetic switch has also been widely
appreciated in the context of cancer and tumorigenesis. In fact two major phenomena have
been observed: on a global scale, tumorigenesis is accompanied by a general decrease in
levels of DNA methylation, defined as a state of ”global hypomethylation” [39]. The origin
and consequences of this phenomenon are still poorly understood. In contrast, on a finer
resolution, several genomic regions that are normally un-methylated acquire high levels of
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DNA methylation, or become ”hypermethylated”. These loci tend to be promoter regions
driving the expression of a class of genes called ”tumor suppressors” [39].
Figure 1.12. Abnormal hyper-methylation of tumor suppressor genes in different
types of tumor
Adapted from [39], this figure depicts the distribution of cases where a particular tumor suppressor gene is
found to be hyper-methylated in a particular type of tumor.
Tumor suppressor genes are normally expressed in order to prevent tumorigenesis by
inhibiting cell growth. Their inactivation often leads to development of cancer. In sev-
eral clinical cases, inactivation of such genes is not accompanied by the presence of muta-
tions in their coding or non-coding regions [39], but instead their promoter is found to be
hyper-methylated (Figure 1.12), with methylation leading to their silencing. Consequently,
demethylating agents such as 5-Azacytidine have been used as chemotherapies in differ-
ent types of cancer. In vitro analysis of its mechanism of action have revealed its ability
to specifically de-methylate tumor suppressor genes that were previously hyper-methylated
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and restore their expression [64]. These results indicate that DNA methylation is a major
epigenetic driver of development and differentiation and plays a prominent role in cancer.
1.2.7 How is de novo DNA methylation targeted?
Because DNA methylation plays an important role as an epigenetic factor,a fundamental
question is to understand how its patterns are established in the first place. As mentioned
above, at the implantation phase of embryonic development the cells of the ICM will re-
establish patterns of DNA methylation following erasure [56]. This patterning will be bi-
modal and its specification is determined by occupancy of an activating chromatin mark: the
methylation of the 4th Lysine of Histone 3, also referred to as ”H3K4me”. When H3K4me
is present, DNA methylation will be absent and vice-versa. This is explained by the re-
quirement of DNMT3L, a member of the DNMT family lacking catalytic activity. DNMT3L
binds to nucleosomes and recruits DNMT3a and DNMT3b, which in turn will methylate
the underlying CpGs [56] (Figure 1.13). However, its interaction with the nucleosomes is
inhibited by the presence of H3K4me, leading to the establishment of the bimodal pattern
[65] (Figure 1.13).
This however can only explain bimodal patterning at implantation. In the following
phases of development, the cells in the embryo will become more and more differentiated
acquiring specific and unique patterns of DNA methylation [66]. The underlying mechanism
specifying these pattern is at this stage not completely understood.
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Figure 1 | Establishment of bimodal methylation. Before implantation, most CpGs 
in the embryonic genome are unmethylated (light purple circles), but some regions 
are packaged with nucleosomes containing methylated (Me) lysine 4 of histone H3 
(H3K4), perhaps as a result of RNA polymerase binding. At the time of implantation, 
the methyltransferases DNMT3A and DNMT3B are expressed. DNA methylation 
(dark purple circles) is facilitated by the DNMT3 binding partner, DNMT3L, which 
binds to chromatin by recognizing the K4 residue on histone H3 (REFS. 8,10). If this 
histone moiety is methylated, however, the complex cannot bind and the underlying 
DNA region is thus protected from de novo methylation. This may be one of the 
mechanisms used to generate a bimodal methylation pattern characterized by 
methylation over most of the genome, but not at CpG islands.
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might be directed by the recognition of common cis-
acting sequences located in CpG islands4–6 and mediated 
by active demethylation7.
Recent studies strongly suggest that the establish-
ment of the basic DNA methylation profile during 
early development might be mediated through histone 
modification8 (FIG. 1). According to this model, the pat-
tern of methylation of H3K4 (including mono, di and 
trimethylation, referred to here as H3K4me) across the 
genome might be formed in the embryo before de novo 
DNA methylation. H3K4 methylation might be directed 
by sequence-directed binding of RNA polymerase II, 
which recruits specific H3K4 methyltransferases9. As 
RNA polymerase II is bound mostly to CpG islands 
in the early embryo, only these regions are marked by 
H3K4me, whereas the rest of the genome is packaged 
with nucleosomes containing unmethylated H3K4. 
De novo DNA methylation is carried out by the DNA 
methyltransferase enzymes DNMT3A and DNMT3B 
complexed with DNMT3L8,10, a closely related homo-
logue that lacks methyltransferase activity11. DNMT3L 
recruits the methyltransferases to DNA by binding to 
histone H3 in the nucleosome, but contact between 
DNMT3L and the nucleosome is inhibited by all forms 
of methylation on H3K4 (REF. 8). As a result, de novo 
methylation in the embryo takes place at the majority of 
CpG sites in the genome, but may be prevented at CpG 
islands because of the presence of H3K4me. This model 
is consistent with the finding of a strong anti-correlation 
between DNA methylation and the presence of H3K4me 
in several cell types12–15.
Targeted de novo methylation in early development. 
Once the basal bimodal pattern of DNA methylation 
is established in the embryo at the time of implanta-
tion, this profile becomes subject to additional targeted 
alterations during development, including both de novo 
methylation and demethylation events12,16. A significant 
change that occurs in early development is the targeted 
repression and de novo methylation of genes that are nec-
essary for preserving pluripotency, such as Oct3/4 (also 
known as Pou5f1). This repression occurs at the time 
of gastrulation — when the embryo begins to separate 
into germ layers17 and concomitantly loses the ability to 
maintain a pluripotent state.
Using embryonic stem cells as a model system, it 
has been shown that Oct3/4 undergoes inactivation 
in a multistage process (FIG. 2). In the first stage, tran-
scription seems to be turned off directly through the 
interaction of repressor molecules with the Oct3/4 
promoter18–20. This is followed by transcription factor-
dependent recruitment of a complex that contains the 
histone methyltransferase G9a and enzymes with a his-
tone deacetylase activity. This complex mediates local 
deacetylation of histones — a change that is associated 
with transcriptional repression. Deacetylation resets 
the lysine residues so that G9a can catalyse methyla-
tion of H3K9. This modification enables binding of the 
chromodomain protein heterochromatin protein 1 (HP1), 
which facilitates local formation of heterochromatin (het-
erochromatinization). In the final stage of silencing, the 
G9a-containing complex also recruits DNMT3A and 
DNMT3B, which catalyse de novo DNA methylation 
at the promoter21. This series of steps, mediated by 
the G9a-containing complex, seems to have a central 
role in post-implantation gene inactivation, with many 
other crucial genes (such as Nanog and Dnmt3L) also 
undergoing repression through this pathway22.
A further example of how de novo DNA methyla-
tion might be linked to histone modification in early 
development is the heterochromatinization of pericen-
tromeric satellite repeats. At these satellite sequences, it 
is the SET domain-containing histone methyltransferase 
enzymes SUV39H1 and SUV39H2 that are responsible 
for trimethylating H3K9 and heterochromatinization. 
These proteins are also required to recruit DNMT3A 
and DNMT3B in order to methylate CpG sites in the 
satellite sequences23,24. Interestingly, this heterochro-
matinization process seems to be initiated by a Dicer-
mediated mechanism that recognizes RNA duplexes 
that are naturally formed at satellite sequences. The 
resulting RNA-induced silencing complex (RISC) is then 
specifically targeted back to pericentromeric regions 
where it probably recruits SUV39H1 and SUV39H2, 
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Adapted from [56], this figur shows the molecular m cha ism explain ng the bimodal pattern of DNA
methylation at embryonic implantation. When H3K4me is absent, DNMT3L binds the nucleosome and
recruits DNMT3a and/or DNMT3b leading to establish ent of DNA methylation. When H3K4me is present,
DNMT3L will not bind the nucleosome and consequently DNA methylation will not be established.
However, over the course of the last 20 years, independent studies have highlighted ex-
amples that may shed some light on this problem [67, 68, 69, 70, 71]. The first example
comes from a class of regions present in the genome called ”CpG islands” [72]. CpG islands
are characterized by having an unusually high density of CpGs (>= 65% of observed to
expected ratio) and GC-rich (>= 55%) sequence content [73] compared to the rest of the
genome. CpG islands are found in > 40% of promoter regions in mammals and for the most
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part are largely un-methylated [72, 74]. Furthermore, when a piece of DNA from a CpG
island is isolated and methylated in vitro, it will become de-methylated once reintroduced
in the stem cells [75]. How do CpG islands establish and maintain their un-methylated state
? The answer comes from the binding a single TF called Sp1 [67]. Sp1 binds to a DNA
motif characterized by the canonical recognition site ”GGGCGGGG” [76] which is enriched
in CpG islands. Its binding has been shown to be sufficient to remove DNA methylation
when exogenously introduced inside a genomic region that was already methylated [67]. Fur-
thermore when naturally occuring sites recognized by Sp1 are mutated, the nearby regions
acquire DNA methylation, both in CpG islands as well as in dynamically methylated regions
such as the Oct4 promoter [67, 77].
These results suggest a model where DNA methylation is specified by cis-acting elements
located in the promoter sequence and the binding of a trans-acting factor, such as a TF, to
those elements can specify patterns of DNA methylation. An additional set of experiments
was performed later on to dissect the methylation patterns occurring on the genome of a
human pathogen, the ”Epstein-Barr” virus (EBV) [68]. EBV is one of the most common
human viruses, infecting 90% of the population world-wide [78] and is the causative agent of
infectious mononucleosis (source: http://www.cdc.gov/ncidod/diseases/ebv.htm). EBV
can infect different human cell types and can exists in a dormant phase called ”latency” inside
the cell nucleus. In this state, EBV is present in the form of a circular DNA genome, called
”episome” [79]. EBV episomes are maintained and replicated by the host cell machinery and
for all intended purposes, behave as mini-chromosomes. EBV’s replication is controlled by
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a viral protein called EBNA-1 which binds to the latent replication origin oriP located on
the viral episome [80]. Methylation analysis of human cells revealed the EBV episome to be
completely methylated except for the regions of oriP bound by EBNA-1 [68] (Figure 1.14a).
Through genetic manipulation of EBV, it was shown that binding of EBNA-1 was sufficient
and necessary to de-methylate oriP and that its effect was replication dependent [68]. This
mechanism is general and holds true for other protein/DNA interactions independently of the
nature of the protein, pointing to binding alone as a sufficient factor[69, 70, 81]. Furthermore,
the amount of de-methylation induced by protein binding was proportional to its affinity to
its cis-acting sequence and its concentration [69, 81] (Figure 1.14b,c).
The data presented so far points to a model where 1) deposition of DNA methylation is
a default non-specific event that occurs everywhere and 2) patterns of DNA methylation are
specified only by either blocking or removing DNA methylation. This model is however con-
tradicted by experimental evidence where DNA methylation is on the other hand established
by protein/DNA interactions [63, 71, 82]. An early example comes again from Oct4, which
acquires methylation during differentiation [62, 63, 82]. As mentioned above, the case of Oct4
DNA methylation is not the default state but instead it results from binding of G9a and its
direct recruitment of DNMT3a and b [63, 82]. A second example comes again from cancer,
specifically from the hyper-methylation of p15, a tumor suppressor gene [71]. It was shown
that the aberrant methylation of p15 was caused by ZNF217, a TF that can bind to the p15
promoter. By inhibiting ZNF217 the methylation of p15 is lost [71] (Figure 1.15a), pointing
ZNF217 as necessary driver of DNA methylation. Similarly to the Oct4 promoter, ZNF217
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Figure 1.14. Protein binding to DNA removes DNA methylation
average 95% lower in cell types with coinciding methylation versus
cell types lacking coinciding methylation (Supplementary Fig. 11c).
Fully 40% of variable methylation was associated with a concomitant
effect on accessibility.
The role of DNA methylation in causation of gene silencing is
presently unclear. Does methylation reduce chromatin accessibility
by evicting transcription factors? Or does DNAmethylation passively
‘fill in’ the voids left by vacating transcription factors? Transcription
factor expression is closely linked with the occupancy of its binding
sites26. If the former of the two above hypotheses is correct, methyla-
tion of individual binding site sequences should be independent of
transcription factor gene expression. If the latter, methylation at tran-
scription factor recognition sequences should be negatively correlated
with transcription factor abundance (Fig. 4b).
Comparing transcription factor transcript levels to average
methylation at cognate recognition sites within DHSs revealed sig-
nificant negative correlations between transcription factor expression
and binding site methylation for most (70%) transcription factors
with a significant association (P, 0.05). Representative examples
are shown in Fig. 4c and Supplementary Fig. 12a. These data argue
strongly that methylation patterning paralleling cell-selective chro-
matin accessibility results from passive deposition after the vacation
of transcription factors from regulatory DNA, confirming and
extending other recent reports27.
Interestingly, a small number of factors showed positive correla-
tions between expression and binding site methylation (Supplemen-
tary Fig. 12b), including MYB and LUN-1 (also known as TOPORS).
Both of these transcription factors showed increased transcription
f
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Figure 3 | Identification and directional classification of novel promoters.
a, DNase I (blue) and H3K4me3 (red) tag densities for K562 cells around
annotated TSS ofACTR3B. b, AveragedH3K4me3 tag density (red, right y axis)
and log DNase I tag density (blue, left y axis) across 10,000 randomly selected
GENCODETSSs, oriented 59R39. Each blue and red curve is for a different cell
type, showing invariance of the pattern. c, Relation of 113,615 promoter
predictions to GENCODE annotations, with supporting EST and CAGE
evidence (bar at right). d–f, Examples of novel promoters identified in K562;
red arrow marks predicted TSS and direction of transcription, with CAGE tag
clusters, spliced ESTs and GENCODE annotations above. d, Novel TSS
confirmed by CAGE and ESTs. e, Novel TSS confirmed by CAGE, no ESTs.
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Figure 4 | Chromatin accessibility and DNA methylation patterns.
a, DNase I sensitivity in 10 cell types with ENCODE reduced representation
bisulphite sequencing data. Inset box: accessibility (y axis) decreases
quantitatively as methylation increases. Other DHSs (right) show low
correlation between accessibility and methylation. CpG methylation scale:
green, 0%; yellow, 50%; red, 100%. b, Model of transcription factor (TF)-driven
methylation patterns in which methylation passively mirrors transcription
factor occupancy. c, Relationship between transcription factor transcript levels
and overall methylation at cognate recognition sequences of the same
transcription factors. Lymphoid regulators in B-lymphoblastoid line GM06990
(left) and erythroid regulators in the erythroleukaemia line K562 (right).
Negative correlation indicates that site-specific DNA methylation follows
transcription factor vacation of differentially expressed transcription factors.
RESEARCH ARTICLE
7 8 | N A T U R E | V O L 4 8 9 | 6 S E P T E M B E R 2 0 1 2
Macmillan Publishers Limited. All rights reserved©2012
reversible. This suggests that high-affinity protein binding is
crucial for demethylation site targeting.
The IPTG concentration is inversely proportional to the
lacO demethylation. We were interested in determining if the
amount of IPTG in the cells correlates with demethylation of
the lacO sites. The 293/ElacI cells were treated with a final
concentration of 5 mM IPTG 4 h prior to transfection with
HhaI-methylated pOLucOriP. The transfected cells were
trypsinized and divided among five or six plates as needed at 3
or 4 days after transfection, as the cells first became confluent.
Various amounts of IPTG were added to each plate. The goal
of the first few sets of experiments was to find the lowest
concentration of IPTG that can effectively prevent demethyl-
ation of the lacO sites. Various final concentrations of IPTG
over the range of 5 mM to 5 nM were tested and compared
with no IPTG treatment. A similar fraction of the plasmid
became demethylated with an IPTG concentration between 0
and 100 nM (data not shown). No demethylation of the lacO
sites was detected from the HhaI-methylated plasmid when the
IPTG concentration was above 10 !M (data not shown). It is
clear that 100 nM or less IPTG is not sufficient to block LacI-
specified demethylation while 10 !M IPTG can effectively pre-
vent demethylation of the lacO sites. Six different intermediate
concentrations of IPTG, 0.1, 0.3, 1, 1.75, 3, and 5.5 !M, were
further tested with 0 and 10 !M IPTG as controls for inhibi-
tion of lacO site demethylation. A higher percentage of plas-
mid became demethylated with decreasing concentrations of
IPTG (Fig. 6). This demonstrates that demethylation of the
lacO sites is directly modulated by the concentration of IPTG
and the ability of LacI to bind to the lacO sites.
The amount of LacI protein in the 293/ElacI cells was esti-
mated by Western blotting using a known amount of purified
LacI protein as a comparison. There was approximately 0.3 !g
of LacI in 2 " 106 293/ElacI cells, equivalent to 2.7 " 106
molecules per cell. The minimum concentration of IPTG in the
medium needed to inhibit demethylation entirely was 10 !M,
equivalent to approximately 4 " 107 molecules per nucleus
based on the findings in Wyborski and Short (26). From this,
we can calculate that approximately a 20-fold excess of IPTG
over LacI may be needed to suppress LacI binding to the lacO
sites sufficiently to prevent all demethylation at those sites in
this system.
Transcriptional activi y does not affect the demethylation of
lacO sites. The lacO sites within an SV40 intr are positioned
between the promoter and the luciferase gene on the episome.
Transcription through this region may affect demethylation in
two possible ways that would lead to opposite effects. It is
possible that active transcription can also interfere with main-
tena ce methylation, thereby enhancing demethylation of the
lacO. If this were the case, increased transcriptional activity
should lead to increased demethylation. Alternatively, it is
possible that transcription can displace LacI binding to lacO. If
so, increased transcriptional activity should lead to decreased
demethylation at lacO sites.
We found that only a slightly smaller fraction of the SssI-
methylated plasmid DNA became demethylated compared
with the HhaI-methylated plasmid (as described above), al-
though the luciferase activity of the SssI-methylated plasmid
was more than 100-fold lower than that of its HhaI-methylated
c unterpart (data not shown). This suggests that transcriptio
does not enhance demethyl ion.
To furth r test the p ssible effects transcription on the
demethylation process, plasmids with the same density of
methylation and different transcriptional activity could be
tested. Plasmid pOLucRLTR was used to vary the transcrip-
tional activity by approximately 40-fold and maintain the same
density of methylation. Plasmid pOLuc#LTR was used as
the promoterless comparison. HhaI-methylated pOLuc#LTR,
pOLucRLTR, or pOLucOriP was transfected into 293/EBNA1
and 293/ElacI cells. The luciferase activity and the fraction of
plasmid demethylation were measured 6 or 7 days after trans-
fection and 11 or 12 days after transfection. The luciferase
activity was normalized by the amount of plasmid DNA in the
cells and was standardized against the luciferase activity of
HhaI-methylated pOLucOriP plasmid in 293/EBNA1 cells.
The luciferase expression from HhaI-methylated pOLucOriP
in 293/ElacI cells was at 43% of the expression level of its
counterpart in 293/EBNA1 cells (Fig. 7A). The luciferase ex-
pression from HhaI-methylated pOLuc#LTR, which does not
have a promoter upstream of the luciferase gene, was 1% of
that of the HhaI-methylated pOLucOriP in 293/EBNA1 cells
(Fig. 7A). The luciferase expression from HhaI-methylated
pOLucRLTR, which has the RSV LTR pointed away from the
luciferase gene, was also approximately 1% of the expression
level of the HhaI-methylated pOLucOriP in the 293/EBNA1
cells (Fig. 7A). Levels of expression from HhaI-methylated
pOLuc#LTR and HhaI-methylated pOLucRLTR were similar
in 293/EBNA1 and 293/ElacI cells (Fig. 7A). Southern blot
analysis of HindIII-HhaI-double-digested plasmid DNA har-
vested from 293/ElacI cells showed a similar degree of demeth-
ylation for all three plasmids (Fig. 7B). The fraction of de-
methylated plasmid from each transfection was calculated
based on the radioactivity in the 467- and 338-bp bands as
described above. Despite these dramatic differences in tran-
scriptional activity, there was only a slight decrease in the
fraction of demethylated HhaI-methylated pOLucOriP com-
pared with either HhaI-methylated pOLuc#LTR or HhaI-
methylated pOLucRLTR (Fig. 7C). The plasmid DNA har-
vested 11 or 12 days after transfection showed similar results to
the DNA harvested 6 or 7 days after transfection (Fig. 7C).
Despite the 40-fold difference in transcriptional activity, de-
methylation of lacO sites occurred to similar extents on
these plasmids. This indicates that the level of transcription
through a DNA region does not play a major role in the
demethylation process and that the presence of the pro-
moter does not play a role in demethylation at the lacO
FIG. 6. Modulation of demethylation by the IPTG concentration. The 293/
ElacI cells were treated with a final IPTG concentration of 5 mM for 4 h before
transfection with HhaI-methylated pOLucOriP. The transfected cells were di-
vided among several plates and treated with lower concentrations of IPTG. The
fraction of plasmids becoming demethylated in the lacO sites was analyzed as
described previously. A linear and invers ly correlated relationship between the
IPTG concentration and d methylati n of lacO was observed.
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demethylase and lead to demethylation in these regions. Sec-
ond, the binding of specific proteins to the EBNA-1 binding
sites within these sequences may protect them from remethy-
lation. Third, the involvement of these two regions in the
initiation of replication could make them inaccessible to the
maintenance methylase.
Demethylati n within the oriP region is not due to the DNA
sequence alone. To determine whether the oriP sequence alone
without replication or EBNA-1 binding can lead to demethyl-
ation of this region, plasmid !p291 was methylated with SssI
and then transfected into either 293 or 293/EBNA1 cells for
comparison. Plasmid !p291 will not replicate in 293 cells be-
cause of the absence of EBNA-1, but it will replicate in the
293/EBNA-1 cells. Demethylation of the HpaII sites within the
oriP region did not occur when !p291 DNA was harvested
from 293 cells 3 days after transfection (Fig. 3). This strongly
suggests that the oriP sequence is not targeted by an active
demethylation process without other factors. Demethylation
clearly took place in the 293/EBNA1 cells, where replication
can occur, during the same time interval (Fig. 3). This indicates
th t demethylation in the oriP region do s not occur without
some aspects of the replication process (EBNA-1 binding [6,
15]), bending of the DNA at the origin [6, 15]), and synthesis
of a new DNA strand). Therefore, neither the sequence of oriP
nor any tructural features intrinsic to its repetitive natu e
leads to demethylation.
These three HpaII sites appear to all be demethylated on all
the molecules that become demethylated within the oriP re-
gion. If this were not the case, additional bands at 6.6, 6.3, 2.5,
and 1.2 kb should be detected. The absen e of these fragment
indicates that demethylation of these three sites most probably
occurred at the same time.
Replication alone without EBNA-1 binding does not lead to
demethylation. To examine whether EBNA-1 binding plays a
role in the demethylation in the oriP region, several mutants
with defective EBNA-1 binding sites in the DS region were
used. Of the four EBNA-1 binding sites in the DS region, only
one pair is required for oriP function (11). The mutant plasmid
dpm1 has two point mutations in EBNA-1 binding site 1 in the
DS region, and these mutations greatly reduce the binding of
EBNA-1 to both sites 1 and 2. Plasmid dpm1"2 has two point
mutations i EBNA-1 binding site 2 in addition to dpm1. This
plasmid has been shown to replicate in mammalian cells, while
the EBNA-1 protein binding to sites 1 and 2 of the DS region
is abrogated, as shown in DNase I protection assays (11). Both
plasmids dpm1 and dpm1"2 can replicate by using sites 3 and
4 (11). Plasmid dpm3"4 has EBNA-1 binding sites 3 and 4
mutated in the DS region, but it eplicates in human cells by
using the wild-type EBNA-1 binding sites 1 and 2.
Methylated DNA from these three plasmids and the control
plasmid, pHEBo, were transfected into 293/EBNA1 cells. The
low-molecular-weight DNA was harvested 10 and 23 days after
transfection and analyzed by Southern blotting. The DNA was
linearized by EcoRI digestion and then digested with HpaII or
MspI. WhileHpaII andMspI recognize the same DNA sequence,
HpaII is CpGmethylation sensitive andMspI is CpGmethylation
insensitive. Subsequently, the Southern blot was probed with an
Nsil to HpaI fragment containing the oriP region.
Three completely digested fragm nts of 326, 396, and 916 bp
and a very faint partially digested band containing the 396- and
the 326-bp fragments were detected in the MspI digests by
using the oriP probe ( ig. 4). In the HpaII digests, a 326-bp
fragment of similar intensity to the same fragment in the MspI
digest was detected in all the DNA samples (Fig. 4B). Quan-
titative analysis revealed that the d fference in radioact vity in
this fragment in the HpaII and MspI digests from the same
DNA harvest is less than 10% (range, 2 to 10%). This indicates
that t e two HpaII sites within th family of repeats (FR)
became demethylated on all the molecules regardless of the
mutations in the DS region. In contrast, the 396-bp fragment
was absent in the HpaII digests of all the DNA samples. This
demonstrates that the HpaII site in the spacer region of the
oriP remained methylated on all the molecules.
The 1.3-kb HpaII fragment, which contains the 396- and the
916-bp fragments, is a result of demethylation of the HpaII site
in the FR that is closer to the DS region and the HpaII site
between EBNA-1 binding sites 1 and 2 in the DS region (Fig.
4A). The HpaII site in the FR that is closer to the DS egion
is clearly digestable on all the plasmids as described above.
Therefore, the reduced intensity of the 1.3-kb band is the result
of lack of digestion at the HpaII site between EBNA-1 binding
sites 1 and 2 in the DS region. The minichromosomes retaining
methylation at the HpaII site between EBNA-1 binding sites 1
and 2 in the DS region would have generated a fragment which
is indistinguishable from the linearized molecules (7 kb for
pHEBo and 6.5 kb for the mutants) instead of the 1.3-kb
fragment (Fig. 4B). The intensity of the 1.3-kb band was much
stronger t an that of t e 7-kb band in the harvested dpm3"4
and pHEBo DNA. In contrast, the 7-kb band was much more
intense than the 1.3-kb band in the harvested dpm1 and
dpm1"2 DNA. This indic es that the majority of the dpm3"4
and pHEBo plasmids were demethylated while most of the
dpm1 and dpm1"2 plasmids retained methylation at this
HpaII site (Fig. 4B). The difference between these plasmi s is
the mutations in the EBNA-1 binding sites in the DS region.
Mutant plasmid dpm1 an dpm1"2 have mutations in bind-
ing site 1 and binding sites 1 and 2, respectively. These plas-
mids have much reduced EBNA1 binding, hile plasmids
dpm3"4 (mutations in binding sites 3 and 4) and pHEBo (wild
type) have normal EBNA-1 binding at these sites. Therefore,
the lack of demethyl tion at the HpaII site between BNA-1
FIG. 3. Demethylation does not occur without EBNA-1 binding and DNA
replication. A Southern blot of DNA harvested 3 days after transfection and
digested with HindIII (for linearization) and HpaII is shown. The plasmids and
cell lines used in the experiments are indicated above the panel. 293E, 293/
EBNA1 cell line. The capability of plasmid replication and the presence of
EBNA-1 in the cells are also indicated above each lane. The probe used is the
NsiI-HpaI fragment, as indicated. For an explanation of the outline l tters, see
the legend to Fig. 4. The asterisk designates the HpaII site from which the partial
digestion product likely derives.
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a
b c
Evidence of protein binding specifying de-methylated DNA sites: ( ) Adapted from [68], this figure shows
methylation status of the oriP sites bound by EBNA-1. Hp II bands at 1.2Kb and 320bp are in icative of
de-methylation and are found only when cells ar replicating and EBNA-1 is expr ssed. (b) Adapted from
[69], this figure shows % demethylation of lacO DNA locus as a function of the inhibition of the protein lacI
by IPTG (underlying biology of lacO and lacI is elucidated in [36]). (c) A apted from [81], his figur shows
the methylation level of in vivo bound binding sites by their corresponding TFs as a f nction of intracellular
TF concentration.
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can specifically recruit DNTM3a through the repressive COREST complex (Figure 1.15b).
This result suggests an alternative model where a TF or trans-acting factor is recruited to
a genomic region and by interacting with co-factors and DNMT s can drive establishment of
de novo methylation.
Figure 1.15. Protein binding to DNA establishes DNA methylation
Figure 2. Knockdown of ZNF217 or DNMT3A Causes DNA Demethylation of the p15ink4b Promoter
(A) Knockdown of DNMT3A using siRNA. MCF7 cells were transfected with the indicated siRNA, and after 72 hr cell extracts were prepared and western blot
analysis was performed with the antibodies as indicated on the left.
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Figure 2. Knockdown of ZNF217 or DNMT3A Causes DNA Demethylation of the p15ink4b Promoter
(A) Knockdown of DNMT3A using siRNA. MCF7 cells were transfected with the indicated siRNA, and after 72 hr cell extracts were prepared and western blot
analysis was performed with the antibodies as indicated on the left.
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a
b
Adapted from [71], this figure shows the mechanism underlying aberrant methylation of the promoter of p15.
(a) Bisulfite sequencing reads indicating methylation status of the p15 promoter: p15 is hyper-methylated in
a cancer cell line (left,dots in a line are single CpGs in a SANGER read, a black dot represents a methylated
CpG, a white dot represents an unmethylated CpG ). When ZNF217 is inhibited (right), methylation is lost.
(b) Model of direct recruitment of DNMT3a by ZNF217 to the p15 promoter.
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At the time of writing of this thesis, the notion of DNA methylation being encoded at the
level of the DNA sequence has been generally accepted and proven [70]. However, the empir-
ical evidence supporting the above mentioned models is still quite limited and the number of
known cis-acting elements driving DNA methylation is very sparse. A major limiting factor
in this endeavor is the lack of a strategy for the high-throughput dissection of the sequence
basis underlying DNA methylation. In the third chapter of this dissertation, I will describe
my effort to bring a solution to this problem by developing a novel ”methylation reporter
system” for the high-throughput dissection of the sequence basis of DNA methylation and
its application to an in vitro model system for neuronal development.
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1.3 Beyond the boundaries of determinism: the stochastic nature of life
1.3.1 Stochasticity in cellular processes overcomes genetics and epigenetics
The addition of epigenetic factors that integrate information from the environment to
the underlying genetic information should in theory be sufficient to explain any phenotypical
variation observed in nature. However that is not entirely the case.
One of the first empirical observations comes from measuring levels of β-galactosidase,
an enzyme important for the metabolism of the sugar galactose, inside the bacterium E. coli
cells [83]. The authors of this paper induced the production of this enzyme and measured
the amount of enzyme in single bacterial cells. The expectation of this experiment would
be that every cell would display similar amounts of enzyme and that this quantity would
increase proportionally to the level of induction. In contrast, what the authors found was
that while the mean level of enzyme across the population was indeed proportional to the
induction, the response at a single-cell level was instead binary: a single cell would either
express the enzyme at fully induced levels or show almost no expression at all (Figure 1.16).
Several implications can be extrapolated from this result:
1. The mean level of induction in a population of cells is dictated by a combination of
induced and non-induced cells.
2. The level of enzyme expressed in either induced or non-induced cells is similar across
the respective population, following a all-or-none response.
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3. Different cells exhibit different phenotypes despite being genetically identical and in
the same environment. Phenotypic variation is therefore very high.
Figure 1.16. Models of β-galactosidase induction in cell populations
100
0
average cell model all-or-none model
As described in [83], this figure illustrates opposing models for the quantitative induction of the β-
galactosidase enzyme in E. coli. Under the ”average cell” model, each cell expresses the same amount
of enzyme, leading to an identical population. In contrast, under a ”all-or-none” model, cells are either fully
induced (blue cells) or completely un-induced (white cells) at different frequency corresponding to different
levels of induction.
The observation that phenotypic variation can occur within a given environmental context
with a fixed genetic background has also been later appreciated in genetics. More specifically,
a particular mutation can manifests its phenotype only in a subset of the individuals that
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carry it, given fixed genetic background and environmental stimuli. This phenomenon has
been described as ”incomplete or partial allele penetrance” [84]. Follow-up studies have
revealed the generality of this behavior in different biological phenomena [85, 86, 87, 88, 89,
90, 91, 92, 93, 94], suggesting that its origin may lie on a common general principle.
How can the same genetic instructions in the same environment be interpreted in radically
different ways within the same cell population? The answer to this question lies in the
context of probability. Physical-chemical, and therefore biological, processes are based on
the interaction of a discrete number of molecules within a system. These interactions are
probabilistic in nature and the average fraction of molecules in a particular state can be
accurately captured through mathematical modeling. In the easier case when the system
reaches ”thermodynamic equilibrium”, this can be achieved by applying the formalisms of
statistical thermodynamics [95]. For instance, let’s consider a protein-DNA interaction, such
as the binding of a TF to its cognate DNA recognition site. Assuming that the concentrations
of TF and DNA do not change, their binding is irreversible (as it usually is), and pressure
and temperature remain invariant, we can described their interaction as:
[TF ] + [DNA]
 [TF ·DNA] (1.2)
where [TF ] and [DNA] represent the unbound species and [TF · DNA] represent the






where Keq is the equilibrium constant of the system. The average fraction of TF-DNA
complex at equilibrium is then described by the Boltzmann distribution as
< TF ·DNA >= [TF ]Keq
1 + [TF ]Keq
(1.4)
where the average is the probability of being the bound state. This model directly relates
to the Bernoulli distribution in probability space [96], in which the mean µ is equal to the
probability of the Bernoulli event to occur:
µ = p (1.5)
the variation in a series of Bernoulli trials is measured by its variance σ2, which is math-
ematically defined as
σ2 = p(1− p) (1.6)
This definition can be easily shown to be equivalent in thermodynamic space as well,
leading to
σ2[TF ·DNA] =< TF ·DNA > (1− < TF ·DNA >) (1.7)
Now given that p is a probability and therefore can only range between 0 and 1, the
relationship between µ and σ2 shows that σ2 is at its peak at intermediate levels of µ (0.5)
and at its lowest at the extreme values of µ (0 and 1) (Figure 1.17).
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Figure 1.17. Relationship between Bernoulli σ2 and µ



















This figure show the relationship of σ2, which is defined as p(1 − p), and µ, defined as p, for a Bernoulli
random variable.
This reflects the fact that a single Bernoulli variable can exist only in two states and can
explain the the original all-or-none expression of β-galactosidase in E. coli. At any given
time point a single E. coli cell can either express it or not and therefore can be modeled
as a Bernoulli variable. Because of this reason, at intermediate levels of induction, the
population of E. coli cells will be at its highest variance as ∼50% will be in the induced
state and the remaining ∼50% will be un-induced. This behavior results from the fact that
E. coli possess only one copy of the gene for β-galactosidase, which leads any single cell to
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exist in a single state of a binary set. In contrast, hypothetically speaking, if E. coli carried a
high number of copies of β-galactosidase, each copy would behave as a Bernoulli variable and,
as a result, each cell would express a continuous amount amount of β-galactosidase. This is
purely a consequence of the limits of statistical sampling and the law or large numbers [97].
These results indicate that phenotypic changes can occur despite uniform environmental and
genetic background purely as a result of sampling from a low number of molecules, resulting
in ”stochastic” variation.
1.3.2 Stochastic variation improves fitness, guides development, and modulates
differentiation dynamics
An important underlying question at the base of stochastic variation is whether it provides
a phenotypic advantage compared to a case of uniform phenotypic response. An illuminating
example comes from experiments conducted on bacterial survival after antibiotic exposure
[88, 98]. In one of these studies [88], single cells of E. coli were exposed in culture to the
antibiotic ”Ampicillin”. Because these strains of E.coli did not carry any ”resistance factor”,
i.e. genes that conferred immunity to the antibiotic used, the expected result was to observe
no surviving cells after the treatment. In contrast, several cells from the original colony were
shown to survive the treatment and eventually be able to repopulate the entire colony once
the drug was removed. This phenomenon was called ”bacterial persistence”. Its manifes-
tation comes from the fact that inside the original population there is a subpopulation of
cells replicating at a slower rate in dynamic ”equilibrium” with the remaining cells. Because
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”Ampicillin” kills replicating cells [99], this population survives the exposure of antibiotic
and eventually reconstitutes the entire original population (FIgure 1.18).
Figure 1.18. Stochastic variation induces bacterial persistence to antibiotics
Adapted from [88], this figure shows ”persistence” of E.coli after exposure to Ampicillin in absence of a
resistance factor. Time points from 0:00 to 1:45 show E.coli cells growing inside a micro-fluidic cell (green
lines).Time point 6:50 shows the presence of cells that persist treatment with Ampicillin and eventually
repopulate the micro-fluidic chamber in subsequent time points after Ampicillin is removed.
In the absence of stochastic variation, the population would have not survived the treat-
ment, suggesting the presence of an associated fitness advantage. Mathematical modeling of
this observation [100] suggests that stochastic phenotype switching provides higher fitness
compared to direct response to enviromental stimuli (Figure 1.19).
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Figure 1.19. Responsive vs stochastic switching of phenotype following enviro-
ment changes
fluctuations experienced by a population over
long periods can select among different genetic
mechanisms for generating diversity. Orga-
nisms whose stochastic switching rates are
better adjusted to environmental fluctuations
can outgrow organisms that use a different set
of switching parameters.
Finally, how does information gathered
by organisms about the fluctuating environ-
ment affect their survival? The two types of
switching differ markedly in this regard. For
responsive switching, information about en-
vironmental changes is conveyed to the
organism directly through the sensing mecha-
nism; whereas for stochastic switching, it is
conveyed indirectly by natural selection.
We consider a simple model that en-
compasses both responsive and stochastic
switching and describes a clonal population
growing in an environment that fluctuates in
time among a finite number (n) of different
environment types (Fig. 1). The fluctuating
environment is a continuous-time stochastic
process, E(t), designating which environment
occurs at time t; the average duration of
environment i is ti (with the average over all
environments equal to t); the occurrence
probability of environment i is pi; and the
probability that environment i follows j is bij
(bii 0 0).
Each individual organism is capable of
exhibiting one of n different phenotypes.
Phenotype i grows with rate fi
(k) in environ-
ment k (growth rates may be positive or
negative). The phenotype with largest growth
rate in environment k is phenotype k (its
growth rate is fk
(k)), and we refer to it as the
fastest-growing phenotype and to all other
phenotypes as slower phenotypes. Individuals
may switch phenotype at any time, with
parameters Hij
(k) giving the switching rate from
phenotype j to phenotype i in environment k.
Taking the simplest model of growth, the
n-dimensional population vector, x(t), whose
ith coordinate is the number of individuals




xðtÞ 0 AE ðtÞxðtÞ
The matrix AE (t) may be one of n different
matrices, depending on the environment,
E (t). Ak can be written as a sum of a diagonal
matrix, whose diagonal entries are the
growth rates of each phenotype in environ-
ment k ( fi
(k)), and the matrix of switching
rates, Hij
(k) (Fig. 1). The sum of all the entries
of x(t) gives the total population size N(t) (19).
The two types of phenotype switching
correspond to different choices of switching
rates. For stochastic switching, these rates are
independent of the environment k; therefore,
for all values k
H
ðkÞ
ij 0 Hij ðstochastic switchingÞ
For responsive switching, the sensing mecha-
nism allows switching rates to depend strongly
on k. In the extreme case, all phenotypes




k j 0 Hm for all j m k ðresponsive switchingÞ
H
ðkÞ
ij 0 0 for all i m k and j m i
The switching rate Hm is physiologically
determined but ideally as large as possible, so
that individuals spend as little time as possible
in slower phenotypes.
To compare the two types of switching,
we calculate the so-called Lyapunov exponent
L (20), which is the asymptotic growth rate of
total population size (21, 22) given by the
large time limit of (1/t) log N(t). L is known to
exist under relatively general conditions (20)
and depends on both the organism (growth
rates of its phenotypes and switching rates) and
on the temporal sequence of the changing
environment E(t). In general, it is difficult to
compute analytically, but we now describe an
approximation that allows such computation
for our model.
We assume that environmental durations
are long enough that the population has time to
reach its equilibrium composition before the
environment changes. In environment j, this
means that x(t) will eventually point essentially
in the direction of the top eigenvector of the
matrix Aj. Upon a change of environment from
j to i, there will be a delay time, Tij
*, during
which the population_s composition changes
Fig. 1. A population is composed of individuals each capable of exhibiting one of n different phenotypes in
n different environments. The growth rate of phenotype i in environment k is fi
(k); among all phenotypes
in environment k, phenotype k grows the fastest. Individuals can switch phenotype at any time,
responsively or stochastically. Hij




HðkÞi j . The boxed growth equation governs the dynamics of the n-dimensional population vector
of phenotypes, x(t). The changing environment is a continuous-time stochastic process, E(t), taking integer
values 1 to n designating the environment at time t. The form of matrices Ak is shown, determining the
combined growth and switching rates of all phenotypes when E(t) 0 k. E (t) is assumed to be constant
on successive time intervals Tl with l 0 1, 2,I; e(l) is the environment occurring at the lth interval,
and L(t) denotes the number of intervals Tl elapsed by time t. Environment change probabilities are bij K
P[e(l) 0 i k e(l – 1) 0 j], so e(l) is a Markov chain (assumed ergodic) with n states and transition matrix b,
with bii 0 0. The equilibrium probability pi of environment i satisfies pi 0
P
j
pjbij ; the average duration
of environment i is ti and the average duration of environments is t K
Pn
i01
piti . Total population size is
NðtÞ K Pn
i01
xiðtÞ. A schematic of the dynamics is shown in which individuals are colored to indicate
phenotype, such that the fastest-growing phenotype in each environment matches the environment’s
color. When environment j changes to i, there is a delay time, Tij
*, in which x(t) rotates (shown in gray)
before the population attains its new composition. In responsive switching, individuals switch directly
to the fastest-growing phenotype. In stochastic switching, subpopulations exist in different
phenotypes; when the environment changes, the fastest-growing subpopulation brings about a
change in population composition. Proportions of slower-growing phenotypes are exaggerated for
the purpose of illustration; they may be as small as ,10–6.
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Adapted from [100], this figure compares stochastic phenotypic switching to response to environmen al
changes.
This phenomenon is not however limited only to e ironmental respons but it is physio-
logically relevant in the context of development and differentiation. One particular example
comes from the development of the eye in t e fruitfly Drosophila melanogaster [91]. The
eye structure in Drosophila is formed by individual optical units called ”ommatidia”, which
exist in two different subtypes (pale and yellow). These subtypes are randomly distributed
in the fruitfly retina and their specification depends on the expression of the protein spine-
less. When spineless is inactivated, almost all ommatidia assume the pale fate whereas its
over-expression induces the yellow fate. These phenotypes are randomly specified in normal
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development as a result of stochasticity in the expression of spineless, allowing the formation
of a complicated biological structure simply by executing a random sampling.
Finally, stochastic switching between different cell types occurs in the context of cancer
[101]. In this work, the authors analyzed two breast cancer cell lines and identified 3 different
subpopulations characterized by different surface markers: luminal, basal, and stem-like
cells. By isolating each type using flow-cytometry the authors showed that each individual
purified fraction could reconstitute the entire population. These results have important
implications in the design of therapies to treat cancer as the effects of specifically targeting
of only one population subtype could be nullified by the ability of every other subtype to
reconstitute the original population. Taken together, these observations and others [92]
indicate that stochastic phenotype transitions are a fundamental component of the process
of cell differentiation and overall are associated to increased fitness.
1.3.3 Gene expression is a stochastic process: noise in the system
Regulation of gene expression has been implicated as a driving factor underlying cellular
differentiation, development, and disease [5, 36, 39]. In many of the cases that we have
observed so far, stochastic switching of a phenotype occurs as a downstream consequence of
variation in the expression of a particular protein regulating the activation of downstream
genes [91, 93]. Because of these reasons, in order to understand stochastic phenotypic vari-
ation, it is important to measure and dissect variation in gene expression.
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One of the first and most widespread empirical appreciation of stochasticity in gene ex-
pression comes from the measurements of cell-to-cell variation in protein levels. By coupling
the coding region of the green fluorescent protein (GFP) naturally found in the jellyfish
Aequorea victoria to a promoter region of interest, the intensity of the light emitted by GFP
upon UV excitation can be used as a readout for protein expression [102, 103]. By adopt-
ing techniques such as fluorescence microscopy and flow-cytometry [86], GFP levels can be
measured at a single-cell resolution (Figure 1.20a).
Figure 1.20. Stochastic variation in gene expression
The advantage that is usually postulated is mediation between
conflicting selection pressures on flagellar expression in the host.
During initial stages of gut infection by S. Typhimurium, flagella
are instrumental for swimming towards the host’s epithelial mucus
layer [14]. During later stages of infection, a switch towards not
expressing flagellin might be of advantage for bacteria that have
invaded epithelial tissue, as it avoids recognition by the innate
immune system [TLR5, Naip/Nalp][21]. There is a second
possible biological function of phenotypic noise in flagella and
other factors involved in the interaction with the host. A recent
study suggested that heterogeneous expression of these traits in
clonal populations of S. Typhimurium promotes the division of
labor between two phenotypically different subpopulations. One
subpopulation invades the gut tissue and elicits an inflammation of
the gut; the other subpopulation remains in the gut and benefits
from the fact that the inflammation reduces competition from
commensal bacteria [22].
Two main insights emerge from this study. The first insight is
that the activity of some S. Typhimurium promoters varies on such
a short time scale that these promoters can absorb rapid
fluctuations in the direction of selection, as imposed during our
experiment. This is an important experimental test of one of the
main ideas for why phenotypic noise can be adaptive: variation in
the phenotypes encoded by a single genotype can increase the
long-term growth rate of this genotype in fluctuating environments
[23,24].
The second insight is methodological: fluctuating selection is a
simple and fast tool to screen large pools of individuals in order to
identify variable promoters in unicellular organisms, and thus
complements exhaustive characterizations of individual genes [7].
Exhaustive characterizations require the construction of ordered
libraries in which fluorescent markers are transcriptionally or
translationally fused to every gene, as well as individual
measurement of all resulting strains. In contrast, the method
presented here only requires the relatively simple construction of a
random genomic library, and sorting of the pooled library. It is
thus also applicable to eukaryotic systems and organisms that are
not genetic model systems, as long as they can be stably
transformed. It should thus be feasible to identify noisy promoters
in a diverse range of environmental, commensal, and pathogenic
organisms, and to ask whether differences in the lifestyle lead to
consistent differences in the types of genes that are variable.
One particular advantage of this tool is that the time-scale at
which the direction of selection changes can be varied. By
changing the direction of selection every few cell divisions, on can
impose selection for promoters that switch at a very high rate;
changing the direction of selection less frequently selects for
promoters that switch at lower rates. It should thus be possible to
identify promoters that vary at different time scales, and to
investigate whether they might be associated with responses to
environmental conditions that vary at different frequencies.
Once noisy promoters are identified, functional studies are
needed to investigate the biological consequences of their
variation. This might lead toward new answers to one of the
fundamental and most challenging questions about the biology of
noise – whether phenotypic noise is beneficial, and what its
possible benefits might be.
Materials and Methods
Growth of Strains
Strains were grown at 37uC on LB agar plates or in 1 ml of
liquid LB broth in 5ml polystyrene round bottom tubes (BD
Falcon), with shaking at 200 rpm until mid-exponential phase.
Ampicillin (Sigma) was used at a concentration of 100 mg/ml in
strains containing plasmid pM968 or its derivatives.
Construction of the Plasmid Library
A plasmid library (76106 clones) was constructed by partially
digesting S. Typhimurium SL1344 wildtype [25] chromosomal
DNA with Bsp143I. Fragments within a size range of 400 bp to
1200 bp were ligated into BamHI digested pM968. This plasmid is
low copy number promoter-less derivative of pBAD24 containing
promoterless gfpmut2, described in [26]. Plasmids were transformed
into E. coli X6060, re-isolated by standard methods and
electrotransformed into S. Typhimurium M324 (D aroA invC::aphT
ssaV::cat [26]). Colonies were selected by growth on LB agar plates
containing Ampicillin, harvested, and pooled.
Growth for Flow Cytometry and Cell Sorting
A 1:1000 dilution of an overnight culture of the plasmid library
was split into ten equal populations; five populations were assigned
to ‘‘selected’’ and five to ‘‘control’’ groups. Cells were grown for
2 hours to reach exponential growth. Cultures were spun down at
Figure 3. Phenotypic noise in a microcolony in gfp expression
from the fliC promoter. A. An image of a microcolony containing the
plasmid-borne fliC promoter driving expression of GFP. The colony was
started from a single cell and grown for about 6 generations. B. A
lineage tree of this microcolony with GFP expression plotted in green
(light colored boxes represent high levels of GFP, and dark boxes
represent low levels), illustrating the temporal pattern of switching of
the fliC promoter. The image and the lineage tree are based on Movie
S1.
doi:10.1371/journal.pgen.1000307.g003
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We find that the phenotypic noise strength shows a strong
positive correlation with translational efficiency (Fig. 2b,
slope=21.8), in contrast to the weak positive correlation
observed for transcriptional efficiency (Fig. 2c, slope=6.5).
Switching from the ERT27 strain t  the ERT25 strain (an
increase in translational effi iency of about 15%; Table 1)
increases the noise strength from 32 to 35 units; the same effect
is achieved only upon dou ling transcriptional efficiency (a
100% increase) from the half-induction to the full-induction
level. Experiments involving the control strains, in which tran-
scription rates w re altered by mutation rather than by operon
induction, supported the weak correlation between noise
trength and transcriptional efficiency (F g. 2c inset, slope=7.3).
The differential nature of our measurements (investigating
changes rather than absolute values) makes our results indepen-
dent of the specific properties of the reporter protein, such as
gene locus or folding characteristics. This suggests that
increased translational efficiency will strongly increase the vari-
ation in the expression of any naturally occurring gene.
A stochastic model for the expression of a single gene (Fig. 3a)
predicts that the noise strength (!p
2/"p#) is greater than Poisson-
ian (!p
2/"p#=1) and is simply an increasing function of transla-
tional efficiency12:
Here, b=kP/$R is the average number of proteins synthesized per
mRNA transcript; these proteins are injected into the cytoplasm
in sharp bursts (Fig. 3b). The measured asymmetry between the
noise contributions of transcriptional and translational parame-
ters is consistent with this prediction and provides evidence of
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Fig. 1 Phenotypic noise in a genetically identical bacterial population. a, Histogram showing the result of a typical experiment in which the expression level
of a fluoresce t reporter protein is m asured in  population of isogenic bacterial cells. Traditional population-averaged measurements would summarize
the entire histogram by its m an value "p#; howev r, our single-cell measurements show that the expression level varies from cell to cell, with a standard devi-
ation !P. The phenotypic noise strength, defined as the quantity !P2/"p#, is a measure of the spread of expression levels in a population. The relative standard
deviation !P/"p#, although a more common measure of phenotypic noise, obscures its essential behavior. For instance, the relative standard deviation for a
Poisson distribution is !P/"p#=1/"p#1/2, which decreases as the mean increases; but the noise strength for this distribution, !P2/"p#=1, is independent of the
mean. In gene al, the noise strength circumvents the trivial effect of decreased noise with increased mean, and measures deviations from Poisson behavior.
b, Phenotypic noise strength for the four different translational mutants at fixed inducer concentration. Noise strength is clearly dependent on translational





































































Fig. 2 Biochemical contribution to phenotypic noise. a, Complete experimental data. Each data point is the summarized result of an entire histogram correspond-
ing to a flow cytometer run of a population of typically 104–105 cells. The phenotypic noise strength of the population (z, in arbitrary fluorescence units) is plotted
as a function of transcriptional efficiency (x, depending on the IPTG concentration) and translational efficiency (y, depending on the translational mutant used).
Transcriptional and translational efficiencies are normalized to those of the wildtype ERT25 strain, allowing these parameters to be directly compared. These data
are fitted to a plane of the form z=a0+axx+ayy using a least-square routine, giving a0=7.1 ± 0.9, ax=6.5 ± 0.4, ay=21.8 ± 0.9. The ratio ay/ax=3.4 gives the relative
effect of translational versus transcriptional efficiency on phenotypic noise strength. b,c, For clarity, the three-dimensional data are projected parallel to the fit
plane onto the boundary planes x=1 (b), noise strength as a function of translation, and y=1 (c), noise strength as a function of transcription. The intersection of
the fit plane with each boundary plane is shown as a solid line; dotted lines indicate an interval of 1 s.d. Data in b are summarized separately for each translational
mutant (dark circles with error bars that represent 95% c.i.). Inset in c shows results of control experiments conducted on transcriptional mutants at full induction.
Three strains (ERT51, ERT53 and ERT55) are very similar, both in transcriptional efficiency and in noise strength, suggesting that biochemical noise is determined by
the actual transcription rate rather than by the specific method used to achieve it. The strain ERT57 shows a highly amplified transcriptional efficiency, allowing
reliable estimation of correlations. Data are summarized separately for each transcriptional mutant. A linear fit through these points gives a slope ax’=7.3 ± 0.3,































Adapted from [104] (a) and [86] (b), this figure shows cell-to-cell variation in the expression of GFP in
E.coli (a). This can be represented as a distribution of measured fluorescence units per cell (b), which is
characterized by a mean (< p >) and a variance (σp).
One of the first application f this t chnology to the context of stochastic expression
comes from measuring the levels of GFP expressed by the bacterium B. subtilis [86]. In this
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work, the authors show that single B. subtilis cells display varying levels of GFP expression,
which follows a distribution across the bacterial population (Figure 1.20b). This distribution
can be parameterized by two numbers. The first is the mean protein value, indicated as < p >
or µp, which corresponds to the average amount of GFP produced in each cell. The second
is the protein variance, indicated as σ2p, which quantifies the amount of variation across the
distribution of single-cell protein levels. Measures of single-cell protein variance have been
obtained for eukaryotes as well such as the budding yeast S. cerevisiae [87], the fruitfly D.
melanogaster [91], and mammalian cells [90, 94], indicating its generality across multiple
organisms.
1.3.4 How is gene expression variance regulated?
Having established its existence and importance, a fundamental goal in the field of
stochastic gene expression is to understand how cell-to-cell variation is controlled and mod-
ulated. The benefits of answering this question are multiple. First, a clear understanding of
how cell-to-cell variation is modulated can predict which genes are going to be susceptible
to high variation and ultimately what downstream phenotypic consequences we can expect
from that. Secondly, the ability to predict expression variance can lead to the ability to
control and ultimately engineer genes that are expressed with a desired level of variation.
A first step into the analysis of stochastic variation in protein levels is to determine the
relationship between µp and σ
2
p. This is important because in many probability distributions,
µ and σ2 are not independent. Through the use of an inducible system for gene expression,
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several studies observed a strong positive correlation between σ2p and µp [86, 87]. To better
describe the changes of noise for different values of µp, two different normalizing metrics
were introduced [105], the ”Fano factor” [106] and the ”coefficient of variation” [107]. These
metrics are used in statistics to normalize inherent mean effects of a stochastic process and
provide a measure of the dispersion of a probability distribution.
The Fano factor was first created by the Italian-American physicist Ugo Fano for the
description of the fluctuations of an electric charge obtained in a detector by comparing it





A Poisson process is a stochastic process counting the number of events in a given time-
interval such that in any given non-zero time point, the distribution of events is Poisson [96].
The Poisson distribution [108] is mathematically described as




where both µ and σ2 are parameterized by λ. This implies that for this particular case
F = λ
λ
= 1. In the context of stochastic gene expression, the Fano factor has been adopted
as a normalization metric with the name of ”noise strength” and its implicit assumption is
that the basal level of noise follows Poissonian scaling [86, 89, 109].
The coefficient of variation or CV is normalized measure of dispersion of a probability






Analogous to the Fano factor, the CV can assume value of 1 under particular circum-
stances, namely whether the underlying distribution of a stochastic process is exponential
[107]. The exponential distribution is mathematically described as
P (X = x) = λe−λx (1.11)
for x ≥ 0. In this context, σ and µ both assume the value of 1
λ
and therefore CV = λ
λ
= 1.
This can also happen in the case of a Bernoulli variable when p = 0.5 as σ2 becomes
p2 following (1.6), indicating that a CV of 1 can be achieved in the case of highest possible
Bernoulli variance. In the context of stochastic gene expression, the CV has been adopted as a
normalization metric with the name of ”noise” and has been used widely throughout the field
[110, 111, 112, 113]. Because of this reason, the study of stochastic gene expression, or gene
expression variance, has been cmmonly defined as the study of ”noise in gene expression”.
1.3.5 Noise in gene expression is modulated by multiple intrinsic and extrinsic
factors
Using these metrics, several studies aimed at dissecting determinants of stochastic varia-
tion focusing on single promoters or genes by performing titration and time course analysis
[87, 89, 110]. The process of gene expression is inherently highly regulated and involves
multiple consecutive steps [60] starting by the specific binding of TFs at the promoter and
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enhancer sequences regulating the expression of the downstream gene. This is followed by
the active recruitment of the ”pre-initiation complex” (PIC) by the bound TFs, which ul-
timately is bound by the active ”RNA Polymerase II holoenzyme” (Pol II). This step is
followed by the initiation of transcription, where the DNA sequence of the gene is copied
into a messenger RNA (mRNA). The process by which the mRNA is transcribed by Pol
II after initiation is called ”elongation”. The transcribed and mature mRNA (for in depth
reference see [4]) undergoes ”translation” resulting in the production of protein molecules
encoded in its sequence. Finally both mRNA and protein molecules are eliminated by a
process of ”active degradation” combined with their dilution as a result of cell division.
Different research efforts focused on the dissection of different steps involved in the pro-
cess of gene expression. An initial analysis in E. coli focused on the effects of changing
transcription and translation rates to cell-to-cell variation. The results indicated that both
process lead to an increase in variance but at different rates. By normalizing cell-to-cell
variance using the noise strength (σ
2
µ
), it was shown that changes translation efficiency pro-
duced a linear increase in noise strength, whereas changes in transcription lead to constant
levels of noise strength. Similar results were observed in the model eukaryotic organism S.
cerevisiae, but in this case changes in transcription lead to wide changes in noise strength as
a result of different promoter kinetics [87]. Specifically, the binding of chromatin regulators
and the presence of the ”TATA-box” sequence in the promoter has been shown to produce
an increase in noise strength, connecting specific molecular factors to gene expression vari-
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ance [89]. Furthermore, a strong link between nucleosomes and noise has been established
through large scale correlation analysis [114] and individual perturbation experiments [115].
Quantitative stochastic modeling of gene expression provides a theoretical basis for un-
derstanding and interpreting single-cell experiments. A stochastic system can be accurately
described through the use of a ”master equation”, a set of first order differential equations











P is the probability distribution expressed as a vector and A is the matrix of
parameters (note that A can also change as a function of time, thereby becoming A(t)).
Commonly used stochastic models consist in a direct analytical solution of a simple system
[117] or, in more complex cases, monte-carlo simulations recapitulating the solution, the most
prominent and famous algorithm being the one created by Dan Gillespie in 1977 [118]. The
application of these models to single-cell experiments allowed the authors of the studies to
recapitulate the observed data and generate hypothesis on the underlying molecular sources
of noise in gene expression.
Finally, an important result in the study of stochastic expression comes from the dis-
tinction between ”intrinsic” and ”extrinsic” sources of noise [110]. Using a system with
two fluorescent reporters driven by the same promoter, the authors were able to appreciate
changes in noise that were concordant within the same cells. These changes were due to fac-
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tors ”extrinsic” of the process of gene expression such as cell-to-cell fluctuations in number
of polymerase molecules, cell-size, and phase of the cell cycle. In contrast, factors that were
”intrinsic” of the process of gene expression, such as promoter kinetics and transcription
and translation rates, would instead produce discordant fluctuations of the two reporters
within the same cell. These results suggest that multiple processes can modulate noise in
gene expression at the same time. An important challenge is then to estimate the magnitude
and generality of each effect with respect to cell-to-cell variance.
1.3.6 The relationship between mean and variance in gene expression
As described above, over the course of the recent years, multiple studies have identified
different factors associated with noise in gene expression. However, different analyses have
been conducted by using different metrics based on the accepted theoretical justifications at
the time of the study. The purpose of using a metric is two-fold: 1) normalizing variance in
gene expression is necessary when genes expressed at different levels are compared with one
another 2) a metric establishes a base-line amount of variation and allows the discovery of
underlying factors that can increase or decrease variance beyond the expected value. The
choice of which normalization metric to use is not trivial as different metrics make different
assumptions on the underlying biophysical processes. The underlying question however
remains: which metric is preferred for the analysis of noise in gene expression? Two seminal
studies in the field approached this issue by performing a large scale survey of values of protein
mean and variance for a representative fraction of the S. cerevisiae proteome [111, 112]. The
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authors of these studies observed a similar trend in their respective datasets: protein noise
levels (expressed as CV2) showed an inverse relationship with protein mean levels (Figure
1.21). This result has profound implications in the analysis of noise: a strong relationship
between mean and noise is indicative of the inadequacy of the metric of choice to normalize
the variance from all the mean effects.
Figure 1.21. Noise in protein levels scales with protein abundance
condition to condition, the generalizability of the conclusions remains
to be seen. Moreover, most studies have been done under optimal
growth conditions but do not consider how environmental conditions
affect the noise. Comparing noise levels between conditions may be of
particular interest because it may explain the enhanced phenotypic
diversity often observed when cells are stressed.
In this study, we measured the cell-to-cell variation of 43
S. cerevisiae genes expressed as fusion proteins in this organism and
grown under 11 different environmental conditions. Motivated by
previous analyses, we attempted to correlate noise and mean expres-
sion levels. However, whereas previous studies have changed expres-
sion levels by explicitly tuning transcription and translation rates, we
have explored the situations in which the levels of expression have
been differently determined by the cells themselves. Differences in
protein abundance between the proteins, and across different condi-
tions, potentially could be achieved in numerous different ways, with
very different effects on the noise. Despite this potential complexity,
we found a strong correlation between cell-to-cell variability and mean
expression level. We were struck that, in all gene classes examined and
over a broad range of expression levels, the variance is roughly
proportional to the mean. We suggest how this effect can be explained
kinetically and how it points toward specific biological mechanisms
both for setting averages and for generating fluctuations. By analyzing
the deviation from this general trend, we find that genes of similar
biological functions show similar noise features, indicating a contri-
bution from pathway-specific components or mechanisms. In parti-
cular, most of the stress genes examined are significantly noisier than
other genes tested, whereas components of the proteasome are the
least noisy.
RESULTS
Noise versus mean protein abundance
We considered 43 proteins associated with four coexpressed transcrip-
tion modules (stress, proteasome, ergosterol and rRNA processing; see
Methods). We subjected cells expressing a GFP-fused version of each
protein25 to 11 different environmental conditions, and we used flow
cytometry analysis to measure the single-cell fluorescence distributions
at six subsequent time points ranging from 0–150 min after the
transfer to each of the environments (see Methods and Fig. 1).
We quantified the noise by the (squared) coefficient of variation
Z2p ¼ s2p=hpi2; that is, the variance s2p of protein abundance normal-
ized by the square mean hpi2. Fluorescence values were normalized to
actual protein numbers using known protein abundances26 (Meth-
ods). Figure 2 shows the noise as a function of mean abundance for all
genes, under all conditions and at all time points.
At low abundances, the GFP concentration is barely detectable over
the autofluorescence background. In this region, the noise seems to
decrease as 1=hpi2, as expected for a constant (autofluorescence) vari-
ance. At very high abundance, the noise is almost uncorrelated with the
mean, reaching a minimum consistent with that reported previously27
(Supplementary Methods online).
Perhaps the most notable behavior is
observed at intermediate abundances, span-
ning about an order of magnitude and includ-
ing most data points. In this region, the noise
is strongly correlated with the mean, following
Z2p ¼ C=hpi, with CE 1,200 as a proportion-
ality constant. Protein molecules that are made
and degraded with constant probabilities per
second are expected to show a similar depen-
dency, with Z2p ¼ 1=hpi. However, the high
proportionality factor observed in our experi-
ment rules out poissonian statistics: a protein
that is present at 100,000 copies in our data set
shows relative fluctuations of 10%, compared
with 0.1% predicted by poissonian statistics.
To better understand the origin of the
scaling behavior, we applied a theoretical
analysis of noise propagation in reaction net-




































Figure 1 Single-cell distributions of fluorescence levels. (a,b) Cells
expressing the high-abundance protein PGM2 were shifted from synthetic
complete medium to medium containing 3% ethanol. (c,d) Cells expressing
the low-abundance protein ARX1 were diluted from stationary phase. The
cells were subjected to flow cytometry analysis at different time points after
the transfer. Fluorescence distributions are shown on linear (a,c) and on
logarithmic (b,d) scales. Blue, green, red, turquoise, magenta and yellow
lines correspond to fluorescence distributions after 0, 30, 60, 90, 120 and
150 min from perturbation start, respectively. For low-abundance proteins,
the fluorescence values appeared to follow normal distributions. By contrast,
at high abundances, we more often observed a deviation from normality,
with overrepresentation of high fluorescence values (see Supplementary































Figure 2 Scaling of noise with mean protein abundance. (a) Noise as a function of mean protein
abundance. All genes in all conditions and time points are shown. Thick curve corresponds to
logðZ2p Þ ¼ 1175$ logðhpiÞ. Green filled circles represent initial, steady-state time points of stress
perturbations (t ¼ 0). Gray points were excluded from the fitting process (see Methods). The fit to the
autofluorescence region (thin curve) corresponds to logðZ2pÞ ¼ 9:9 % 105 $ 2 % logðhpiÞ. (b–e) Noise
versus mean protein abundance shown separately for genes belonging to a common module.
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protein mean levels (µp).
Previous analyses [111, 112] have shown that σ2 and µ are connected to one another
but the xact hape of the relat onship has not been revealed. In order to address thi ,
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several recent studies took a new unbiased approach to the problem [94, 119]. Because this
relationship is not know, one can assume that σ2 and µ would scale following a general
exponential relationship in the form of
σ2 = kµj (1.13)
which in log-space becomes
log(σ2) = jlog(µ) + log(k) (1.14)
by fitting (4.15) to single-cell fluorescence data from a dataset of Jurkat T-cells express-
ing GFP [94], the authors of the study found that protein variance and mean were related
together by a power-law like relationship with an exponent j = 1.7. Similar results were ob-
tained in E. coli [120], suggesting that this relationship is indeed general. Most importantly,
if we assumed an underlying Poissonian scaling or exponential scaling, the baselines implied
by the Fano factor and the CV respectively, we would have expected exponents equal to 1
and 2 respectively. This result indicates that the current metrics of noise do not completely
remove underlying mean residues in their normalization. As a consequence of this, it is cur-
rently not clear what processes affect protein variance solely through changes on the mean
level and what processes instead regulate protein variance independently of the mean. Fur-
thermore the biophysical origin of this relationship has not yet been revealed and modeled.
In chapter 4, I will explore and dissect the biophysical origin of this relationship by applying
a stochastic model of gene expression to genome-wide protein variance data collected in the
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model organism S. cerevisiae. Using this model, I will then reveal which molecular factors
increase protein variance solely through mean effects and which factors increase variance by
modulating the power-law relationship. This work was done in collaboration with members
of the laboratory of Barak Cohen, PhD.
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2. Detection of rare genetic variants in pooled DNA samples
2.1 Foreword
This chapter describes the development of a fast and cost-effective strategy for the discov-
ery of rare genetic variants in large cohorts of patients. This strategy combines a new exper-
imental protocol involving next-generation sequencing with a novel computational strategy
designed to analyze its data. This work was pioneered by Todd E Druley, MD PhD, who
motivated the study and developed the pooled DNA sequencing protocol, which forms the
basis of this work. I started this project first as a collaboration with Todd by developing
the computational strategy to analyze the data generated from pooled DNA sequencing and
then by extending this strategy to more types of genetic variants. The first section of this
chapter has been adapted from
Todd E Druley, Francesco LM Vallania, Daniel J Wegner, Katherine E Varley, Olivia L Knowles, Jacqueline A Bonds,
Sarah W Robison, Scott W Doniger, Aaron Hamvas, F Sessions Cole, et al. Quantification of rare allelic variants from pooled
genomic dna. Nature Methods, 6(4):263–265, 2009
in which I created the computational framework to detect rare single nucleotide polymor-
phisms (SNPs) in pooled DNA samples that Todd generated for this work. This framework
is embodied in the software package SNPSeeker. This work was driven by Todd E Druley
who designed the pooled-DNA sequencing strategy with Robi D Mitra and Katherine E Var-
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ley and executed all the sequencing experiments. In this section I designed and wrote the
SNPSeeker algorithm and then performed data analysis with Robi D Mitra. Daniel J Weg-
ner and Sarah W Robinson performed all the Taqman validation assays. Olivia L Knowles
and Jacqueline A Bonds punched the bloodspots from filter paper. Justin C Fay and Scott
W Doniger designed and executed the comparative genomics analysis. Daniel J Wegner,
Aaron Hamvas and F. Sessions Cole provided reagents and advice. The second section of
this chapter has been adapted from
Francesco LM Vallania, Todd E Druley, Enrique Ramos, Jue Wang, Ingrid Borecki, Michael Province, and Robi D Mitra.
High-throughput discovery of rare insertions and deletions in large cohorts. Genome research, 20(12):1711–1718, 2010
in which I extended my algorithmic framework into a new software package named SPLIN-
TER to detect rare insertions and deletions (indels) in pooled DNA samples. In this section,
I designed and developed the SPLINTER algorithm and then tested its performance by gen-
erating synthetically engineered pooled-DNA samples. The experiments performed in this
study were designed by Robi D. Mitra, Todd E Druley and myself. I then performed the
sequencing experiments on the synthetic and real samples and the data analysis and vari-
ant validation. Jue Wang and Enrique Ramos performed sequencing on the GWA sample
and analyzed its frequency correlation. Ingrid Borecki and Mike Province provided the real
pools used for sequencing in this work. The methods developed in this chapter have been
successfully applied to several association studies through collaborations [122, 123, 124] and
have been expanded and featured in subsequent protocol papers [125, 126].
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2.2 Quantification of rare allelic variants from pooled genomic DNA
2.2.1 Abstract
We report a targeted, cost-effective method to quantify rare single-nucleotide polymor-
phisms from pooled human genomic DNA using second-generation sequencing. We pooled
DNA from 1,111 individuals and targeted four genes to identify rare germline variants. Our
base-calling algorithm, SNPSeeker, derived from large deviation theory, detected single-
nucleotide polymorphisms present at frequencies below the raw error rate of the sequencing
platform.
2.2.2 Intro/Results
The cumulative impact of rare variants on common disease is currently unknown, but
recent studies have implicated rare genetic variants in many complex traits and diseases.
Consequently, it has been suggested that the combined effects of rare deleterious mutations,
could explain a substantial fraction of the genetic susceptibility to many common diseases
[16, 17]. Identifying rare variants necessitates genotyping large populations of individuals,
either sequentially (e.g. the 1000 Genomes Project [127]) or, to minimize cost and time, as
a pooled sample. However, it has proven difficult to quantify the prevalence of deleterious
alleles in pooled samples. Sanger and array-based resequencing are expensive for the amount
of sequencing coverage obtained, thus incompatible with large pools. Second-generation
sequencing has lowered sequencing costs by over 100-fold, but high error rates have hindered
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the analysis of large pooled samples, since it is difficult to distinguish rare variants from
sequencing errors.
Due to cost and time savings, pooled-sample sequencing should be useful for studying
rare, human-specific genetic variation in large populations; characterizing deleterious alleles
at multiple loci that may impact disease susceptibility and treatment; quantifying the abun-
dance of rare somatic mutations; and identifying germline variants associated with disease
state.
We have implemented a novel combination of molecular biology techniques and compu-
tational analysis to achieve targeted resequencing and rare variant detection in 13 kb per
individual from 1,111 individuals using the Illumina Genome Analyzer I. We pooled a normal-
ized amount of DNA isolated from dried blood on 1,111 de-identified Guthrie cards collected
for newborn screening. The Missouri Department of Health and Senior Services Institutional
Review Board and the Washington University Human Research Protection Office reviewed
and approved use of de-identified DNA samples (Supplementary Methods). Using specific
primers (Supplementary Table 1), we PCR-amplified 15 loci covering 14.5 kilobases of the
surfactant protein B (SFTPB), TP53, APC and β-actin (ACTB) genes. Amplicons were
ligated into long concatemers, randomly fragmented, and prepared for Illumina sequencing
according to the manufacturers protocol. This generated 4.4∗107 sequences, 83.4% (3.7∗107
reads = 1.3 gigabases) of which aligned to the reference, allowing for up to 2 mismatches. To
quantify sequencing errors, we included a 1,276 bp region of the pUC19 plasmid as an internal
control. We used the first 800 bases to train our algorithm and the remaining 476 bases as
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a test set. We found that the first twelve bases of each Illumina read contained significantly
fewer errors than later bases (Figure 2.1a), so we used only these to identify sequence varia-
tion. However, sequencing errors were still present at a higher frequency than that of a single
allele in the pool, making an accurate error model essential to distinguishing bona fide vari-
ants from sequencing errors. Since existing second- generation base-calling programs cannot
detect and quantify rare variants in large pooled samples, we developed SNPSeeker, an al-
gorithm based on Large Deviation Theory (www.genetics.wustl.edu/rmlab). SNPSeeker
uses a 2nd order dependency error model for SNP identification and takes into account the
position in the sequencing read (i.e. cycle number) and the identity of the two upstream
bases. Consequently, only mismatches at bases 312 of each sequencing read were used to
identify SNPs (this reduces the effective coverage per allele to 13.8-fold in these experi-
ments). Unexpectedly, we found that incorporating quality scores did not improve results
beyond these parameters (Figure 2.4 and Results). For each machine run, we trained a
new error model using the internal pUC19 control, because we found that error rates varied
significantly between machine runs (Figure 2.1b).
The SNPSeeker algorithm significantly improved the specificity of SNP calling (Figure 2.5
and Results). Using SNPSeeker, no SNPs were called in the training sequence (bases 1800),
in the negative control (bases 8011,276) or in 656 of the 658 bp without a known SNP in the
SFTPB amplicon. This yields a specificity of 99.8% and demonstrates that our base-calling
algorithm is specific and able to accurately model sequencing and PCR errors. We validated
called SNPs by comparing them to prior individual Sanger sequencing at the SFTPB locus
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Figure 2.1. Error model reveals hidden trends in error rates
Figure 1.
Error modeling. (a) The cumulative likelihood of every possible misincorporation event for
sequencing cycles 1–32 is depicted for both the sense (+) and antisense (−) strands. The
Illumina data filtering process truncated the data from two dates at 32 bases instead of 36,
which is why only 32 cycles are represented here. INSET. Higher resolution of the error
probability across cycles 1–12. (b) The intra- and inter-day variability for the A→C
misincorporation event from four different sequencing dates. The error bars represent the
standard deviation between different flowcell channels from the same date. INSET. Higher
resolution of cycles 1–12.
Druley et al. Page 5






















Error modeling. (a) The cumulative likelihood of every possible misincorporation event for sequencing cycles
132 is depicted for both the sense (+) and antisense (-) stran s. e Illumina da a filtering process truncated
the data from two dates at 32 bases instead of 36, which is why only 32 cycles are represented here. INSET.
Higher resolution of the error probability across cycles 1-12. (b) The intra- and inter-day variability for the
A→C misincorporation event from four different sequencing dates. The error bars represent the standard
deviation between different flowcell channels from the same date. INSET. Higher resolution of cycles 1-12.
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in this cohort4 and performing additional Taqman assays (Supplementary Tables 2 and 3)
To estimate our methods sensitivity, we sequenced a 665 bp region of the SFTPB gene with 7
known SNPs. Our method identified all 7 SNPs at very similar frequencies to those found by
Sanger. Three of these SNPs were present at < 1.5% in this population demonstrating that
this method has the sensitivity to detect rare SNPs in this pooled sample (Supplementary
Table 3a). We also identified two SNP positions within SFTPB that were not identified
by Sanger. We performed individual Taqman assays on each of these positions and neither
mutation was identified.
In addition to the 9 called SNPs in SFTPB, 55 additional SNPs were called in ACTB,
TP53, and APC (Supplementary Table 4). Of these, 37 (67%) were previously described
in dbSNP (build 128). By chance, one would expect less than 1 SNP, on average, to be
shared between these two sets. Using Fishers Exact Test, we found that the observed degree
of overlap is highly significant (P < 1.3 ∗ 10−56). Therefore, it is highly likely that the 37
SNPs identified by SNPSeeker and found in dbSNP are bona fide variants. Many of these
SNPs were rare: 26 of the 37 dbSNPs that were identified had estimated allele frequencies
of less than 1.5% in our population (Supplementary Table 4). We also performed a com-
parative genomic analysis of the deleterious nature of the non-synonymous SNPs identified
(Supplementary Results and Table 5).
To estimate the positive predictive value of our method, we chose seven called SNPs in
these genes for independent validation by individual Taqman genotyping. All seven SNPs
were predicted to be rare, with estimated minor allele frequencies (MAF) ranging from 0.5
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1.2%. Three of the selected SNPs were previously reported in dbSNP, though not in our
population, and the remaining four have not been previously described. Taqman genotyping
validated all seven called rare variants (Supplementary Table 3b). When combined with
SFTPB results, we validated 14 of 16 predicted SNPs, giving a positive predictive value of
87%. To determine if the pooled sample sequencing method could accurately quantify allele
frequencies, we plotted the predicted versus true MAFs for each of the 14 validated SNPs
(Figure 2.2). The observed and predicted frequencies were highly correlated (r2 = 0.96)
across a wide range of frequencies: from a single allele (0.05%) up to several hundred alleles
(21.2%). When we plotted predicted SNP average heterozygosities against reported average
heterozygosity values for all SNPs in common with dbSNP, the correlation remained strong
at r2 = 0.82 (Figure 2.3). These findings indicate that pooled sample sequencing is able to
accurately determine the population frequency of common and rare alleles.
2.2.3 Supplementary Results
Error Model Generation using pUC19
For all sequencing performed, an internal control consisting of a 1,276 bp PCR amplified
sequence from E.coli -cloned pUC19 vector was included in order to model the likelihood of
observing errors in a SNP free context. Bases 1-800 of this amplicon were used to parame-
terize the algorithm with each machine run. Bases 801-1,276 were then used as a negative
control test sequence. This model specifies the probability of observing an error in a sequenc-
ing read as a function of 1) the true identity of the base being sequenced, 2) the identity of
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Figure 2.2. SNPseeker accurately quantifies SNPs found by pooled-DNA sequenc-
ing
Figure 2.
Allele frequency by sequencing vs. genotyping. The allele frequency as determine by
sequencing is plotted against the actual frequencies as determined by individual Taqman
assay for the 14 validated SNPs in our dataset (correlation coefficient r2 = 0.96).
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Allele frequency by sequencing vs. genotyping. The allele frequency as determine by sequencing is plotted
against the actual frequencies as determined by individual Taqman assay for the 14 validated SNPs in our
dataset (correlation coefficient r2 = 0.96).
the observed base, 3) the identities of the two reference bases immediately upstream of the
base being sequenced, and 4) the current cycle number of the sequencing read (i.e. cycle 1
to 36). For each sequencing cycle j in the read, we calculated the probability of observing
a base x, where x ∈ B,B = {A,C,G, T,N}, given a base n in the reference sequence such
that n ∈ ℵ,ℵ = {A,C,G, T}. Due to observed variability in sequencing errors between
machine runs (Figure 2.1B), we created a new error model for each machine run. SNPSeeker
uses a 2nd Order Model which assumes a 2nd order dependency between reference sequence
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Supplementary Figure 3. Pooled-sample versus dbSNP average heterozygosity.  Of the 44 SNPs that
were described in dbSNP, 37 had average heterozygosity values listed.  These values (with standard
error bars) are plotted on the Y-axis against the corresponding average heterozygosity value as 
determined from the SNP frequency in the pooled-sample (correlation coefficient r2 = 0.82). The solid
line is a plot of the idealized 1:1 correlation between data sets and the dashed line is the actual linear
regression.
Pooled-sample versus dbSNP average heterozygosity. Of the 44 SNPs that were described in dbSNP, 37
had aver ge heterozygosity values listed. These values (with standard error bars) are plotted on the Y-axis
against the corresponding average heterozygosity value as determined from the SNP frequency in the pooled-
sample (correlation coefficient r2 = 0.82). The solid line is a plot of the idealized 1:1 correlation between
data sets and the dashed line is the actual linear regression.
nucleotides. Thus, we assume that the likelihood of i being sequenced correctly depends on
i − 1 and i − 2 (this model is computed starting from read cycle 3). We found that the
first twelve bases of each Illumina read contained significantly fewer errors than later bases
(Figure 2.1A) so we only used these bases to identify sequence variation. Since we use a
2nd order dependency model for SNP identification, only mismatches at bases 3-12 of each
read were used to identify SNPs. On average, each position in the reference sequence was
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observed 30,593 times in bases 3-12 of the Illumina sequencing reads (i.e. 13.8-fold coverage
of 1,111 diploid genomes).
Illumina Quality Scores
Our error models do not take into account the ILLUMINA quality scores since we did
not find any improvement by including them in our error models. As shown in Figure 2.4,
we have plotted the quality scores (QS) generated by the Illumina Genome Analyzer against
the true quality scores, defined as the −log10 of the probability of incorporating a nucleotide
different from the reference sequence base (calculated from the negative control vector as
described). As shown in Figure 2.4 quality scores less than 10 are informative of poor bases,
but higher quality scores do not accurately reflect true error rates, as is evident by the
plateau in the trend line for quality scores above 10. Since most bases with quality scores
less than 10 occured at the ends sequencing reads, and this information is already accounted
for by our read position parameter, incorporating QS into the algorithm did not improve
SNP calling. However, for other applications needing to utilize QS data, these measurements
are easily integrated into the Large Deviation Theory framework.
Non-specific PCR amplification analysis.
To assure that non-specific PCR amplification across the human genome was not a source
of error in our SNP calling, we performed the following analyses. First, all primer combina-
tions were designed to avoid repetitive regions of the human genome. Second, we performed
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Supplementary Figure 1. Illumina Genome Analyzer I quality score analysis.
The quality scores generated by the Illumina Genome Analyzer I are plotted 
along the X-axis while the true quality scores, defined as –log10 of the probability
of incorporating a nucleotide different from the reference sequence bases (as
calculated from the negative control vector as described).
Supplementary Figure 1. Illumina Genome Analyzer I quality score analysis.
Illumina Genome Analyzer I quality score analysis. The quality scores generated by the Illumina Genome
Analyzer I are plotted along the X-axis while the true quality scores, defined as log10 of the probability
of incorporating a nucleotide different from the reference sequence bases (as calculated from the negative
control vector as described).
in silico PCR for each primer combination (via the UCSC Genome Browser) against the en-
tire human genome to demonstrate that a single, unique PCR product, spanning the region
of interest, was the only product expected. Finally, we used our alignment algorithm to map
back all sequencing reads against the entire human genome. We found that 544,195 reads
(1.45% of the total) mapped back to more than one location in the human genome. We then
excluded these reads from further SNP calling analysis and found that none of our 64 SNP
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calls were significantly altered in terms of identity or frequency. These results indicate that
non-specific PCR amplification is not adversely affecting SNP identification.
How SNPSeeker improves SNP calling
A single allele, occurring in a population of 2222 alleles, has a frequency of 0.00045.
Despite limiting the data for SNP calling at bases 1-12, the average likelihood of an error
across these bases was 0.00065 and rose dramatically as more bases were included in the
analysis. In order to identify, with a high degree of certainty, true polymorphisms that
occurred in the pool at a frequency less than the incipient error rate of the sequencing
platform, we designed SNPSeeker, an algorithm based on Large Deviation Theory, and
implemented SNPSeeker into the analysis. Figure 2.5 demonstrates how SNPSeeker further
refines SNP identification above and beyond simply using the first 12 bases of each read.
When considering pUC19 and trying to identify a single allele in the pool, using 32 bases
per read identified 785 bases (out of 800 in the training set) as potential SNPs. When
only considering the first 12 bases per read without using the algorithm, 705 bases out of
800 were identified as SNPs. By implementing SNPSeeker, zero positions were identified as
SNPs. Figure 2.5 demonstrates how each of these conditions would affect SNP calling in the
SFTPB amplicon. Using 12 bases and a frequency cutoff calculated on pUC19, we identified
19 potential SNP sites. By applying SNPSeeker, over 50% of the sites are eliminated and
only 9 SNP positions remain.
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Figure 2.5. SNPSeeker improves SNP calling by removing sequencing errors
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How SNPSeeker improves SNP calling. In each panel, the X-axis depicts the sequential 665 bp of the
SFTPB amplicon and the Y-axis is the percent likelihood of a mismatched ba e w n co pared to the
reference sequence. (a) When using 32 bases per read to perform SNP calling, there are 218 positions in the
SFTPB amplicon th ar considered likely to contain a SNP. (b) When using only the first 12 bases of each
read and a frequency cutoff calculated by the error model generated from pUC19 data, there are 19 base
positions considered to have potential SNPs. INSET: Ten-fold higher resolution plot showing a maximum
1% likelihood of mismatch. (c) When implementing SNPSeeker on the data from cycles 1-12, only 9 SNP
positions remain. INSET: Ten-fold higher resolution plot showing a maximum 1% likelihood of mismatch.
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Comparative Genomics Analysis Demonstrates that Rare Non-synonymous SNPs
are Deleterious
Twelve nonsynonymous SNPs from all four genes tested were identified in this analysis.
Of these 12 sites, SIFT identified 7 as deleterious, PolyPhen 3, and the LRT predicted that 5
would disrupt highly significant positions (dN/dS <1 and LRT, P <0.001) (Supplementary
Table 5). Five of the 7 sites identified by SIFT are not found in dbSNP. One of these five,
position 112207052 in APC (marked with †), was validated by Taqman assay. Four of the
five non-dbSNP sites (2 in TP53 and 2 in APC, marked with asterisks), including APC
112207052, were previously published in the germline of individuals with cancer [128, 129,
130, 131]. Four of the five evolutionarily conserved amino acid positions identified by the
LRT are perfectly conserved across all species. If recessive, the phenotypic effects of the
deleterious SNPs should rarely be observed and may be quite severe.
2.2.4 Discussion
A deeper understanding of genetic variation in the human population will allow us to
dissect the causative factors that contribute to a wide array of human disease, understand
the genetic characteristics that make us uniquely human, and quantify the impact of selec-
tion across our genome throughout history. We have successfully resequenced 13,237 bases
per 1,111 individuals at approximately 2% of the cost of the original analysis by Sanger
sequencing [132]. Importantly, this cost savings did not come at the price of sensitivity or
accuracy.
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The positive predictive value of 87% obtained in this study is consistent with previously
published values of 85% [133] and 92% [134] in assays identifying SNPs from multiple organ-
isms via second-generation sequencing, but we analyzed over an order of magnitude more
individuals (1,111 vs. 2 [133] or 66 [134]) than these studies. The ability to pool larger
numbers of individuals enables the discovery of rare SNPs, which is important, since most
deleterious SNPs are unlikely to be present at frequencies greater than 1%. Furthermore,
our method more accurately estimates MAFs (r2 = 0.96 vs. 0.67 [134]), which is important
to accurately identify disease-associated alleles when comparing disease and normal cohorts.
At the SFTBP locus, we successfully detected a single mutant allele in a background of
2,221 wild-type alleles; however, there were not enough private mutations in our validation
set to determine the sensitivity of our method for the detection of private SNPs (MAF <
0.05%) in this population. For applications where it is important to detect singleton SNPs
with a high sensitivity, we recommend choosing a pool size such that private mutations are
present at frequencies similar to those of the rare SNPs validated here (MAF = 0.5 −1.2%).
There are various applications for this method. Sequencing large, random populations
at various genetically significant loci would enable the study of human-specific variation
and selection. Quantification of rare somatic mutations in tumors and precancerous lesions
would facilitate improved understanding of tumorigenesis. Finally, sequencing case-control
or matched sample cohorts will enable identification of rare mutations associated with com-
plex diseases [16, 17]. Candidate genes can be selected based on prior knowledge [16, 17]
or they can be informed by genome wide association studies. Combining pooled-sample se-
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quencing with genomic selection strategies [135, 136, 137] makes it possible to move beyond
the candidate gene approach and perform a more systematic survey of protein-coding DNA.
Such knowledge would be a valuable tool for disease screening, assigning risk stratification,
providing longitudinal preventative care, and tailoring risk-appropriate therapy.
2.2.5 Materials and methods
Genomic DNA Samples
We extracted genomic DNA from 1,111 random, anonymous Guthrie cards collected
for newborn screening between 1993 and 2000 by the Missouri Department of Health and
Senior Services (DHSS) [132, 138]. Both the Missouri DHSS Institutional Review Board
and the Washington University Human Research Protection Office reviewed the project and
approved waiver of individual consent for use of de-identified DNA samples under regula-
tion 45CFR467.116d (for the regulation, see http://www.hhs.gov/ohrp/humansubjects/
guidance/45cfr46.htm#46.116). Each individual DNA sample was anonymously linked to
clinical characteristics in a vital statistics (birth-death certificate) database maintained by
the Missouri DHSS to determine ethnicity. Ethnicities within the population were as follows:
European-American = 871 (78.4%), African-American = 196 (17.6%), Hispanic = 34 (3.1%),
Asian = 5 (0.5%) and unknown = 5 (0.5%).
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Genomic DNA Extraction
Genomic DNA extraction was adapted from previously described methods by Hamvas
et al [132]. Modifications to this process included sequential incubation in 200 µL distilled
water at room temperature for 60 min and 45 min on an orbital shaker at 400 rpm. DNA was
extracted in a solution of 200 µL of 10 mM Tris with 1 mM EDTA, pH 6.8 and 2% (wt/vol)
Chelex 100 Molecular Biology Grade chelating resin (Bio-Rad, Hercules, CA, U.S.A.).
DNA Quantification
High-throughput DNA quantification was performed using a fluorescent nucleic acid stain
in a 384-well format. To mimic the fragmented and denatured quality of the sample DNA,
commercial human genomic DNA at 163 ng/µL (Promega, Madison, WI, U.S.A.) was son-
icated for 15 seconds at maximal power using a Misonix XL2020 Ultrasonic Processor son-
icator (Misonix, Farmingdale, NY, U.S.A.) and then heated at 100oC for 25 minutes. This
DNA was then serially diluted by 50% eight times. DNA concentrations of 20.38, 10.19, 5.09,
2.55, 1.27 and zero ng/µL were added, as described below, to the 384 plate in duplicate to
be used as a DNA standard. SYBR Gold (Molecular Probes, Eugene, OR, U.S.A.) was the
fluorescent nucleic acid stain used due to its ability to bind both single and double-stranded
DNA. Immediately prior to each quantification experiment, the stain was diluted 1:1000 in
10 mM Tris with 1 mM EDTA, pH 7.5 and protected from light. For quantification deter-
mination, each well on a black 384-well polystyrene Fluotrac 200 microtiter plate (Greiner
Bio-One, Monroe, NC, U.S.A.) contained a final volume of 20 µL consisting of 2 µL DNA
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suspension, 8 µL of 10 mM Tris with 1 mM EDTA, pH 7.5 and 10 µL SYBR Gold 1:1000
suspension. The plate was protected from light until processing. Fluorescent detection was
done on a Synergy HT (Biotek, Winooski, VT, U.S.A.) plate reader. With excitation at
485/20 and emission 528/20, the machine automatically determined the optimum sensitivity
level for each experiment by scaling fluorescence against the negative control wells. The
fluorescent plate reader then determined the fluorescent level in each well on the plate. A
mean fluorescent value was determined for each concentration of the DNA standard and a
linear regression was then generated. The equation of the linear regression was then used to
calculate the concentration of DNA in each sample well.
Pooling of DNA
We elected to pool 80 ng of DNA per individual. This amount was chosen simply to have
a pool of DNA large enough to perform multiple PCR and sequencing reactions. Pooling
was done manually and the final volume was over 29 mL. Concentration of pooled DNA was
done using the Qiagen QIAvac 96-well vacuum manifold and QIAquick 96 PCR Purification
Kit (Qiagen, Valencia, CA, U.S.A.). This kit is intended to purify DNA from 100 bp to 10
kb. Gel electrophoresis of the highly fragmented genomic DNA isolated from blood spots
shows a mean size of approximately 3 kb with no visible smear above 10 kb (not shown).
The resulting DNA suspension was approximately 2 mL with a concentration, determined
by SYBR Gold staining, of 2.6 ng/µL.
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PCR
PCR primers were designed using Primer 3 (http://frodo.wi.mit.edu/primer3/input.
htm) with parameters previously described [139]. All primers were purchased through Inte-
grated DNA Technologies (Coralville, IA, U.S.A.). Reference sequence for each human gene
was obtained from the UCSC Genome Browser (http://genome.ucsc.edu/index.html)
and, for the pUC19 vector, from New England Biolabs NEBcutter website (http://tools.
neb.com/NEBcutter2/index.php). Refseq accession numbers for human reference sequences
were: TP53, NM000546; SFTPB, NM000542; APC, NM000038; ACTB, NM001101. Each
individual PCR reaction was designed to include an average of 30 genome equivalents per
individual. Assuming a Poisson distribution for the number of molecules input into the
pool, this amount was determined to minimize the likelihood that one individual DNA sam-
ple would be omitted in a PCR reaction, while keeping the volume of PCR reactions within
common standards as well as optimizing the allocation of the pooled DNA. The thermostable
polymerase utilized was PfuUltra High-Fidelity DNA Polymerase (Stratagene, La Jolla, CA,
U.S.A.) due to its reported extreme accuracy. PCR reaction contents were as follows: 1X final
concentration of 10X PfuUltra Buffer, 200 µM dNTPs (Invitrogen, Carlsbad, CA, U.S.A.),
400 nM forward primer, 400 nM reverse primer, 1M betaine (Sigma-Aldrich/Fluka, St. Louis,
MO, U.S.A.), 2.5 units PfuUltra DNA polymerase and 150.8 ng of pooled genomic DNA.
The final reaction volume was 100 µL. Annealing temperatures and extension times varied
slightly between reactions and are listed, along with primer sequences, in Supplementary
Table 1. In general, all PCR reactions were as follows: 1) 93oC x 2 minutes; 2) 93oC x 30
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seconds; 3) 56-62oC x 30 seconds; 4) 65oC x 1-5 minutes; 5) steps 2-4 for 28 cycles; 6) 65oC
x 10 minutes; 7) hold at 4oC. In total, there were 14 human PCR amplicons covering 13,237
bp and 19 exons in the four genes samples as well as a single amplicon from the pUC19 vec-
tor. All PCR products then went through the QIAquick PCR purification protocol (Qiagen,
Valencia, CA, U.S.A.) and quantified using the Nanodrop ND-1000 spectrophotometer.
Random Amplicon Ligation.
Next-generation sequencing was designed to sequence major portions of or even whole
genomes in a single machine run. Equal coverage across the genome is dependent upon
random fragmentation followed by aligning and tiling the millions of small DNA sequences
against the reference genome. Our computational analysis suggested that random fragmen-
tation by sonication cannot be achieved for small DNA sequences such as PCR amplicons
less than about 1500 bp (not shown). A majority of such fragments would be fragmented in
the middle of the sequence resulting in overrepresentation of the unfragmented end pieces
of the amplicon in the final sequencing output. To overcome this, we randomly ligated
a normalized number of pooled PCR-amplified products and sonicated the resulting con-
catamers. From each PCR product, 40x1010 molecules of each amplicon were pooled. A
blunt ended ligation (PfuUltra generates blunt ended products) was performed as follows:
1X of 10X T4 DNA Ligase Buffer (New England Biolabs, Ipswitch, MA, U.S.A.), 2400 units
of 400 units/µL T4 DNA Ligase (New England Biolabs, Ipswitch, MA, U.S.A.), 120 units of
10 units/µL T4 Polynucleotide Kinase (New England Biolabs, Ipswitch, MA, U.S.A.), 15%
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(wt/vol) polyethylene glycol 8000 MW (Sigma-Aldrich, St. Louis, U.S.A.) and the PCR am-
plicon pool brought the total volume to 600 µL. This volume was aliquoted into four equal
parts and incubated for 17 hours at 22oC, followed by 20 minutes at 65oC and held at 4oC
thereafter. Agarose gel electrophoresis was performed with a small amount of the resulting
product to confirm concatenation. Electrophoresis confirmed concatenated products >10kb
(not shown).
Sonication
Random fragmentation of the ligated concatemers was performed using the Covaris S2
sonicator (Covaris, Woburn, MA, U.S.A.). Each 150 µL ligation aliquot was diluted in 350
µL of sterile, distilled water and transferred to a 13mm x 65mm borosilicate glass tube with
polypropylene screw-top (Covaris, Woburn, MA, U.S.A.). The samples were sonicated indi-
vidually with the sonicator programmed as follows: 15 cycles, duty cycle 20%, intensity 10,
cycles/burst 1000, time 60 seconds, bath temperature limit 20oC. Agarose gel electrophoresis
confirmed fragmentation of concatenated DNA as a smear from approximately 75-3000 bp
with maximal ethidium bromide staining intensity between 150-200 bp (not shown).
DNA Library Preparation for Sequencing
Following fragmentation, a DNA library for sequencing was prepared according to the pro-
tocol described in the Preparing Samples for Sequencing Genomic DNA document provided
by Illumina for the Genome Analyzer and starting with the end repair step. A difference
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from the described protocol included gel excision and purification of fragments from 125-400
bp. The concentration of PCR-enriched, adapter-ligated DNA fragments following clean up
was determined by Nanodrop ND-1000 spectrophotometer and found to be 29.3 ng/µL.
Sequencing
While we could have generated all data from a single flowcell, we were sharing flowcell
lanes with other investigators. Therefore, the same DNA library was sequenced in a total
of 12 flowcell lanes from four different dates. The protocol for preparing DNA samples for
sequencing is described on page 12 of the Illumina document entitled Preparing Sample
DNA for Cluster Generation. Sample DNA was diluted to 10 nM in Qiagen EB buffer as
recommended. In the initial sequencing run, a titration of DNA concentrations of 0.5, 1
and 2 pM was performed in three separate lanes to determine optimum cluster generation.
Two pM was determined to be optimal and all subsequent sequencing was performed at this
concentration. From the same library, we performed an additional 9 lanes of sequencing on
three separate dates.
TAQMAN Assays
For independent, individual validation of putative SNPs, we performed Taqman assays
on all individuals in our pool. The primers / probes design, manufacture, and testing is done
at Applied Biosystems (ABI) manufacturing facilities. Each designed probe set contains 2
probes, with VIC (allele 1) and FAM (allele 2) reporter dyes linked to the 5’ end of each
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respective probe, a MGB, and a nonfluorescent quencher (NFQ) at the 3’ end of both probes.
The primers and probes for the nine sites tested in this study are listed in Supplementary
Table 2. Sites found in dbSNP had pre-existing primers and probes that are commercially
available and proprietary to ABI. For each SNP site of interest, we submit a sequence file
identifying the polymorphic base, along with 300 flanking bases both 5’ and 3’ of each
SNP site to ABI. ABI then designs an assay using proprietary algorithms that minimize
adverse assay effects, such as base runs or secondary structure formation. Primers and probe
sequences are matched by melting temperature, permitting universal PCR assay conditions.
They also use mass spectrometry to verify the oligonucleotide sequence and perform further
testing to ensure proper formulation of the primer and probe mix. The assays are also
functionally tested using an allelic detection test prior to delivery, then delivered in a single
tube format. We assayed 12 96-well plates with no-template (blank) controls in wells H10,
H11, H12 of each plate for the nine SNP positions listed in Supplementary Table 2. For
each plate, a master mix was made of 1,250 µl 2X Taqman genotyping master mix (ABI,
part # 4371357) and 125 µl 20X SNP genotyping assay mix (ABI, part # 4332027). Next,
13.75 µl master mix is aliquoted into each well of a 96-well optical reaction plate (ABI, part
# 4346906). Then, 1 µl of genomic DNA from each test plate, along with 10.25 µl DNase-
free water, is added to each well of the optical reaction plate. Plates are then covered with
an optical adhesive film (ABI, part # 4311971) and PCR is performed on an MJ PCT-225
thermocycler. An initial enzyme activation is required at 95C for 10 minutes, followed by
40 cycles of denaturing at 92C for 15 seconds and anneal/extension at 60C for 1 minute.
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Upon completion of the PCR amplification, endpoint plate reading and genotype calls are
performed on the ABI 7500 FAST Real Time PCR system.
Large Deviation Theory applied to Illumina Genome Analyzer output.
We found that existing second-generation base calling programs were unable to detect
and quantify rare variants in a large pool of multiple individuals (Vallania and Mitra, unpub-
lished results), so we developed a new base calling method based on Large Deviation Theory
and named SNPSeeker. All the software and sequence data used for the analysis is available
at (http://www.genetics.wustl.edu/rmlab/). Sequences were mapped back to reference
by using an ungapped alignment algorithm and allowing 2 mismatches (this allowed unam-
biguous mapping) and then positions were considered separately. For each position i in the
reference, all the sequence bases aligned to that position are analyzed. This analysis relies
on the assumption that the sequencing process generates sequences independent from one
another. A second assumption is that sequences are formed by nucleotides (corresponding
to sequencing cycles) that are independent from one another as well.
Given these assumptions, it is possible to define subsets of nucleotides for each cycle j,
sequencing run d and strand s. These nucleotides are drawn from the same background
probability distribution and, as part of our assumptions, are independent from one another.
Each set can be therefore defined as a series of n i.i.d. random variables (where n is the
number of total bases for each considered subset)
Xj,d,s,1, Xj,d,s,2, Xj,d,s,3, . . . , Xj,d,s,n
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drawn according to a distribution Qj,d,s(x) with symbols χ = {A,C,G, T,N}. For each



















If we assume the null hypothesis of observing no polymorphism at position i, i − 1 and
i− 2 in the reference sequence, then Qj,d,s(x) will exactly correspond to the distribution of





Pr(x|Mi = n, j, d) ∗ Pr(Mi = n|s, τ) (2.1)
where:
• Pr(x|Mi = n, j, d) corresponds to the distribution of errors computed from pUC19 and
indicates the probability of seeing a base x in the sequence at cycle position j on run
d given that the original base at position i in the reference, Mi, is equal to n, where
x ∈ B and n ∈ ℵ (see Error Model Generation using pUC19 section).
• Pr(Mi = n|S, s, τ) corresponds to the probability of observing nucleotide n in the ref-
erence sequence at position i, Mi = n, given the strand s and the true allele frequency
vector τ .
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To determine the likelihood of observing a SNP at position i, we compute the amplitude
of the deviation between Pj,d,s and Qj,d,s, formulated as the probability of observing a number
of nucleotides different from the major allele (the nucleotide in the reference at position i)
equal or greater than the number observed in the analyzed subset. According to Sanov’s
theorem [140], this is equivalent to
Qnj,d,s(E) = 2
−nj,d,sD(Pj,d,s‖Qj,d,s) (2.2)
id est the probability of generating a set of types E satisfying the above described conditions.
D(Pj,d,s ‖ Qj,d,s) corresponds to the relative entropy or Kullback–Leibler distance 4 between
Pj,d,s and Qj,d,s. Since we expect true SNPs to be detected on both strands and errors to








given the previous independence assumptions. Each probability value Qnj,d,s(E) is Bonferroni-
corrected for the total number of tests performed at position i and Qs(E) is additionally
corrected for the total number of tests performed at each position in the reference sequence
(corresponding to its length). In order for position i to be called as a SNP, Qs(E) must be
below a significancy cutoff (α = 0.05) given the appropriate corrections. If this is true for
both strands then position i contains at least one allele variant.
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Estimation of the true SNP frequencies by Non-Linear Least Square Fit.
For every position in which a SNP was found, we estimated its true allele frequencies by
performing a non-linear least square fit. Given the relative entropy term in (2.2), we can
decompose it as








Given Pj,d,s and Qj,d,s, their relative entropy will converge to 0 the closer they will get to
each other. That will correspond to a descrease in the difference between nj,d,sH(Pj,d,s) and
−nj,d,s
∑





If we repeat this consideration for each cycle j, day d and strand s, we can define an

























As defined in (2.1), Qj,d,s will depend on Pr(Mi = n|s, τ) which is conditioned on τ . τ
is defined as a stochastic vector with 4 entries, each representing the probability of seeing
a particular nucleotide in a given position in the reference sequence (with respect to the
forward strand as the adopted convention). The τ vector that minimizes |y− ŷ| is defined τ̂
and corresponds to

















Pr(x|Mi = n, j, d) ∗ Pr(Mi = n|S, s, τ)
]}2
(2.7)
This is computed iteratively, initially defining all possible τ probability vectors starting
with a resolution ρ of 1 significant digit (0.1) and then selecting the vector that minimizes
|y − ŷ|. After this step, ρ is decreased 10-fold (0.01 or 2 significant digits) and only vectors
located within a range defined as τ̂ ± 20 ∗ ρ for each vector entry are then analyzed. This
allows the values of τ̂ to be refined without requiring massive computational power. These
steps are iterated progressively until the estimate at each step is refined to resolution of 3
significant digits (the final resolution is a user defined parameter).
Comparative Genomics Analysis using SIFT, PolyPhen, and the Likelihood Ra-
tio Test
While most common SNPs are likely neutral, 50% of rare (< 5% in the general population)
nonsynonymous SNPs have been estimated to be deleterious [141], many of which may
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produce significant phenotypic effects, even if heterozygous. We thus sought to determine if
any of the identified nonsynonymous SNPs are deleterious. The genome sequences of multiple
vertebrate species make it possible to identify functional sequences by their conservation
across species. Given enough evolutionary time, even a single amino acid position has a very
small probability of being conserved by chance.
To test whether any of the nonsynonymous SNPs are deleterious, we used three differ-
ent prediction algorithms. Two of the algorithms, SIFT [142] and PolyPhen [143], make
predictions based on conservation and structural motifs, respectively. However, without a
formal probabilistic framework the rate of false positive prediscitons is difficult to know.
The third algorithm is based on a likelihood ratio test (LRT) that compares the probability
of conservation across species at a single amino acid position under a neutral model and a
model of selective constraint [144]. Under the neutral model, the probability of amino acid
conservation is calculated using the synonymous substitution rate for each gene. Under the
model of selective contraint, the nonsynonymous substitution rate is allowed to be a fraction
of the synonymous rate. This codon based test is similar to a test developed for noncoding
sequences.
For each gene, coding sequences were downloaded from ENSEMBL (www.ensembl.org),
the translated protein sequences were aligned using ClustalW, and then translated back into
their corresponding DNA sequences. The number of species ranged from 15 (ACTB) to 21
(APC ) with the most distant species ranging from Platypus (SFTPB) to Zebrafish (TP53 ).
The maximum likelihood phylogenetic relationship of each gene was obtained using Phylip
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and the maximum likelihood estimate of the synonymous substitution rate was obtained us-
ing HyPhy and the MG94xHKY85 3x4 nucleotide substitution model. The total synonymous
substitution rate ranged from 4.37 for SFTPB to 14.98 for TP53. The likelihood ratio test
compares two models in order to determine whether a nonsynonymous SNP is deleterious and
disrupts a conserved amino acid position. Under the null model, the likelihood of the data
was calculated assuming no constraints such that both the synonymous and nonsynonymous
substitution rate of the SNP containing codon were equal to the synonymous rate for the
entire gene. Under the alternative model, the likelihood of the data was calculated assuming
the SNP containing codon was constrained such that the nonsynonymous rate was a fraction
of the synonymous rate. Deleterious SNPs were defined as those for which nonsynonymous
rate was significantly less than the synonymous rate.
ACTB
• Species: 16
• Tree order: human, chimp, pongo, macaca, treeshrew, mouselemur, dog, elephant,






• Tree order: human, chimp, macaque, mouselemur, elephant, tenrec, cat, dog, cow,






• Tree order: human, chimp, orangutan, macaque, elephant, tenrec, cow, bat, dog, horse,





• Tree order: human, chimp, macaque, mouselemur, cat, cow, microbat, shrew, armadillo,
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2.2.7 Supplementary tables
Figure 2.6. Supplementary Table 1. PCR primers and conditions
TEMPLATE LEFT (5'ĺ3') RIGHT (3'ĸ5')
1 pUC19 gacctgcaggcatgcaag gtatcaacggactgaggggcagcac 1276 62 C 4 min
2 ACTB , exons 2/3 gcctccgaccagtgtttgcctttta acgcgggaaagagtgaccaagagag 755 60 C 90 sec
3 ACTB , exons 4/5 ccccagcacacttagccgtgttctt acagaaaggacggactcgactggac 853 60 C 90 sec
4 ACTB , exons 6 gctgtcacatccagggtcctcactg cacactgaaacaccacaccgaccca 821 60 C 90 sec
5 SFTPB , exons 7/8 agtggaggcttgccaagtgaaggtc ctgtggatcctacccggtcttacct 665 58 C 90 sec
6 TP53 , exon 1 cctccccaactccatttcctttgct ccactcaccctaccttcgaaccgat 423 58 C 90 sec
7 TP53 , exon 2-4 tgctggatccccacttttcctcttg gtagggtagtgtgggagtcgtagag 884 60 C 90 sec
8 TP53 , exon 5/6 ttgctgccgtcttccagttgcttta agagaccctcctccccaattcccac 530 58 C 90 sec
9 TP53 , exon 7-9 ggcctcatcttgggcctgtgttatc tacggagtttctgttaccgaggacc 928 58 C 4 min
10 TP53 , exon 10 acttctccccctcctctgttgctgc aaggtaagagtaggacggaagtacc 223 56 C 60 sec
11 TP53 , exon 11 ttgaattcccgttgtcccagcctta ggactcagacgttactcacacccga 1495 60 C 5 min
12 APC 1, exon 15 cccaccccctgcaaatgttttaagc gttatgggtcggctggatcgggtat 1332 62 C 5 min
13 APC 2, exon 15 caatacccagccgacctagcccata tacgacgtcaagtctcccaggtcca 1447 62 C 5 min
14 APC 4, exon 15 taccagacagaggggcagcaactga ggttcttcactcagacggaggtttcc 1381 62 C 5 min
15 APC 5, exon 15 ccaagaagtgagtctgcctccaaagg acaatctcccaaaaacaagaccttcg 1500 62 C 5 min
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Supplementary Table 1. PCR primers and conditions.  For each amplified region of 
genomic DNA, the specific primer combination, size of the resulting amplicon, PCR 
annealing temperature, and extension time are listed. 
Supplementary Table 1. PCR p imers and conditions.
PCR primers and conditions. For each amplified region of genomic DNA, the specific primer combination,
size of the resulting amplicon, PCR annealing temperature, and extension time are listed.
Figure 2.7. Supplementary Table 2. Taqman assay primers and probes.
SNP Forward primer Reverse Primer
TP53;  rs17881850 proprietary by ABI proprietary by ABI
TP53;  rs17880847 proprietary by ABI proprietary by ABI
TP53;  chr17:7512477 TCCCCTCCTTCTCCCTTTTTATATCC GTTCACCCCTCAGACACACA
ACTB;  chr7:5534814 CAGCCATGTACGTTGCTATCCA CCATCACGATGCCAGTGGTA
APC;  rs2229994 proprietary by ABI proprietary by ABI
APC;  chr5:112202922 CCATCCAAGTTCTGCACAGAGTAG TCTACACAATAAGTCTGTATTGTTTCTTGGTT
APC;  chr5:112207052 CCGCAAAAGGAACATGGAGAAAA TGAGGAAACGGTCTGAGAAGTACTA
SFTPB;  chr7:85744364 CCTGGCTGAGCGCTACTC GGGCAGTGGGCTCACTT
SFTPB;  chr7:85744391 GCGGGCGGCATCTG CCCAGCAGCGTGTCGA
SNP Probe 1 Probe 2
TP53;  rs17881850 proprietary by ABI proprietary by ABI
TP53;  rs17880847 proprietary by ABI proprietary by ABI
TP53;  chr17:7512477 CTTATTTTACAATAAAACTTTG TTATTTTACAATACAACTTTG
ACTB;  chr7:5534814 CCCTGTACGCCTCTG TCCCTTTACGCCTCTG
APC;  rs2229994 proprietary by ABI proprietary by ABI
APC;  chr5:112202922 CCTCAAAAGGCTGCC CTCAGAAGGCTGCC
APC;  chr5:112207052 TTGTGGGAGAAAAT TTGTGGGACAAAAT
SFTPB;  chr7:85744364 CTGGGCCGCATGC CTGGGCCACATGC
SFTPB;  chr7:85744391 CTCCGTCATCCTGC CTACTCCATCATCCTGC
Supplementary Table 2. T qman assay primers and probes.
a
b
Supplementary Table 2. Taqman assay primers and probes. The specific primers (a) and
probes (b) for the nine sites tested in this study are listed. Commercially available primers 
and probes for specific dbSNP sites are proprietary to Applied Biosystems (ABI).
Taqman assay primers and probes. The specific primers (a) and probes (b) for the nine sites tested in this
study are listed. Commercially available primers and probes for specific dbSNP sites are proprietary to
Applied Biosystems (ABI).
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Figure 2.8. Supplementary Table 3. Taqman validation.



















































































































Supplementary Table 3a. SFTPB SNP comparison between Sanger and pooled sequencing
Supplementary Table 3. Validated SNPs. (a) SNP comparison between Sanger and pooled-
sample sequencing at the SFTPB locus. (b) The 7 rare SNP positions validated by Taqman assay 
at the TP53, APC and ACTB loci.  The correlation between called and actual frequencies for these
14 SNP positions shown in the main text Fig. 2.Validated SNPs. (a) SNP comparison between Sanger and pooled- sample sequencing at the SFTPB locus.
(b) The 7 rare SNP positions validated by Taqman assay at the TP53, APC and ACTB loci. The correlation
between called and actual frequencies for these 14 SNP positions shown in the main text in Figure 2.2
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Figure 2.9. Supplementary Table 4. Known and putative SNP positions identified
by pooled-sample sequencing
Gene


















TP53 7520526 (intron 2) C  G 78.1 -4547.5 -13062.7 rs1642785 0.468 ± 0.122 intronic
Chr17 7520344 (intron 3) C  A 5.9 -481.6 -233.6 rs17883323 0.1 ± 0.2 intronic
7520304 (exon 4) G  A 0.8 -29.1 -11.0 rs1800370 0.013 +/- 0.079 synonymous
7520273 (exon 4) C  T 0.4 -4.9 -4.2 rs1800371 0.027 +/- 0.114 CCG(P) TCG(S)
7520197 (exon 4) C  G 69.2 -16138.0 -13782.3 rs1042522 0.49 ± 0.07 CCC(P) CGC(R)
7519200 (exon 5) C  T 0.1 -2.4 -5.0 n/a CCG(P) CTG(L)
7519072 (intron 5) C  T 0.1 -1.4 -1.6 n/a intronic
7518935 (exon 6) A  G 1.2 -111.0 -172.2 rs1800372 0.024 +/- 0.106 synonymous
7518274 (exon 7) C  T 0.1 -9.3 -5.8 n/a synonymous
7518272 (exon 7) G  A 0.4 -89.8 -49.8 n/a GGC(G) GAC(D)
7518152 (intron 7) C  T 8.1 -2118.2 -4662.7 rs12947788 0.246 +/- 0.250 intronic
7518132 (intron 7) T  G 7.9 -2800.5 -2665.4 rs12951053 0.296 +/- 0.246 intronic
7517566 (intron 9) T  C 1.5 -175.9 -99.8 rs1800899 unknown intronic
7514622 (intron 10) A  T 0.6 -103.8 -95.0 rs17880847 0.011 +/- 0.074 intronic
7513806 (intron 10) G  C 0.2 -3.7 -4.3 rs17883043 0.012 +/- 0.076 intronic
7513782 (intron 10) C  T 1 -98.4 -96.7 rs17881850 0.012 +/- 0.076 intronic
7513447 (exon 11) G  A 0.4 -4.8 -30.7 rs16956880 0.019 +/- 0.095 UTR
7513324 (exon 11) G  A 0.3 -6.3 -4.5 rs17881366 0.010 +/- 0.071 UTR
7513243 (exon 11) C  A 0.5 -23.7 -22.6 n/a UTR
7513167 (exon 11) G  A 1.8 -328.8 -255.0 rs4968187 0.095 +/- 0.196 UTR
7512826 (exon 11) G  A 3.9 -1122.7 -404.3 rs17884306 0.137 +/- 0.223 UTR
7512544 (exon 11) A  C 0.2 -2.8 -2.5 n/a UTR
7512539 (exon 11) A  C 0.5 -17.0 -39.7 n/a UTR
7512477 (exon 11) A  C 0.7 -109.2 -23.6 n/a UTR
7512431 (intergenic) G  C 0.5 -69.5 -24.9 rs17883782 0.044 +/- 0.142 intergenic
ACTB 5535853 (intron 1) C  T 29.4 -17920.7 -7530.5 rs2908425 0.172 +/- 0.237 intronic
Chr7 5535824 (intron 1) G  T 0.3 -18.3 -1.6 rs13447394 0.011 +/- 0.074 intronic
5535625 (intron 2) A  G 0.4 -2.9 -29.0 n/a intronic
5535302 (intron 3) C  T 0.5 -39.9 -36.9 n/a intronic
5535288 (intron 3) C  G 0.1 -1.4 -3.0 rs13447399 0.011 +/- 0.074 intronic
5534892 (intron 3) T  C 46.6 -37145.2 -39328.9 rs852423 0.496 +/- 0.046 intronic
5534814 (exon 4) G  T 0.5 -89.3 -77.1 n/a synonymous
5534731 (exon 4) C  T 0.1 -4.3 -7.7 n/a GCC(A) GTC(V)
5534242 (exon 5) C  T 0.1 -4.0 -1.7 rs13447407 0.011 +/- 0.075 synonymous
5534203 (exon 5) G  A 2.7 -1085.8 -1080.7 rs11546939 0.068 +/- 0.171 synonymous
5534010 (exon 6) C  T 0.5 -3.4 -56.5 rs11546907 unknown synonymous
5533695 (exon 6) C  T 0.4 -1.7 -25.2 rs13447411 0.011 +/- 0.074 UTR
5533645 (exon 6) G  A 0.4 -24.3 -32.9 rs11546906 unknown UTR
5533638 (exon 6) G  A 31.9 -14272.0 -9855.0 rs7612 0.558 +/- 0.180 UTR
5533625 (exon 6) G  A 0.3 -17.3 -5.9 rs11546905 unknown UTR
5533452 (exon 6) C  G 1.5 -294.6 -82.7 rs3210032 0.049 +/- 0.148 UTR
APC 112201308 (intron 14) A  T 0.7 -13.5 -7.8 n/a intronic
Chr5 112201798 (exon 15) C  T 0.5 -35.7 -6.2 rs33974176 0.025 +/- 0.109 CCA(P) TCA(S)
112202576 (exon 15) T  C 0.3 -9.9 -1.9 n/a TTG(L) TCG(S)
112202661 (exon 15) G  A 0.4 -8.1 -24.5 n/a synonymous
112202922 (exon 15) A  G 0.8 -28.6 -82.3 n/a synonymous
112203139 (exon 15) G  C 1.3 -419.9 -96.7 rs1801166 unknown GAA(E) CAA(Q)
112203516 (exon 15) T  A 0.5 -70.7 -43.9 n/a synonymous
112205070 (exon 15) G  A 60.5 -11973.1 -15140.9 rs465899 0.436 +/- 0.167 synonymous
112206111 (exon 15) G  A 0.4 -26.5 -14.9 rs2229993 0.044 +/- 0.142 synonymous
112206391 (exon 15) C  T 1.2 -66.5 -56.4 rs2229994 0.023 +/- 0.104 synonymous
112206694 (exon 15) G  A 1.6 -148.5 -368.0 rs2229995 0.038 +/- 0.132 GGT(G) AGT(S)
112206894 (exon 15) A  G 2.1 -141.0 -321.2 rs35043160 0.193 +/- 0.243 synonymous
112207052 (exon 15) C  G 1.1 -151.5 -26.8 n/a TCT(S) TGT[C]
112207808 (intergenic) C  A 5.8 -293.4 -247.8 rs1804197 0.166 +/- 0.236 UTR
SFTPB 85744391 (exon 7) G  A 0.5 -81.4 -108.8 n/a GTC(V) ATC(I)
Chr2 85744363 (exon 7) G  A 0.3 -46.7 -28.6 n/a CGC(R) CAC(H)
85744339 (exon 7) G  A 0.4 -60.0 -78.8 rs3024809 0.030 +/- 0.119 CGC(R) CAC(H)
85744311 (exon 7) C  T 3.5 -1377.3 -1554.2 rs3024810 0.223 +/- 0.249 synonymous
85744307 (exon 7) G  A 0.5 -98.1 -96.0 rs36210375 unknown GCT(A) ACT(T)
85744282 (intron 7) C  A 8 -3819.7 -3600.3 rs893159 0.081 +/- 0.185 intronic
85744269 (intron 7) A  G 21.9 -20234.0 -13347.0 rs2304566 0.310 +/- 0.243 intronic
85744264 (intron 7) T  C 11.8 -8190.4 -6199.5 rs762548 0.310 +/- 0.243 intronic
85744119 (exon 8) C  T 0.1 -2.4 -3.8 rs35076740 unknown synonymous
Supplementary Table 4. Known and putative SNP positions identified by pooled-sample sequencing
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Figure 2.10. Supplementary Table 5. Comparative genomics analysis of non-
synonymous SNPs
Gene Position in reference sequence
Frequency in 
data set (%)







ratio      
P-value
Amino acid conservation 
across species
TP53 7520273 (exon 4) 0.4 rs1800371 CCG(P)ĺTCG(S) 1.83 tolerated benign 0.1717 PPPAPPSASYPSSGXXAX
7520197 (exon 4) 69.2 rs1042522 CCC(P)ĺCGC(R) 0.34 tolerated benign 0.0256 PPPPAAPPPPPPPLEEEE
7519200 (exon 5) 0.1 ** CCG(P)ĺCTG(L) 0.000 not tolerated probably damaging 1 x 10-6 PPPPPPPPPPPPPPPPPP
7518272 (exon 7) 0.4 ** GGC(G)ĺGAC(D) 0.000 not tolerated probably damaging 9 x 10-8 GGGGGGGGGGGGGGGGGG
ACTB 5534731 (exon 4) 0.1 GCC(A)ĺGTC(V) 0.000 not tolerated benign 6 x 10-5 AAAAAAAAAAAAAXA
APC 112201798 (exon 15) 0.5 rs33974176 CCA(P)ĺTCA(S) 0.33 tolerated benign 0.0314 PPPPAPPTPPPPPPPPPPPPS
112202576 (exon 15) 0.3 ** TTG(L)ĺTCG(S) 0.14 not tolerated benign 0.0040 LLLLLLLLLLLLLLLLLLLLH
112203139 (exon 15) 1.3 rs1801166 GAA(E)ĺCAA(Q) 0.40 tolerated benign 0.0479 EEEEEQDEEEEEEEEEEEEGD
112206694 (exon 15) 1.6 rs2229995 GGT(G)ĺAGT(S) 0.00 not tolerated benign 1 x 10-6 GGGGGGGGGGGGGGGGGGGGG
112207052 (exon 15) 1.1 **† TCT(S)ĺTGT[C] 0.44 not tolerated possibly damaging 0.0760 SSSSSSSSSSXSSSSSSSATL
SFTPB 85744339 (exon 7) 0.4 rs3024809 CGC(R)ĺCAC(H) 0.09 not tolerated benign 3 x 10-4 RRRGGGGGGGGGGGGGGG
85744307 (exon 7) 0.5 rs36210375 GCT(A)ĺACT(T) 2.24 tolerated benign 0.0290 AAATTFLSGTAATIMALT
Supplementary Table 5. Comparative genomics analysis of non-synonymous SNPs
Supplementary Table 5. Comparative genomics analysis of non-synonymous SNPs demonstrating
amino acid conservation among vertebrates.  The 12 non-synonymous SNPs identifed in the data
analysis were analyzed for their likelihood of being deleterious.  The phylogenetic order of species
at each locus is listed in the Supplementary Methods.  SNP positions marked with asterisks (**) have 
been published in the germline of individuals or families with a history of various cancers.  The SNP
position marked with a dagger (†) was independently validated by Taqman assay.
Comparative genomics analysis of non-synonymous SNPs demonstrating amino acid conservation among
vertebrates. The 12 non-synonymous SNPs identifed in the data analysis were analyzed for their likelihood
of being deleterious. The phylogenetic order of species at each locus is listed in the Supplementary Methods.
SNP positions marked with asterisks (**) have been published in the germline of individuals or families with
a history of various cancers. The SNP position marked with a dagger (†) was independently validated by
Taqman assay.
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2.3 High-throughput discovery of rare insertions and deletions in large cohorts
2.3.1 Abstract
Pooled-DNA sequencing strategies enable fast, accurate, and cost-effect detection of rare
variants, but current approaches are not able to accurately identify short insertions and
deletions (indels), despite their pivotal role in genetic disease. Furthermore, the sensitivity
and specificity of these methods depend on arbitrary, user-selected significance thresholds,
whose optimal values change from experiment to experiment. Here, we present a combined
experimental and compu- tational strategy that combines a synthetically engineered DNA
library inserted in each run and a new computational approach named SPLINTER that
detects and quantifies short indels and substitutions in large pools. SPLINTER integrates
information from the synthetic library to select the optimal significance thresholds for every
experiment. We show that SPLINTER detects indels (up to 4 bp) and substitutions in large
pools with high sensitivity and specificity, accurately quantifies variant frequency (r = 0.999),
and compares favorably with existing algorithms for the analysis of pooled sequencing data.
We applied our approach to analyze a cohort of 1152 individuals, identifying 48 variants
and validating 14 of 14 (100%) predictions by individual genotyping. Thus, our strategy




Understanding the genetic basis of common diseases is an important step towards the goal
of personalized medicine [10]. At present, two distinct hypotheses are under debate [11, 12].
The Common Variant, Common Disease (CVCD) hypothesis states that disease-causing al-
leles are common in the human population (frequency > 5%) [13]. In contrast, the Rare
Variant, Common Disease (RVCD) hypothesis posits that multiple disease-causing alleles,
which individually occur at low frequencies (<< 1%), cumulatively explain a large portion
of disease susceptibility [16, 17]. Recent evidence favors the RVCD hypothesis as common
variants have failed to explain many complex traits [12] while rare genetic variants have been
successfully associated with HDL levels [16], blood pressure [17], obesity [145], and colorectal
cancer [146, 147]. Due to their low frequencies, identifying rare, disease-associated variants
requires genotyping large cohorts in order to reach the appropriate statistical power (for ex-
ample 5,000 individuals are required to detect mutations present at 0.1% in the population
with a probability of 96%). Collapsing methods in which rare variants are grouped together
before association with disease have been shown to improve statistical power [148] but analy-
sis of large cohorts is still required. One recent strategy for genotyping large cohorts consists
of pooled-sample sequencing, where individual samples are pooled prior to analysis on a
next- generation sequencing platform [121, 134, 149, 150, 151]. By leveraging the massively
parallel output of second-generation DNA sequencing, pooled-sample sequencing allows fast
and accurate detection of rare variants in thousands of samples at a fraction of time and
cost of traditional methods. Individual sample identities can be recovered using a combi-
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natorial pooling strategy (such as DNA sudoku [151]). Despite the promise of this method
for studying rare genetic variants, current computational approaches pose a bottleneck, be-
cause they are focused either on single individual genotyping [152] or on the detection of
common variants in small sized pools [149]. Our previously developed SNPseeker algorithm
allows the detection of single nucleotide substitutions in large pooled samples [121] but still
fails to address two important key challenges in rare variant detection. First, to date, no
algorithm has been able to detect indels in pools larger than 42 individuals and without
the presence of many false positives (∼40%) [149], despite the fact that they account for a
quarter of the known mutations implicated in mendelian diseases [10, 153]. In particular,
short indels represent the most common type of this class of variation [10] and have been
reported to occur as rare germ-line variants associated to genetic disease, such as breast
and ovarian cancer [154]. Efforts to detect disease-associated genetic variants will therefore
greatly benefit from the ability to accurately detect rare short indels. Second, in order to
accurately detect rare variants in a large pooled sample, an optimal significance cutoff for
the accurate discrimination of true variants from false positives must be chosen. This pa-
rameter is in practice affected by sequencing error rates and average coverage, which have
been shown to change for every run [121]. Failure to define an optimal cutoff results in lower
sensitivity and increased false positive rate. Since the rare variant hypothesis posits that
individual disease-associated mutations will be extremely rare (but cumulatively common),
it is absolutely critical to be able to specifically discriminate, in every experiment, a single
heterozygous individual in a large cohort from the background noise. Until now, this has
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not been reliably demonstrated. To address these important challenges, we have developed
a novel experimental and computational strategy that combines a synthetically engineered
DNA library inserted in each run and a new computational approach named SPLINTER
(Short indel Prediction by Large deviation Inference and Non-linear True frequency Estima-
tion by Recursion). This approach allows accurately detection and quantification of short
insertions, deletions and substitutions by integrating information from the synthetic DNA
library to tune SPLINTER and quantify specificity and sensitivity for every experiment
in order to accurately detect and quantify indels and substitutions (Figure 2.11 and 2.12).
SPLINTER requires the presence of two components: a negative control (1-2 KB cloned
plasmid DNA) used to generate a run-specific error model, and a positive control consisting
of a synthetic DNA library simulating an artificial pool with mutations engineered at known
position and frequency. We tested SPLINTER on synthetically engineered pooled samples
containing different mutations at different frequencies in a variety of sequence context back-
grounds, obtaining 100% sensitivity with no false positives in pools up to 500 individuals.
SPLINTER was also able to accurately quantify allele frequencies predicted and observed
allele frequencies were correlated with a correlation of 0.999. We find that SPLINTER sig-
nificantly outperforms all the other algorithms for the analysis of pooled sequencing data by
being the most sensitive approach despite also returning almost no false positives. We then
applied our strategy to multiple pooled-samples, identifying novel and already described
sequence variants, all of which were independently validated.
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Figure 2.11. Experimental and computational pipeline for detection of indels and
substitutions in large pooled-DNA samples
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Pipeline for the detection of rare substitutions and indels in pooled DNA samples. DNA samples from a
selected group of patients are individually pooled in a complex mixture to be used as a template for PCR
amplification of selected genomic loci. The pooled PCR products are then combined in an equimolar mix
containing a DNA fragment without variants (negative control) and a synthetic pool with engineered variants
(positive control). The mix is then sequenced on a Illumina Genome Analyzer IIx. The negative control
reads are used to generate an error model to be used in the variant calling phase. The positive control
allows determination of the optimal cutoff. SPLINTER will then be used to detect and quantify indels and
substitutions present in the pool.
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Visual schematics of the steps used by SPLINTER to find and quantify rare variants in pooled DNA samples.
SPLINTER detects true segregated variants by comparing the frequency vector of observed read bases to
an expected frequency vector defined by the error model. If the observed vector is significantly different
than the expected vector, then SPLINTER will call that position a sequence variant. For each identified
variant, SPLINTER will then perform maximum likelihood fit in order to estimate its frequency in the pooled
sample.
2.3.3 Results
Detection of rare insertions and deletions in synthetic libraries
For each experiment, we first pooled equimolar amounts of sample DNA together with
the controls and generated a DNA library to be sequenced on the Illumina Genome Analyzer
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IIx sequencing platform. We then mapped back the sequencing reads to their reference and
built a run-specific error model from the negative control reads. Next, we optimized our
cutoff parameters on the positive control and then called SNPs and indels on our sample
(see Supplementary Materials and Methods). We first sought to determine the upper limit
of the number of samples that SPLINTER can analyze in a pool. To do so, we generated 3
synthetic DNA libraries each containing 15 different indels and substitutions (Supplementary
Table 1,2 and Material and Methods) introduced at frequencies of 0.005, 0.002 and 0.001
respectively (corresponding to cohorts of 100, 250 and 500 diploid individuals). We sequenced
these libraries using the workflow depicted in Figure 1. In each instance, SPLINTER was
able to correctly identify every variant (15/15 variants) without making false positive calls
(2254/2254 true negatives) (Figure 2.15). We concluded that SPLINTER can accurately
and reliably detect single heterozygous mutations in pools of up to 500 individuals.
Estimation of required sequencing coverage for optimal indel and substitution
detection
We next investigated how SPLINTERs accuracy changed as a function of average se-
quencing coverage. To do so, we sampled the sequencing data obtained for each of the three
previous libraries at different fractions (Supplementary Materials and Methods) and then
computed the accuracy of our predictions in form of an area under an receiver-operator
curve (AUC), a commonly used metric of accuracy ranging from 0.5 (random guessing) to
1 (100% sensitivity and specificity). By plotting AUC as a function of average sequencing
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coverage we found that accuracy increased with coverage, with high-frequency variants re-
quiring less coverage than lower-frequency variants (Figure 2.13 A). By analyzing AUC as
a function of coverage per allele, we observed a clear overlap of the curves for each pool,
reaching AUC equal to 1 at 30-fold average coverage per haploid genome (Figure 2.13 B),
indicating that accurate detection can be achieved given enough coverage independently of
pool size. Recent re-sequencing efforts show that indel detection remains challenging as their
false-positive rate is 15-fold higher than substitutions [155]. Our initial data suggested that
indels can be detected as sensitively and accurately as substitutions. To test this hypothesis,
we generated 5 additional DNA libraries with synthetic insertions, deletions and substitu-
tions included at a wide range of frequencies (from 1 to 50 variants in 1000 total alleles)
(Supplementary Table 2,4). We achieved 100% sensitivity for all the pools (9/9 indel vari-
ants and 10/10 substitution variants), with specificities between 99.91 and 100% (between
2263/2265 to 2259/2259 true negatives). We then plotted the relationship between AUC
and coverage for each set. Indels converged to AUC equal to 1 at a rate comparable to
substitutions, independently of the frequency of the mutation (Figure 2.14 A,B,C). Thus we
conclude that SPLINTER detects indels as accurately and as sensitively as it does substi-
tutions. Since many deleterious indels are 4bp or shorter [10, 154], we wanted to determine
whether SPLINTER could accurately detect indels as large as 4bp. We generated and se-
quenced two synthetic pools containing 8 and 10 4bp indels with frequencies ranging from
0.001 to 0.020 and from 0.025 to 0.045 respectively. SPLINTER achieved 100% sensitivity
10/10 variants) and 100% specificity (2253/2253 true negatives) for allele frequencies be-
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tween 0.025 and 0.045 and 100% sensitivity (8/8 variants) and 99.5% specificity (2243/2253
true negatives) between 0.001 and 0.020 (Supplementary Table 3,4). These results suggest
that SPLINTER is sensitive and specific in detecting 4bp indels.
Figure 2.13. Relationship between variant detection accuracy and average se-
quencing coverage per base
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(a) Accuracy expressed as AUC (area under the curve) (y-axis) plotted as a function of average sequencing
coverage per base (x-axis) for synthetic pools with variants present at frequencies 1/200, 1/500 and 1/1000.
(b) Same as in a with average sequencing coverage per base per allele on the x-axis.
Comparison of SPLINTER with other variant discovery approaches
We next compared SPLINTER to existing tools for variant calling. We used the syn-
thetic DNA libraries previously described to benchmark the sensitivity and positive predic-
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Figure 2.14. Relationship between variant detection accuracy and average se-
quencing coverage per base for substitutions and indels
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a b c
AUC (y-axis) as a function of average sequencing coverage per base (x-axis) for insertions (a), deletions (b)
and substitutions (c). Variants are present at frequencies 1/1000, 5/1000, 10/1000, 15/1000 and 50/1000.
tive value of each method. We compared SPLINTER with SNPseeker [121], MAQ [152],
SAMtools [156] and VarScan [149] for the detection of substitutions (Figure 2.15 A,B) and
with SAMtools and VarScan for the detection of indels (Figure 2.15 C,D). For each data set
analyzed, SPLINTER significantly outperformed every other approach. In all of the syn-
thetic libraries containing substitutions, SPLINTER detected all of the synthetic variants
with no false positives, thus achieving a 100% sensitivity and specificity. SNPseeker also
achieved perfect accuracy in the pool simulating 100 individuals, but had a 20% positive
predictive value in the libraries simulating 250 and 500 individuals, and had only an 80%
sensitivity in the 500 individual library. The other approaches detected variants with sub-
stantially lower sensitivity and positive predictive values in all libraries. For each indel set,
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SPLINTER returned all of the true variants with no false positives, except for the indel 1 set
and the 4bp 1 set (∼ 30% and ∼ 50% positive predictive values respectively). In comparison,
every other approach resulted in false positive rates greater than 80% while achieving low
sensitivity, with the exception of the second 4bp set. We also compared SPLINTER with a
recently published new algorithm for pooled DNA variant detection called CRISP [19] for
both substitution and indel detection (Figure 2.16). SPLINTER outperformed CRISP in
both sensitivity (at most 40% increment) and positive predictive value (at most 80% incre-
ment). In order to distinguish whether the improved accuracy in variant finding originated
from improved alignments or improved variant calling, we also compared the performance
of SPLINTER using our alignment algorithm (RAPGAP) versus using reads aligned with
Novoalign (www.novocraft.com). Both aligners resulted in a comparable performance in
finding true variants (Figure 2.17), although our aligner showed small increases sensitivity
and positive predictive value in several of the analyzed pools. This result suggests that im-
proved variant calling accuracy mostly depended on the variant calling algorithm and not the
underlying aligner. Taken together, there results demonstrate that SPLINTER outperforms
other approaches at detecting single nucleotide substitutions and indels in large pools.
Estimation of the frequency of rare insertions and deletions in synthetic libraries
Having established that SPLINTER could detect rare variants in pooled samples, we
next examined whether SPLINTER could also accurately determine the frequencies of the
identified variants. We compared estimated and expected indel frequencies from all our
100




























































































































































































































































































































































































































































































































































































































































































































































































































































































































Substitutions (a,b) and indels (c,d) were analyzed independently. For each approach, performance was
evaluated by assessing sensitivity (fraction of true positive hits divided by total positives in the set) and
positive predictive value (fraction of true positive hits divided by total hits).
libraries (frequency range 0.001∼0.050) and found a very high correlation (r = 0.969, P <
2.2 e-16; Figure 2.18A) indicating that SPLINTER was able to accurately estimate allele
frequencies. We next sought to better understand the causes of the observed errors in our
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Performance comparison between SPLINTER and CRISP. For each pool, sensitivity and positive predictive
value for SPLINTER (blue columns) and CRISP (green columns) were generated. Both SNPs and indels
were considered for this analysis.
allele frequency estimates. Allele quantification can be affected by pipetting errors during
DNA pooling and by preferential amplification of specific alleles in the pooled PCR. To
distinguish between these two sources of error, we constructed all our plasmids so that each
contained 2 mutations spaced far enough apart to be analyzed independently (i.e. with no
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Comparison of the effect of different aligner algorithms to SPLINTER performance. For each pool, sensitivity
and positive predictive value for SPLINTER run on reads mapped by RAPGAP aligner (blue columns)
compared to SPLINTER run on reads mapped by NOVOALIGN (red columns) were generated. Both SNPs
and indels were considered for this analysis.
overlapping reads). If pipetting error and amplification bias are the major sources of error in
allele quantification, then the estimated allele frequencies of mutations on the same plasmid
will be highly correlated. This was indeed the case. Frequency estimates for mutations
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within the same molecule were very highly correlated (r = 0.995, P < 2.2e-16; Figure 2.18
C), indicating that most of the noise in variant quantification was due to experimental error.
We similarly observed very high correlations with substitutions (frequency correlation r =
0.956, P < 2.2e-16; pair correlation r = 0.993, P < 2.2e-16; Figure 2.18 B and D) and
4bp indels (frequency correlation r = 0.962, P = 1.501e-11; pair correlation r = 0.939, P =
5.599e-05) (Figure 2.19). Based on these results, we reasoned that robotic pooling of samples
might improve allelic quantification. Therefore, we robotically pooled and sequenced a large
cohort of 974 people previously analyzed in a GWA study (Materials and Methods). As
expected, we observed an almost perfect correlation (r = 0.999, P < 2.2e-16; Figure 2.20)
between the GWA frequencies and the frequencies estimated by SPLINTER, indicating that
inaccurate pipetting was indeed a primary source of error.
High-throughput discovery of rare indels in large patient cohorts
Finally, we applied SPLINTER to a large human cohort as a real-world test of the al-
gorithm. We sequenced 14 loci (2596bp total) in 1152 individuals, which were divided into
9 pools (94 to 178 individuals per pool) (see Materials and Methods). For every sequenced
pool, we included a negative and positive control to tune SPLINTER. We identified on av-
erage 19 variants per pool (for a total of 151 variants, see Supplementary Table 6). To
confirm SPLINTERs accuracy, we examined the overlap of our hits with variants listed in
dbSNP. We observed large overlapping fractions – between 68.5% and 100% of the iden-
tified variants in each pool could be found in dbSNP (Supplementary Table 5,6). In all
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(a,b) Correlation between variant frequency measured by SPLINTER (y-axis) and expected variant frequency
(x-axis) from 8 synthetic pools for indels (a) and substitutions (b). (c,d) Pair correlation between mutation
pairs present in the same DNA molecule for indels (c) and substitutions (d).
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Figure 2.19. Precise quantification of 4bp insertions and deletions




















































































































(a) Correlation between variant frequency measured by SPLINTER (y-axis) and expected variant frequency
(x-axis) from 2 synthetic pools containing 4bp indels. (b) Pair correlation between mutation pairs present
in the same DNA molecule.
cases, statistical significance was reached (Fishers Exact Test, Supplementary Table 7). We
selected 14 variants (3 novel variants and 11 from dbSNP) from the largest analyzed pool
for independent validation by individual genotyping using the Sequenom iPLEX platform.
All 14 variants were confirmed, resulting in 100% positive predictive value. Furthermore,
allele frequencies were highly correlated with those estimated by SPLINTER (r = 0.985, P
= 5.958e-09, Supplementary Table 8 and Figure 2.21). Together, these results demonstrate
the utility of the SPLINTER methodology for the rapid analysis of large populations of in-
dividuals. All the computational tools, source code and the experimental datasets presented
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Correlation between variant frequency measured from GWA study and SPLINTER estimated frequency.
in this paper can be accessed at http://cgs.wustl.edu/~fvallania/4_splinter_2010/
5_splinter_webpage/SPLINTER_supporting_material.html.
2.3.4 Discussion
Rare genetic variation is likely to describe a substantial portion of heterogeneity in com-
mon and complex diseases. Identifying disease-associated rare variants requires the analysis
of multiple loci in large cohorts. We have shown that a novel experimental design combined
with SPLINTER can accurately identify genetic variants in large pools, leading to several
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Figure 2.21. Correlation between variant quantification by SPLINTER Vs Se-
quenom




























Correlation between variant frequency measured from single individual genotyping by Sequenom and SPLIN-
TER estimated frequency.
advantages over other computational strategies. First, we found that SPLINTER identified
genetic variants with high sensitivity and precision, whereas the other methods were unable
to detect a large fraction of the variation present in the samples. We found that a sequencing
coverage of ∼30x per haploid genome was required to detect mutations with high sensitivity
and specificity. In earlier work, we successfully analyzed pooled-samples using SNPseeker
at lower sequencing coverage ( 13.8-fold per haploid genome) [121] However, in that study
most of the variants were present in many individuals in the pool, suggesting that, in order
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to detect singleton alleles with ∼100% confidence in a variety of different sequence contexts,
a higher sequence coverage is required. This finding is confirmed by recent re-sequencing
studies of single cancer genomes where near optimal accuracy of somatic SNP detection (3%
false-discovery rate) was achieved at ∼40-fold average haploid genome coverage [155], and by
the lower performance of SNPseeker when compared to SPLINTER in detecting substitutions
present at 1 in a 1000 in both sensitivity and precision. Second, our strategy incorporates a
synthetic positive control and a negative control, which allow estimation of sensitivity and
specificity for each experiment. This is important because run-to-run variations in sequenc-
ing error rates can influence accuracy and perturb the optimal p-value cutoffs. The inclusion
of the control DNA has a negligible impact on experiment cost. One single-end sequencing
lane (∼30 million 36bp long reads per lane) can provide enough coverage to analyze 25 Kb
of genomic DNA in 500 patients, with the control sequences accounting for ∼4% of the total
sequencing data. Third, SPLINTER can accurately and sensitively detect indels with a high
sensitivity and accuracy. Detection of indels even in single genome resequencing studies is
indeed a challenging problem due to the difficulties in reducing the false positive rate while
retaining good sensitivity [155]. In addition, previously published approaches cannot detect
indels [121, 152], or can only be applied to small-sized cohorts (42 people)[149]. Together,
these issues have limited the application of pooled-DNA sequencing. We have shown here
that SPLINTER can accurately discriminate single indels in pools as large as 500 individuals
with high sensitivity and specificity. In comparison, the best performing algorithm achieved
at best 80% false positive rate. Fourth, SPLINTER can accurately quantify the frequency
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of the alleles present in the pool. Although high correlations between real and estimated
frequencies were observed, small discrepancies may result in errors in variant association to
a phenotype if the variant is rare and the effect of the variant is high. Our pair correlation
analysis shows that the major source of errors in quantification does not come from SPLIN-
TER but rather from pipetting errors in pool construction, as indicated by the improved
correlations after robotic pipetting of the pools. This issue can in fact be resolved by per-
forming orthogonal validation of the samples, which will be highly facilitated by the overall
performance of SPLINTER in detecting rare variants as opposed to other methods. In con-
trast, the major source of error in array-based pooled-DNA analysis is array variation, being
7 times higher than pool construction variation [157]. This observation argues that our ap-
proach shows higher accuracy even compared to other experimental platforms. Finally, our
approach can be applied to any pooled cohort or any heterogeneous sample of any size and
can be easily scaled up to whole-exome and whole-genome analysis. Given the presence of a
positive control to infer the optimal parameters, pooled-samples can accurately be analysed
without limitations on experimental design or achieved coverage. In this study, we used PCR
to amplify the various genomic regions, but our strategy is also compatible with solid and
liquid-phase genomic capture approaches [158]. We found that alignment errors decreased
our ability to detect large indels. This explains why SPLINTER performed slightly worse
in the analysis of the 4bp indel libraries relative to the 1-2 bp indel libraries. To detect the
longer indels, it was necessary to allow larger gaps in our read alignments, which increased
the overall alignment noise. We believe this was due to potential sequencing artifacts or
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sample contaminants aligning back to the reference sequence, thereby reducing the signal
coming from true variants. This limitation can be overcome with longer sequencing read
lengths, which should reduce the ambiguity in aligning reads while allowing larger gaps (in
this work, all sequencing reads were 36bp in length). Similarly, while whole genome analysis
may present additional challenges due to increased sequence complexity compared to the
analyzed synthetic controls, we expect it to mostly impact the read alignment step in the
analysis pipeline, which can be overcome by generating paired-end and/or longer sequencing
reads. In addition, with reduced error rate, fewer observations at a given variant position
will be needed to provide confidence in the variant call. Nevertheless, our approach is the
first one to accurately call short indels in large pooled-samples. One departure of our algo-
rithm from other variant calling programs is that SPLINTER does not incorporate quality
scores in any step of the analysis. We have found that our error model captures essentially
the same information that is contained in quality scores (see Supplementary Materials and
Methods, [121]), and so including quality score information does not improve SPLINTERs
performance. The high performance of our method compared to others that use quality
scores [149, 152] suggests that this viewpoint is likely correct. Additionally, analysing reads
aligned with quality scores resulted in equal or lower performance when compared to reads
aligned using our aligner (Figure 2.19). To obtain a complete understanding of the molec-
ular causes of common diseases, it is critical to be able to detect and analyze rare variants
[121, 134, 149, 150, 151]. Pooled-DNA sequencing is an important method for rare variant
analysis, since it enables the rapid and cost- effective analysis of thousand or tens of thou-
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sands of individuals. SPLINTER will also be useful for analyzing samples that are naturally
heterogeneous e.g. for the detection and quantification of rare somatic mutations in a tumor
samples [159]. A second promising application is detection of induced mutations in in vitro
evolution experiments [92, 160]. Thus, we expect SPLINTER will become useful tool for the
analysis of data generated by next-generation sequencing methods.
2.3.5 Materials and methods
Preparation of the Synthetic Pools
Every synthetic pool library consists of a mixture of different oligonucleotides where one
is referred to as the wild-type allele and the other are mutants with respect to the wild type.
We used the consensus sequence of the 72 bp exon 9 from TP53 (RefSeq accession number:
NM 000546) as the wild type insert into a pGEM-T Easy vector (Promega, Madison, WI,
U.S.A.). We then designed a panel of different variations of this consensus sequence (see
Supplementary Table 1,2,3) containing single, double and 4bp IN/DELs as well as single
nucleotide substitutions . These vectors could then be pooled such that each mutation was
present at different frequencies. Once pooled, a single PCR reaction was performed using
primers that flanked the insertion site and generated a 335 bp amplicon. To facilitate ligation
into the vector, each oligonucleotide was ordered with 5’ phosphorylation and an overhanging
3’ A from Integrated DNA Technologies (Coralville, IA, U.S.A.). Complimentary oligonu-
cleotide pairs were annealed as follows: 1µl of sense and antisense oligonucleotide at 100µM
were mixed with 5µl of 10X PCR Buffer (Sigma-Aldrich, Saint Louis, MO, U.S.A.) and
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brought to a final volume of 50µl. The annealing mix was then warmed up to 95C for 5
minutes followed by 20 minutes at 25C. Each annealed sequence was then ligated into the
pGEM-T Easy Vector (Promega, Madison, WI, U.S.A.) according to the manufacturer’s pro-
tocol and reagents. The final ligation product was then transformed into GC-10 competent
cells (GeneChoice, Frederick, MA, U.S.A.) using standard cloning protocol. Colonies were
screened using ’Blue/White’ selection induced by Xgal and IPTG, White colonies were picked
and grown on Luria broth agar with ampicillin for 12-16 hours. Plasmid was then recov-
ered from the transformed bacteria suspension using Qiaprep Spin Miniprep Kit according
to the manufacturer’s protocol (Qiagen, Hilden, Germany). Following insert validation by
Sanger sequencing, plasmid pools were prepared by pooling each plasmid at the appropriate
number of molecules in order to introduce the desired mutations at the desired frequency
with respect to the wild-type background. Each pool was generated with a total number of
1011 plasmid molecules. This was chosen in order to have mimic at the best the conditions
described in the original pooled-DNA sequencing protocol [121] to maximize the number of
molecules available for analysis while keeping fluid volumes tractable. Each pool was then
PCR amplified using primer sequences flanking the plasmid insertion site (see Supplemen-
tary Table 4). Each PCR reaction was performed as follows: 1) 93C for 2 minutes 2) 93C
for 30 seconds 3) 56C for 30 seconds 4) 65C for 2 minutes 5) repeat steps 2-4 for 18 cycles
6) 65C for 10 minutes. Each PCR mix contained 2.5µl of 10X PfuUltra Buffer, 10µM of
forward and reverse primers, 1M Betaine (Sigma-Aldrich/Fluka, St. Louis, MO, U.S.A.),
1.25 units PfuUltra DNA polymerase and between 30 and 50 ng of template DNA in a final
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volume of 25 µL. Each pool was then sequenced using a single lane of the Illumina Genome
Analyzer II platform.
Pooled-DNA sample sequencing from single individuals
We performed pooled-DNA sequencing on 974 individuals enrolled in the Family Heart
Study (FHS) [161] and 178 individuals enrolled in the Silent Cerebral Infarction Transfusion
Trial (SIT) [162]. Each pool of human DNA was designed to contain 450 ng of DNA per
individual. Pooling was performed robotically using the Eppendorf epMotion 5075 pipetting
robot (Eppendorf, Hauppauge, NY, U.S.A) in order to minimize dilution errors. Patients
from the FHS study were divided into 8 pools ranging from 94 to 150 individuals, whereas the
remaining 178 patients were pooled into a single ninth pool. We computationally generated
a list of 14 genomic loci selected on the basis that they contained at least one single or double
base pair insertion or deletion reported in dbSNP129 at various frequency ranges. We defined
a genomic region of 400 bp centered on the targeted IN/DEL and we designed primers in
order to target the known variant in a final amplicon with length ranging from 150 to 200 bp.
Primers were designed as described previously [121]. Each PCR reaction for each pool was
repeated multiple times in order to minimize the likelihood of PCR errors appearing as rare
variants in the sequencing output. Each PCR reaction was performed as described above
with the exception of undergoing 28 total cycles. Each PCR mix contained 2.5 µl of 10X
PfuUltra Buffer, 10 µM of forward and reverse primers, 1M Betaine (Sigma-Aldrich/Fluka,
St. Louis, MO, U.S.A.), 1.25 units PfuUltra DNA polymerase and between 30 and 50 ng of
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template DNA, representing 50 genome copies per individual (see Supplementary Table 4).
For every analyzed pool a positive and a negative control were generated. The positive control
consisted of a synthetic pool containing substitutions and IN/DELs at the lowest possible
frequency for each of the analyzed pools (i.e. 1 divided by the total number of alleles in
the pool). The positive control was prepared as described, with PCR reactions performed
for 28 cycles in order to match the sample preparation. The negative control consisted of a
DNA fragment for which the sequence is known in order to generate a run-specific second
order error model to be used in the data analysis. In order to generate a negative control,
we performed PCR amplification on the M13 plasmid (New England Biolabs, Ipswich, MA,
U.S.A.) generating a 1934 bp product (see Supplementary Table 4). PCR reaction was
performed as described above and repeated multiple times. We then sequenced our samples
using a single lane per pool and mapped back all the sequencing reads.
Four candidate loci identified by a GWA study performed on the 974 FHS patients
were targeted in a total of 36 PCR reactions spanning 20,729 base pairs per individual
(data not shown). Sample preparation, sequencing and analysis was performed as described.
We identified a total of genomic variants that were also represented by the Illumina 6.0
genotyping array performed on each individual. Pearson correlation coefficient between
GWAS and SPLINTER variant frequencies was calculated by using the frequency of the
minor allele for each variant (Figure 2.20).
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Independent Validation of Putative Variants
Independent validation of putative variants identified by SPLINTER was performed by
Sequenom (Sequenom, San Diego, CA, U.S.A.) according to the manufacturers protocol (for
probes see Supplementary Table 5). Sanger sequencing validation was performed using the
same primer pairs used for initial PCR amplification prior to pooled-DNA sequencing.
Semi-local gapped sequence alignment
In order to efficiently map sequencing reads with gaps without compromising mapping
accuracy (i.e. deviating from the optimal mathematical solution of the alignment), we de-
veloped a new Smith-Waterman-like alignment strategy [163]. This allowed us to have a
pure and controlled implementation of dynamic programming while being feasible in terms
of speed. Quality scores are ignored for the alignment. We first build a hash-map of the
reference sequence with hash key size equal to k, which is defined as
k = b l − c
c+ 1
c
where l is the length of the sequencing read and c is the maximum edit distance cutoff
between the read sequence r and the reference sequence s. k is guaranteed to be the largest
possible stretch of perfect match nucleotides achieved in the case of maximum entropy,
i.e. when the edits are distributed uniformly in the reads, minimizing the length of the
shortest read fragment. While l is run-dependent, c is defined by the users at the time of
the alignment, leading to a consequent user-defined value of k.
116
When r is aligned to s, the first step is to hash-map all the substrings of r of length k to
s. Every mapped susbtring allows to define the boundaries of a dynamic programming (DP)
matrix for sequence alignment. The value of c determines the dimensions of the DP matrix,
which are equal to l and l + 2 ∗ c, assuming that the read will contain all the allowed edits.
Once the boundaries of the DP matrix are defined, we perform DP programming in the
following way: first the matrix is initialized by setting the values of the first column to 0
(s dimension) as in Smith-Waterman [163] whereas the first row is set to 0 at position 0
and at progressively adding a gap penalty for every increasing position (r dimension) as in
Needleman-Wunsch [164]. This strategy allows every alignment to start at any position in
the reference sequence but always at the first position of the read, therefore being semi-local.
Gaps are inserted according to an affine-gap penalty model [165], adopting a gap insertion
penalty of 2 and gap extension penalty of 1.
Traceback is peformed starting from the highest scoring position in the last column
(corresponding to the last position in r) until the first position of r is reached. The final
result is the optimal mathematical solution for the gapped semi-local alignment of r with
respect to s. r and its reverse complement are both mapped to the positive strand of s.
If r aligns to multiple loci of s with the same minimum edit distance, its alignment to s
is discarded in order to minimize noise due to spurious mapping. Insertions and deletions
present inside a nucleotide homopolymer (i.e. AAA,CCC,GGG . . . ) are aligned at the
beginning of the homopolymer on the positive strand by default, as their true position in
the sequence is arbitrarily established.
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We previously reported that error rates change significantly for every sequencing run
[121] and therefore, for every run we calculated an independent error model. Quality scores
have been discarded as they have been previously shown to be less informative than an
empirically derived run-specific error model [121]. This finding is further supported by
the lower performance of every other approach that we compared to SPLINTER that also
integrated quality scores in the analysis (see Figures 2.15 and 2.17).
Since this approach does not take into account quality score information, in order to
save computing time while preserving the same amount of information, we compressed the
original SCARF file by keeping only unique reads sequence in it and adding a weight to each
read counting the number of times a read with the same sequence appeared in the original
file. This strategy generated files at the best 10% of the original size of the SCARF output,
linearly reducing the alignment run-time of the same factor.
Error model calculation
A 2nd-order error model was parameterized from a negative control sequence included in
every sample, i.e. a DNA fragment consisting of a PCR product from the M13 vector. The
negative control allows to estimate the likelihood of a sequencing error defined as the rate of
observed mutations in the sequencing reads without variants being present in the analyzed
DNA fragment. Briefly, for every base n and its context defined as the two preceding bases
m and l, we calculate the likelihood of observing a substitution s, an insertion i or a deletion
d where l,m, n, s ε {A,C,G, T,N}, i ε {InsertionA,C,G,T}, and d ε {D}. For substitutions,
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we calculate Pr(s|n,m, l, j, r) for each read base j and run r as the ratio between the number
of observed read bases with base equal to s and the total number of observed read bases.
Deletion error rates are calculated the same way as substitutions, where j in this case is
assumed to be the read base number preceeding the deletion. Insertions are analyzed by
selecting only reads that overlap consecutive loci n and o. Pr(i|o ∼ n,m, l, j, r) is therefore
computed as the ratio between the reads that contain one or more inserted bases between n
and o and the total number of reads overlapping n and o.
SPLINTER: IN/DEL and substitution detection using Large Deviation Theory
Since previously designed algorithms are unable to precisely call and quantify short
IN/DELs in large pools, we designed and implemented SPLINTER (Short IN/DEL Predic-
tion by Large deviation Inference and Non-linear True frequency Estimation by Recursion),
a new algorithm based on Sanov’s theorem, which is part of the information theoretic treate-
ment of Large Deviation Theory [140]. SPLINTER takes in input aligned sequencing reads.
For every position i of the reference sequence, SPLINTER stores the counts of each observed
base character b = {A,C,G, T,N,D} as well as the counts for each inserted base stretch g
between i and its consecutive position i+1 of length c (maximum number of accepted edits).
SPLINTER assumes that sequencing reads are generated independently from one another
and that read bases within the same read are incorporated independently from one another.
Substitution variants can be detected at a particular position i by estimating the distance of
the empirical distribution P of observed nucleotides A,C,G,T,N from the expected distribu-
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tion Q representing the expected frequency of nucleotides assuming that i does not harbor
any variant present in the pool. Q is computed as a linear product between the error model
matrix A for each read base j and sequencing run r and the true frequency vector τi,null
under the null hypothesis that only the reference base is present as
Qj,r,s = Ai,j,r ∗ τi,null (2.8)
The distance between P and Q is computed independently for each read base j, sequenc-
ing run r and strand s as equation 2.2 :
Q
nj,r,s
j,r,s (E) = 2
−nj,r,sD(Pj,r,s‖Qj,r,s)
where D(Pj,d,s ‖ Qj,d,s) is the Kullback–Leibler distance between P and Q. Qnj,r,sj,r,s (E) is
a p-value calculated by testing the hypothesis that P was sampled from Q. Since j and r
are independent, according to the initial assumptions, a cumulative p-value for each strand
s is computed as
Qnss (E) = 2
−∑r∑j nj,r,sD(Pj,r,s‖Qj,r,s) (2.9)
equivalently to equation 2.3. Deletions are detected by estimating the distance of the
fraction of observed deletions PD from the fraction of expected deletions QD. PD and QD















where dj,r,s and Cj,r,s represent the number of observed deletions and the total observed
coverage and ADi,j,r,s corresponds to the expected likelihood of observing a deletion at i for
j, r and s given the error model matrix A.




(E) = 2−nDj,r,sD(PDj,r,s‖QDj,r,s ) (2.12)








j nDj,r,sD(PDj,r,s‖QDj,r,s ) (2.13)
Insertions are analyzed as stretches of nucleotides (g) of maximum length c located be-
tween the adjacent and consecutive positions i and i + 1 and are detected by comparing












AIi∼i+1,j,r,s , 1− AIi∼i+1,j,r,s
)
(2.15)
whereAIi∼i+1,j,r,s corresponds to the expected likelihood of observing a insertion at i ∼ i+1
for j, r and s given the error model matrix A. Calculation of the p-value for each strand s
is performed as described for deletions.
Presence or absence of any given variant at position i is assessed by asking the p-values
for both strands to be equal or less than a user-defined empirical cutoff α (where α <= 0.05).
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We find that requiring both strands to pass α greatly increases the accuracy of our method,
as previously observed [121]
Frequency estimation of identified pool variants
For every identified pool variant, SPLINTER performs estimation of the true variant
frequency vector τi at position i and/or the true insertion frequency vector τi∼i+1 between i
and i+ 1. τ is fit by maximum likelihood








j nj,r,sD(Pj,r,s‖Qj,r,s,τ ) ∗ Pr(τ) (2.16)
where we implicitly assume that Pr(τ), the prior distribution for τ , is uniform, leading
to








nj,r,sD(Pj,r,s ‖ Qj,r,s,τ ) (2.17)
SPLINTER is significantly different from our previous pooled DNA SNP caller algorithm,
SNPseeker [121] at various levels. First, it is able to detect indels in large pools by using new
models and new integrated data structures, whereas SNPseeker can only detect substitutions.
Secondly, SPLINTER is more sensitive and specific than SNPseeker as it integrates infor-







(E) (p-value cutoff) at every position i. Thirdly, SNPseeker implemented a non-linear
least-square fit for estimating the true frequency vector τ [121], whereas SPLINTER uses a
maximum likelihood method. We found that this leads to more accurate frequency estimates
(data not shown) but it also allows incorporation of prior information.
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Evaluation of sensitivity and specificity of variant calling and accuracy of fre-
quency estimation
In order to determine the discriminatory power of our method, we calculated sensitivity
and specificity in a p-value cutoff-independent way by iterating over a range of p-value cutoff
values from 0 to -3000 with increments of -0.001 at each round. The optimal cutoff was
determined as the value that minimized the Euclidean distance between the corresponding
specificity and sensitivity (ranging from 0 to 1) to perfect specificity and sensitivity (1,1).
This strategy was repeated by analyzing the data incorporating 12, 18, 21, 24 bases per read
(cycles) and comparing sensitivity and specificity of the analysis, resulting in the definition
of the optimal cutoff and incorporated read bases. This was done because we have previously
demonstrated that the likelihood of sequencing errors increases for later cycles [121],, and
different error rates will affect the accuracy of discrimination between signal and noise. The
optimal combination between cycles and cutoff was then used for data analysis. Accuracy
of the frequency estimation was measured by calculating Pearson’s correlation coefficient
between the observed and estimated frequencies.
Monte Carlo sampling and calculation of Receiver Operating Characteristics
Curves
In order to determine the relationship between p-value and coverage per base per strand
for any given variant, we performed Monte Carlo sampling on aligned reads for a selected
synthetic pool. We randomly sampled fractions equivalent to 0.005, 0.010, 0.015, 0.020,
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0.025, 0.05, 0.10, 0.20, 0.30, 0.40, 0.50, 0.60, 0.75, 0.90 of the total number of aligned reads
100 times each and performed an analysis with SPLINTER on every sample. This allowed us
to generate a distribution of p-values for each coverage point. For each set of 100 samples we
calculated a Receiver Operating Characteristics (R.O.C.) curve. ROC curves plot a methods
sensitivity (here, the fraction of mutant positions correctly identified) versus the false positive
rate (the fraction of the bases without mutation that were incorrectly reported) for different
p-value cutoffs. For each ROC curve we computed the corresponding Area Under the Curve
(A.U.C.), and we used it as a metric for assessing the lowest value of coverage per base at
which 100% specificity and 100% sensitivity (AUC equal to 1) are reached.
Comparison between different variant callers
In order to compare the performance of SPLINTER with that of other approaches, we ap-
plied SNPseeker [121], MAQ v0.7.1 [152], SAMtools [156] and VarScan [149] to the synthetic
pool datasets. We separately compared the performance of each approach for detection of
substitutions and indels given the fact that indels are not supported by SNPseeker and MAQ.
Performance was evaluated by determining sensitivity (fraction of true positives identified
by the method over total true positives in the set) and positive predicted value (fraction of
true positives identified by the method over total positions identified by the method) and
values were plotted and compared for each approach. For substitutions, Pools 4 and 5 were
used in their entirety (renamed sub 1 and sub 2 in Figure 2.15) whereas only substitutions
were considered for the pools simulating 100, 250 and 500 samples. For indels, Pools 1,
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2 and 3 were used in their entirety (renamed indel 1, indel 2 and indel 3) whereas only
indels were considered for the pools simulating 100, 250, and 500 samples. SNPseeker was
run as previously described and performance was computed after determining the optimal
p-value cutoff and that maximized its performance. MAQ was run as described in [152]
with snp filtering after its execution in order to reduce the number of false positives. For
SAMtools and VarScan, files were previously aligned using Novoalign at its default settings
www.novocraft.com, and SAM files were then converted into BAM and then pileup files.
For SAMtools, variants were called from the pileup file, variants are unfiltered because when
filtering was applied no hits were returned in output for any of the tested libraries. VarScan
was run on the SAMtools pileup files and results were filtered by finding the optimal p-value
cutoff that maximized its performance. We compared also the performance of CRISP [19]
by running the approach applied to all the pools using the default settings. We additionally
compared the performance of the Genome Analysis Toolkit (GATK) framework on our set
[166] using the suggested default parameters but we could not detect any of the true positives
in any of the synthetic sets, so we decided not to include this analysis in the comparison.
We believe that this result was due to the Unified Genotyper being optimized for single
individual genotyping rather than large pools sequencing. Additionally, GATK is not able
to detect indels in its current iteration (v1.0.3864).
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2.3.7 Supplementary Tables
Figure 2.22. Supplementary Table 1
Synthetic Strain Mutation 1 Mutation 2 Sequence
IN/DEL Strain 1 155 Deletion 174~175 Insertion A CACTGCCCAACAACACCAGCTCCTCTCCCAGCCAAAGAAGAAACCaACTGGATGGAGAATATTTCACCCTTCAG
IN/DEL Strain 2 161 Deletion 177~178 Insertion C CACTGCCCAACAACACCAGCTCCTCTCCCCAGCAAAGAAGAAACCACTcGGATGGAGAATATTTCACCCTTCAG
IN/DEL Strain 3 173 Deletion 183~184 Insertion A CACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACACTGGATGGAaGAATATTTCACCCTTCAG
IN/DEL Strain 4 152 Deletion 185~186 Insertion C CACTGCCCAACAACACCAGCTCCCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGcAATATTTCACCCTTCAG
IN/DEL Strain 5 163~164 Insertion GT / CACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAgtAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAG
Substitution Strain 1 158 Substitution C->T 197 Substitution C->G CACTGCCCAACAACACCAGCTCCTCTCCCTAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCGTTCAGA
Substitution Strain 2 149 Substitution T->G 182 Substitution G->A CACTGCCCAACAACACCAGCGCCTCTCCCCAGCCAAAGAAGAAACCACTGGATAGAGAATATTTCACCCTTCAGA
Substitution Strain 3 170 Substitution A->T 188 Substitution T->C CACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGTAACCACTGGATGGAGAACATTTCACCCTTCAGA
Substitution Strain 4 152 Substitution T->C 185 Substitution G->A CACTGCCCAACAACACCAGCTCCCCTCCCCAGCCAAAGAAGAAACCACTGGATGGAAAATATTTCACCCTTCAGA
Substitution Strain 5 137 Substitution A->T 173 Substitution C->T CACTGCCCTACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAATCACTGGATGGAGAATATTTCACCCTTCAGA
4bp IN/DEL Strain 1 159~162 Deletion 183~184 Insertion AAAA CACTGCCCAACAACACCAGCTCCTCTCCCCAAAGAAGAAACCACTGGATGGAAAAAGAATATTTCACCCTTCAGA
4bp IN/DEL Strain 2 148~151 Deletion 177~178 Insertion AAAA CACTGCCCAACAACACCAGCCTCCCCAGCCAAAGAAGAAACCACTGGGGGGATGGAGAATATTTCACCCTTCAGA
4bp IN/DEL Strain 3 170~173 Deletion 199~200 Insertion CCCC CACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGCACTGGATGGAGAATATTTCACCCTTCCCCCAGA
4bp IN/DEL Strain 4 137~140 Deletion 191~192 Insertion CCCC CACTGCCCAACCCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTCCCCTCACCCTTCAGA
4bp IN/DEL Strain 5 134~137 Deletion 163~164 Insertion TTTT CACTGACAACACCAGCTCCTCTCCCCAGCCATTTTAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGA
Figure 2.23. Supplementary Table 2
Synthetic Pool IN/DEL 1 IN/DEL 2 IN/DEL 3 IN/DEL 4 IN/DEL 5 Substitution 1 Substitution 2 Substitution 3 Substitution 4 Substitution 5 Wild-Type
100  Samples 0.005 0.005 0.000 0.000 0.005 0.005 0.005 0.005 0.005 0.005 0.960
250  Samples 0.002 0.002 0.000 0.000 0.002 0.002 0.002 0.002 0.002 0.002 0.984
500  Samples 0.001 0.001 0.000 0.000 0.001 0.001 0.001 0.001 0.001 0.001 0.992
Synthetic Pool 1 0.050 0.010 0.001 0.005 0.001 0.000 0.000 0.000 0.000 0.000 0.933
Synthetic Pool 2 0.010 0.050 0.005 0.002 0.001 0.000 0.000 0.000 0.000 0.000 0.932
Synthetic Pool 3 0.000 0.000 0.000 0.000 0.000 0.025 0.030 0.035 0.040 0.045 0.825
Synthetic Pool 4 0.000 0.000 0.000 0.000 0.000 0.001 0.005 0.010 0.015 0.020 0.949
Synthetic Pool 5 0.000 0.000 0.000 0.000 0.000 0.010 0.020 0.030 0.040 0.050 0.850
Figure 2.24. Supplementary Table 3
Synthetic Pool 4bp IN/DEL 1 4bp IN/DEL 2 4bp IN/DEL 3 4bp IN/DEL 4 4bp IN/DEL 5 IN/DEL 1 Wild-Type
4bp Pool 1 0.000 0.001 0.005 0.010 0.015 0.001 0.968
4bp Pool 2 0.025 0.030 0.035 0.040 0.045 0.000 0.825
Figure 2.25. Supplementary Table 4
Synthetic Pool Engineered Variants Sensitivity Specificity Incorporated Read Bases Optimal Cutoff
100 Diploid Samples 15 1.0000 1.0000 24 1e-61.002
250 Diploid Samples 15 1.0000 1.0000 24 1e-53.157
500 Diploid Samples 15 1.0000 1.0000 21 1e-26.850
POOL 1 9 1.0000 0.9991 12 1e-13.103
POOL 2 9 1.0000 1.0000 21 1e-38.349
POOL 3 9 1.0000 1.0000 24 1e-257.683
POOL 4 10 1.0000 1.0000 12 1e-16.807
POOL 5 10 1.0000 1.0000 24 1e-368.192
4BP POOL1 10 1.0000 0.9947 18 1e-30.763
4BP POOL2 10 1.0000 1.0000 24 1e-1253.532
Figure 2.26. Supplementary Table 5
Pool Alleles Engineered Variants Incorporated Read Bases (Cycles) Sensitivity Specificity log10p cutoff
Pool 1 260 15 21C 1.0000 1.0000 -19.273
Pool 2 258 15 21C 1.0000 0.9996 -19.707
Pool 3 248 15 21C 1.0000 0.9996 -29.115
Pool 4 188 15 24C 1.0000 1.0000 -36.583
Pool 5 226 15 24C 1.0000 1.0000 -49.160
Pool 6 230 15 24C 1.0000 1.0000 -39.887
Pool 7 238 15 18C 1.0000 0.9991 -15.226
Pool 8 300 15 18C 1.0000 1.0000 -42.108
Pool 9 356 15 18C 1.0000 0.9991 -17.781
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Figure 2.27. Supplementary Table 6 part1
Pool Amplicon Name Chromosome Genomic Position Start Genomic Position End Amplicon Size Genomic Position Amplicon Position Mutation p-value + p-value - Major Allele Minor Allele Coverage + Coverage - dbSNP 129
Pool 1 INDEL 6 X 133437395 133437566 172 133437464 70 S -250,931296 -897,956485 0,922 0,078 1738 6573 rs2070888
Pool 1 INDEL 6 X 133437395 133437566 172 133437486~133437487 92~93 I -28,075262 -28,067039 0,995 0,005 3196 4200 rs17879579
Pool 1 INDEL 6 X 133437395 133437566 172 133437487 93 D -95,685601 -61,934177 0,990 0,010 3221 3980 rs17879579
Pool 1 INDEL 2 11 47310399 47310551 153 47310475 77 S -134,984587 -84,173947 0,980 0,020 5664 4184 No
Pool 1 INDEL 1 14 19881224 19881410 187 19881282 59 S -106,561387 -223,600166 0,974 0,026 2997 4388 rs3093873
Pool 1 INDEL 1 14 19881224 19881410 187 19881286 63 S -20,045679 -21,879294 0,994 0,006 3256 4889 rs3093874
Pool 1 INDEL 1 14 19881224 19881410 187 19881347 124 S -240,138902 -36,327948 0,984 0,016 10267 1633 No
Pool 1 INDEL 12 14 99042658 99042823 166 99042738 81 D -424,237954 -156,921571 0,977 0,023 5345 3426 rs3918110
Pool 1 INDEL 12 14 99042658 99042823 166 99042739 82 D -450,356158 -158,910859 0,977 0,023 5557 3442 rs3918110
Pool 1 INDEL 18 20 2268180 2268350 171 2268211 32 S -59,474042 26,436566 0,992 0,008 7174 2659 No
Pool 1 INDEL 18 20 2268180 2268350 171 2268255 76 S -108,709118 -103,314264 0,990 0,010 5413 7275 rs45598640
Pool 1 INDEL 4 19 48739570 48739760 191 48739666 97 S -35076,97794 -42654,97066 1,000 0,000 9773 12778 rs2682557
Pool 1 INDEL 5 8 18124763 18124959 197 18124924 162 S -1832,202378 -98,31166 0,774 0,226 33 52 rs8190861
Pool 1 INDEL 5 8 18124763 18124959 197 18124931 169 S -1876,207301 -271,543286 0,690 0,310 69 107 rs15561
Pool 1 INDEL 9 13 95235008 95235184 177 95235099 92 S -32,795261 -19,369099 0,996 0,004 14394 5726 No
Pool 1 INDEL 11 6 42018135 42018308 174 42018234 100 D -771,817827 -110,081591 0,976 0,024 11744 1714 rs3050130
Pool 1 INDEL 11 6 42018135 42018308 174 42018235 101 D -630,972652 -119,97128 0,974 0,026 11455 1721 rs3050130
Pool 2 INDEL 6 X 133437395 133437566 172 133437464 70 S -186,004945 -487,410847 0,966 0,034 3566 8748 rs2070888
Pool 2 INDEL 6 X 133437395 133437566 172 133437486~133437487 92~93 I -44,388505 -50,465368 0,996 0,004 3974 6516 rs17879579
Pool 2 INDEL 6 X 133437395 133437566 172 133437487 93 D -138,553645 -107,257341 0,991 0,009 4000 6258 rs17879579
Pool 2 INDEL 2 11 47310399 47310551 153 47310475 77 S -69,070271 -31,503161 0,993 0,007 10870 6928 No
Pool 2 INDEL 2 11 47310399 47310551 153 47310475~47310476 77~78 I -61,016974 -24,521008 0,997 0,003 10720 6928 No
Pool 2 INDEL 1 14 19881224 19881410 187 19881282 59 S -178,821949 -122,456581 0,980 0,020 7904 6519 rs3093873
Pool 2 INDEL 1 14 19881224 19881410 187 19881316~19881317 93~94 I -405,414212 -285,138602 0,980 0,020 10216 5964 No
Pool 2 INDEL 12 14 99042658 99042823 166 99042738 81 D -170,727123 -98,870495 0,992 0,008 8112 4771 rs3918110
Pool 2 INDEL 12 14 99042658 99042823 166 99042739 82 D -171,703597 -92,934083 0,992 0,008 8234 4742 rs3918110
Pool 2 INDEL 18 20 2268180 2268350 171 2268211 32 S -169,552602 -51,122591 0,992 0,008 22519 9053 No
Pool 2 INDEL 18 20 2268180 2268350 171 2268255 76 S -21,48087 -30,152055 0,996 0,004 8263 8427 rs45598640
Pool 2 INDEL 18 20 2268180 2268350 171 2268322 143 D -46,951973 -60,456769 0,998 0,002 7516 23130 No
Pool 2 INDEL 17 16 79680482 79680631 150 79680546 65 D -128,118067 -60,990586 0,995 0,005 9664 5346 rs8177888
Pool 2 INDEL 4 19 48739570 48739760 191 48739665 96 S -45,783903 -27,347479 0,996 0,004 10963 12156 No
Pool 2 INDEL 4 19 48739570 48739760 191 48739666 97 S -39647,40251 -40597,76285 1,000 0,000 11042 12150 rs2682557
Pool 2 INDEL 5 8 18124763 18124959 197 18124924 162 S -7159,150252 -752,937186 0,796 0,204 2787 284 rs8190861
Pool 2 INDEL 5 8 18124763 18124959 197 18124931 169 S -6259,595998 -1310,094253 0,610 0,390 3159 459 rs15561
Pool 2 INDEL 16 12 51783075 51783234 160 51783149 75 D -119,907452 -140,050449 0,996 0,004 13226 11731 rs17884136
Pool 2 INDEL 16 12 51783075 51783234 160 51783150 76 D -116,801469 -148,894364 0,996 0,004 13738 11751 rs17884136
Pool 2 INDEL 11 6 42018135 42018308 174 42018157 23 S -189,190316 -39,12541 0,991 0,009 26232 3737 rs3218085
Pool 2 INDEL 11 6 42018135 42018308 174 42018234 100 D -358,434995 -112,335133 0,989 0,011 13841 3854 rs3050130
Pool 2 INDEL 11 6 42018135 42018308 174 42018235 101 D -288,279987 -119,071575 0,989 0,011 13592 3986 rs3050130
Pool 3 INDEL 6 X 133437395 133437566 172 133437464 70 S -663,536875 -2321,303173 0,918 0,082 4382 13551 rs2070888
Pool 3 INDEL 6 X 133437395 133437566 172 133437486~133437487 92~93 I -47,66922 -65,012124 0,996 0,004 32 25 rs17879579
Pool 3 INDEL 6 X 133437395 133437566 172 133437487 93 D -152,657328 -125,53123 0,992 0,008 5298 9339 rs17879579
Pool 3 INDEL 2 11 47310399 47310551 153 47310475 77 S -309,486024 -163,816621 0,981 0,019 13993 9239 No
Pool 3 INDEL 2 11 47310399 47310551 153 47310476 78 D -45,051444 -31,005828 13959 9198 No
Pool 3 INDEL 1 14 19881224 19881410 187 19881282 59 S -478,990363 -419,621081 0,968 0,032 11547 11037 rs3093873
Pool 3 INDEL 1 14 19881224 19881410 187 19881316~19881317 93~94 I -401,454994 -407,73453 0,987 0,013 214 181 No
Pool 3 INDEL 1 14 19881224 19881410 187 19881347 124 S -70,93169 -30,281458 0,996 0,004 16903 8089 No
Pool 3 INDEL 1 14 19881224 19881410 187 19881368 145 S -146,642698 -97,174683 0,989 0,011 8669 10169 No
Pool 3 INDEL 12 14 99042658 99042823 166 99042738 81 D -540,156332 -240,550758 0,984 0,016 10919 6473 rs3918110
Pool 3 INDEL 12 14 99042658 99042823 166 99042739 82 D -571,320059 -266,417228 0,983 0,017 10887 6390 rs3918110
Pool 3 INDEL 18 20 2268180 2268350 171 2268322 143 D -28,124426 -44,646258 0,999 0,001 7981 24941 No
Pool 3 INDEL 17 16 79680482 79680631 150 79680592 111 S -65,29345 -59,052194 0,993 0,007 10361 12614 No
Pool 3 INDEL 4 19 48739570 48739760 191 48739666 97 S 62016,75828 -62531,67829 1,000 0,000 17229 18729 rs2682557
Pool 3 INDEL 4 19 48739570 48739760 191 48739740 171 S -34,286619 -2028,505838 0,992 0,008 5586 55587 rs3213397
Pool 3 INDEL 5 8 18124763 18124959 197 18124924 162 S -7291,475527 -292,765298 0,760 0,240 2998 142 rs8190861
Pool 3 INDEL 5 8 18124763 18124959 197 18124931 169 S -6205,133093 -546,785599 0,605 0,395 3365 204 rs15561
Pool 3 INDEL 16 12 51783075 51783234 160 51783149 75 D -130,285138 -146,642527 0,997 0,003 22059 17973 rs17884136
Pool 3 INDEL 16 12 51783075 51783234 160 51783150 76 D -140,566709 -182,461744 0,997 0,003 22593 17628 rs17884136
Pool 3 INDEL 11 6 42018135 42018308 174 42018157 23 S -447,481452 -95,217989 0,983 0,017 24499 3398 rs3218085
Pool 3 INDEL 11 6 42018135 42018308 174 42018234 100 D -193,019974 -61,639782 0,995 0,005 18574 4343 rs3050130
Pool 3 INDEL 11 6 42018135 42018308 174 42018235 101 D -155,484463 -64,395678 0,995 0,005 17996 4402 rs3050130
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Figure 2.28. Supplementary Table 6 part2
Pool 4 INDEL 6 X 133437395 133437566 172 133437464 70 S -508,008104 -1070,492592 0,951 0,049 6329 12346 rs2070888
Pool 4 INDEL 6 X 133437395 133437566 172 133437486~133437487 92~93 I -93,141771 -119,186593 0,993 0,007 57 47 rs17879579
Pool 4 INDEL 6 X 133437395 133437566 172 133437487 93 D -179,063194 -185,124866 0,990 0,010 5826 9334 rs17879579
Pool 4 INDEL 2 11 47310399 47310551 153 47310475 77 S -79,102525 -64,174439 0,992 0,008 10090 7182 No
Pool 4 INDEL 1 14 19881224 19881410 187 19881282 59 S -1292,013551 -1223,577903 0,930 0,070 11305 10861 rs3093873
Pool 4 INDEL 1 14 19881224 19881410 187 19881347 124 S -72,534051 -39,777164 0,995 0,005 14889 8253 No
Pool 4 INDEL 1 14 19881224 19881410 187 19881368 145 S -218,443583 -156,311616 0,987 0,013 10410 9800 No
Pool 4 INDEL 12 14 99042658 99042823 166 99042738 81 D -404,673559 -231,702863 0,987 0,013 10648 6842 rs3918110
Pool 4 INDEL 12 14 99042658 99042823 166 99042739 82 D -428,569986 -232,397551 0,986 0,014 10589 6771 rs3918110
Pool 4 INDEL 17 16 79680482 79680631 150 79680592 111 S -57,482685 -70,888047 0,994 0,006 11076 15414 No
Pool 4 INDEL 4 19 48739570 48739760 191 48739665 96 S -128,625138 -63,529794 0,995 0,005 12972 14240 No
Pool 4 INDEL 4 19 48739570 48739760 191 48739666 97 S -47160,36252 -47931,91734 1,000 0,000 13109 14346 rs2682557
Pool 4 INDEL 4 19 48739570 48739760 191 48739740 171 S -39,227282 -1537,939998 0,991 0,009 4307 100513 rs3213397
Pool 4 INDEL 5 8 18124763 18124959 197 18124924 162 S -7517,203596 -730,570315 0,755 0,245 3107 281 rs8190861
Pool 4 INDEL 5 8 18124763 18124959 197 18124931 169 S -7866,343721 -1193,341355 0,695 0,305 3665 395 rs15561
Pool 4 INDEL 11 6 42018135 42018308 174 42018157 23 S -760,041271 -92,007839 0,990 0,010 64447 4748 rs3218085
Pool 4 INDEL 11 6 42018135 42018308 174 42018234 100 D -411,298967 -149,440949 0,865 0,135 13973 6414 rs3050130
Pool 4 INDEL 11 6 42018135 42018308 174 42018235 101 D -330,36378 -155,069646 0,865 0,135 13835 6441 rs3050130
Pool 5 INDEL 6 X 133437395 133437566 172 133437464 70 S -823,730508 -2283,560033 0,928 0,072 6359 16476 rs2070888
Pool 5 INDEL 6 X 133437395 133437566 172 133437486~133437487 92~93 I -87,714141 -115,532389 0,994 0,006 55 45 rs17879579
Pool 5 INDEL 6 X 133437395 133437566 172 133437487 93 D -235,977618 -178,452748 0,990 0,010 6658 10714 rs17879579
Pool 5 INDEL 6 X 133437395 133437566 172 133437495 101 S -69,237294 -54,390716 0,992 0,008 6504 8214 rs17879338
Pool 5 INDEL 2 11 47310399 47310551 153 47310475 77 S -287,344786 -233,308903 0,980 0,020 12278 9001 No
Pool 5 INDEL 1 14 19881224 19881410 187 19881282 59 S -357,753903 -326,037653 0,976 0,024 12198 11383 rs3093873
Pool 5 INDEL 1 14 19881224 19881410 187 19881316~19881317 93~94 I -263,082519 -138,220294 0,992 0,008 153 75 No
Pool 5 INDEL 12 14 99042658 99042823 166 99042738 81 D -575,75925 -387,442678 0,983 0,017 11608 9124 rs3918110
Pool 5 INDEL 12 14 99042658 99042823 166 99042739 82 D -604,779779 -369,000663 0,983 0,017 11637 9081 rs3918110
Pool 5 INDEL 18 20 2268180 2268350 171 2268211 32 S -834,704674 -266,378678 0,978 0,022 30957 13939 No
Pool 5 INDEL 18 20 2268180 2268350 171 2268255 76 S -146,55124 -122,325277 0,993 0,007 14017 13613 rs45598640
Pool 5 INDEL 8 1 20271863 20272035 173 20271939 77 S -130,4358 -329,52478 0,992 0,008 17139 22638 No
Pool 5 INDEL 4 19 48739570 48739760 191 48739665 96 S -156,0812 -88,037301 0,994 0,006 16502 20394 No
Pool 5 INDEL 4 19 48739570 48739760 191 48739666 97 S -59921,56125 -69625,94809 0,999 0,001 16660 20842 rs2682557
Pool 5 INDEL 5 8 18124763 18124959 197 18124924 162 S -10027,75781 -1264,400271 0,860 0,140 3519 436 rs8190861
Pool 5 INDEL 5 8 18124763 18124959 197 18124931 169 S -10606,436 -1926,331813 0,791 0,209 4205 567 rs15561
Pool 5 INDEL 11 6 42018135 42018308 174 42018157 23 S -945,078677 -119,472013 0,987 0,013 76250 6043 rs3218085
Pool 5 INDEL 11 6 42018135 42018308 174 42018234 100 D -588,014453 -130,037458 0,989 0,011 21701 6705 rs3050130
Pool 5 INDEL 11 6 42018135 42018308 174 42018235 101 D -488,780852 -139,41771 0,989 0,011 21563 6782 rs3050130
Pool 6 INDEL 6 X 133437395 133437566 172 133437464 70 S -335,090829 -916,67261 0,965 0,035 6526 15650 rs2070888
Pool 6 INDEL 6 X 133437395 133437566 172 133437486~133437487 92~93 I -94,448338 -93,839601 0,994 0,006 60 42 rs17879579
Pool 6 INDEL 6 X 133437395 133437566 172 133437487 93 D -240,47146 -229,572709 0,989 0,011 6705 10617 rs17879579
Pool 6 INDEL 1 14 19881224 19881410 187 19881282 59 S -725,691191 -534,231247 0,957 0,043 11681 11215 rs3093873
Pool 6 INDEL 1 14 19881224 19881410 187 19881286 63 S -208,534096 -222,108161 0,987 0,013 12311 12017 rs3093874
Pool 6 INDEL 12 14 99042658 99042823 166 99042738 81 D -661,916829 -322,360264 0,982 0,018 11433 8441 rs3918110
Pool 6 INDEL 12 14 99042658 99042823 166 99042739 82 D -696,07999 -335,852299 0,982 0,018 11481 8384 rs3918110
Pool 6 INDEL 18 20 2268180 2268350 171 2268211 32 S -402,335996 -151,903214 0,985 0,015 25245 10635 No
Pool 6 INDEL 18 20 2268180 2268350 171 2268212 33 S -85,79327 -59,623789 0,994 0,006 23527 10807 No
Pool 6 INDEL 18 20 2268180 2268350 171 2268255 76 S -229,096561 -227,830153 0,988 0,012 11226 11156 rs45598640
Pool 6 INDEL 17 16 79680482 79680631 150 79680592 111 S -240,097499 -226,228225 0,981 0,019 10561 15014 No
Pool 6 INDEL 4 19 48739570 48739760 191 48739666 97 S -47695,78236 -53283,02714 1,000 0,000 13254 15943 rs2682557
Pool 6 INDEL 5 8 18124763 18124959 197 18124924 162 S -6317,882141 -888,382606 0,795 0,205 2455 342 rs8190861
Pool 6 INDEL 5 8 18124763 18124959 197 18124931 169 S -7468,018309 -2012,396572 0,790 0,210 3078 602 rs15561
Pool 6 INDEL 16 12 51783075 51783234 160 51783149 75 D -119,228449 -94,553203 0,998 0,002 21039 16837 rs17884136
Pool 6 INDEL 16 12 51783075 51783234 160 51783150 76 D -116,287022 -107,466429 0,998 0,002 21288 16579 rs17884136
Pool 6 INDEL 11 6 42018135 42018308 174 42018157 23 S -3474,657371 -82,027113 0,960 0,040 106804 5221 rs3218085
Pool 6 INDEL 11 6 42018135 42018308 174 42018234 100 D -319,081612 -106,640536 0,994 0,006 21225 8393 rs3050130
Pool 6 INDEL 11 6 42018135 42018308 174 42018235 101 D -247,124969 -107,694371 0,992 0,008 21104 8445 rs3050130
Pool 7 INDEL 6 X 133437395 133437566 172 133437464 70 S -610,575048 -1725,668301 0,913 0,087 3755 10230 rs2070888
Pool 7 INDEL 6 X 133437395 133437566 172 133437486~133437487 92~93 I -47,766465 -76,359613 1,000 0,000 4181 7521 rs17879579
Pool 7 INDEL 6 X 133437395 133437566 172 133437487 93 D -129,612588 -113,205424 0,991 0,009 4200 7250 rs17879579
Pool 7 INDEL 2 11 47310399 47310551 153 47310475 77 S -604,109281 -417,856615 0,956 0,044 8950 6617 No
Pool 7 INDEL 1 14 19881224 19881410 187 19881282 59 S -589,775478 -434,837051 0,950 0,050 8305 7282 rs3093873
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Figure 2.29. Supplementary Table 6 part3
Pool 7 INDEL 12 14 99042658 99042823 166 99042738 81 D -1117,886613 -538,964576 0,952 0,048 6745 4971 rs3918110
Pool 7 INDEL 12 14 99042658 99042823 166 99042739 82 D -1178,109656 -526,013896 0,952 0,048 6687 4938 rs3918110
Pool 7 INDEL 18 20 2268180 2268350 171 2268211 32 S -358,831395 -115,750071 0,976 0,024 12939 6553 No
Pool 7 INDEL 18 20 2268180 2268350 171 2268255 76 S -123,817034 -92,922965 0,990 0,010 7281 7501 rs45598640
Pool 7 INDEL 17 16 79680482 79680631 150 79680592 111 S -240,171781 -221,352025 0,974 0,026 8944 11061 No
Pool 7 INDEL 4 19 48739570 48739760 191 48739665 96 S -172,838903 -52,571483 0,990 0,010 8233 8134 No
Pool 7 INDEL 4 19 48739570 48739760 191 48739666 97 S -30253,8579 -27520,948 1,000 0,000 8408 8233 rs2682557
Pool 7 INDEL 4 19 48739570 48739760 191 48739679 110 S -19,052913 -29,947174 0,998 0,002 7914 10264 rs2307182
Pool 7 INDEL 4 19 48739570 48739760 191 48739740 171 S -16,801444 -220,818919 0,992 0,008 2077 18127 rs3213397
Pool 7 INDEL 5 8 18124763 18124959 197 18124924 162 S -3979,998521 -251,639048 0,814 0,186 1506 103 rs8190861
Pool 7 INDEL 5 8 18124763 18124959 197 18124931 169 S -4449,22759 -361,240836 0,768 0,232 1801 117 rs15561
Pool 7 INDEL 16 12 51783075 51783234 160 51783149 75 D -132,669422 -97,939419 0,996 0,004 13879 10576 rs17884136
Pool 7 INDEL 16 12 51783075 51783234 160 51783150 76 D -120,805113 -111,412426 0,996 0,004 14164 10320 rs17884136
Pool 7 INDEL 11 6 42018135 42018308 174 42018234 100 D -464,613957 -243,637792 0,984 0,016 12961 4852 rs3050130
Pool 7 INDEL 11 6 42018135 42018308 174 42018235 101 D -389,740466 -265,109681 0,984 0,016 12644 5011 rs3050130
Pool 8 INDEL 6 X 133437395 133437566 172 133437464 70 S -58,238992 -396,612637 0,956 0,044 820 4171 rs2070888
Pool 8 INDEL 1 14 19881224 19881410 187 19881282 59 S -107,777191 -134,062874 0,950 0,050 1481 2362 rs3093873
Pool 8 INDEL 12 14 99042658 99042823 166 99042738 81 D -359,338378 -180,839152 0,964 0,036 2906 2125 rs3918110
Pool 8 INDEL 12 14 99042658 99042823 166 99042739 82 D -391,172461 -215,456437 0,964 0,036 2949 2063 rs3918110
Pool 8 INDEL 18 20 2268180 2268350 171 2268255 76 S -64,275749 -74,708385 0,980 0,020 2135 3235 rs45598640
Pool 2 INDEL 17 16 79680482 79680631 150 79680546 65 D -66,680835 -45,876402 0,995 0,005 3111 2345 rs8177888
Pool 8 INDEL 4 19 48739570 48739760 191 48739666 97 S -14500,44891 -15700,45578 0,999 0,001 4035 4703 rs2682557
Pool 8 INDEL 5 8 18124763 18124959 197 18124924 162 S -374,049006 -57,857707 0,831 0,169 136 20 rs8190861
Pool 8 INDEL 5 8 18124763 18124959 197 18124931 169 S -417,508006 -62,242398 0,710 0,290 178 21 rs15561
Pool 8 INDEL 11 6 42018135 42018308 174 42018234 100 D -248,304768 -63,707338 0,976 0,024 4154 698 rs3050130
Pool 8 INDEL 11 6 42018135 42018308 174 42018235 101 D -212,568372 -66,130491 0,976 0,024 4106 689 rs3050130
Pool 9 INDEL 6 X 133437395 133437566 172 133437448 54 S -812,136633 -1191,80288 0,957 0,043 10773 12122 No
Pool 9 INDEL 6 X 133437395 133437566 172 133437464 70 S -35,656438 -96,919255 0,995 0,005 9119 19662 rs2070888
Pool 9 INDEL 6 X 133437395 133437566 172 133437481 87~88 I -819,84957 -218,04421 0,985 0,015 11647 18688 No
Pool 9 INDEL 6 X 133437395 133437566 172 133437486~133437487 92~93 I -123,868701 -155,679235 0,994 0,006 9616 18191 rs17879579
Pool 9 INDEL 6 X 133437395 133437566 172 133437487 93 D -296,61149 -786,211855 0,989 0,011 9671 17792 rs17879579
Pool 9 INDEL 10 13 95152472 95152649 178 95152553 82~83 I -4880,888294 -8390,772074 0,903 0,097 21193 27107 rs17885121
Pool 9 INDEL 10 13 95152472 95152649 178 95152587 116 S -4620,349611 -4663,636616 0,911 0,089 27159 28110 No
Pool 9 INDEL 2 11 47310399 47310551 153 47310475 77 S -953,022903 -916,653834 0,95 0,05 13921 11668 No
Pool 9 INDEL 13 4 148653433 148653591 159 14853674 84 D -6592,52907 -6764,997395 0,886 0,114 19860 19864 rs10305888
Pool 9 INDEL 13 4 148653433 148653591 159 14853675 85 D -6663,146472 -6528,074021 0,884 0,116 19855 20416 rs10305888
Pool 9 INDEL 1 14 19881224 19881410 187 19881282 59 S -9230,697535 -9585,191291 0,587 0,413 5612 6001 rs3093873
Pool 9 INDEL 1 14 19881224 19881410 187 19881328 105~106 I -246,929118 -99,846304 0,99 0,01 13789 5600 No
Pool 9 INDEL 1 14 19881224 19881410 187 19881364 141 S -283,052967 -170,343449 0,978 0,022 11466 7301 rs3093876
Pool 9 INDEL 12 14 99042658 99042823 166 99042738 81 D -47,624355 -23,951272 0,998 0,002 15663 14972 rs3918110
Pool 9 INDEL 12 14 99042658 99042823 166 99042739 82 D -56,983084 -33,803741 0,998 0,002 15392 14867 rs3918110
Pool 9 INDEL 18 20 2268180 2268350 171 2268211 32 S -939,220506 -419,647851 0,966 0,034 21780 9719 No
Pool 9 INDEL 18 20 2268180 2268350 171 2268252 73 D -785,131453 -713,209961 0,981 0,019 12203 13606 No
Pool 9 INDEL 18 20 2268180 2268350 171 2268255 76 S -800,480175 -706,782668 0,966 0,034 11368 13976 rs45598640
Pool 9 INDEL 17 16 79680482 79680631 150 79680546 65 D -9615,324495 -6756,209889 0,884 0,116 28178 19992 rs8177888
Pool 9 INDEL 17 16 79680482 79680631 150 79680578 97 S -26,558427 -65,579619 0,998 0,002 16877 22851 No
Pool 9 INDEL 8 1 20271863 20272035 173 20271945 83 D -1628,286374 -3142,392414 0,974 0,026 17782 26344 rs11573206
Pool 9 INDEL 8 1 20271863 20272035 173 20271952 90 S -1432,562603 -813,761063 0,955 0,045 18802 24324 rs11573207
Pool 9 INDEL 4 19 48739570 48739760 191 48739665 96 S -1421,22059 -736,607298 0,961 0,039 13849 15824 No
Pool 9 INDEL 4 19 48739570 48739760 191 48739666 97 S -54770,8592 -55017,67119 0,999 0,001 14145 15711 rs2682557
Pool 9 INDEL 5 8 18124763 18124959 197 18124924 162 S -11404,90291 -1876,815807 0,573 0,427 6004 992 rs8190861
Pool 9 INDEL 5 8 18124763 18124959 197 18124931 169 S -7737,992952 -3270,738926 0,502 0,498 5398 1466 rs15561
Pool 9 INDEL 9 13 95235008 95235184 177 95235107 100~101 I -134,007499 -112,515637 0,995 0,005 18740 17643 rs17884136
Pool 9 INDEL 16 12 51783075 51783234 160 51783149 75 D -4293,752472 -3012,096929 0,945 0,055 28558 18328 rs9658624
Pool 9 INDEL 16 12 51783075 51783234 160 51783150 76 D -4532,381085 -3097,268579 0,944 0,056 29114 18239 rs9658624
Pool 9 INDEL 16 12 51783075 51783234 160 51783173 99 S -109,462386 -103,945493 0,99 0,01 21146 13723 No
Pool 9 INDEL 11 6 42018135 42018308 174 42018234 100 D -66,780582 -33,193141 0,998 0,002 19505 8622 rs3050130
Pool 9 INDEL 11 6 42018135 42018308 174 42018235 101 D -59,333553 -35,015111 0,998 0,002 18873 8667 rs3050130
Figure 2.30. Supplementary Table 7
Pool dbSNP129 Variants Total Variants Fraction Fisher's Exact Test P-value Bonferroni Corrected P-values
Pool1 13 17 76.47% 4.91E-22 4.42E-21
Pool2 16 22 72.73% 1.38E-26 1.24E-25
Pool3 15 22 68.18% 3.35E-24 3.02E-23
Pool4 13 18 72.22% 1.75E-21 1.58E-20
Pool5 14 19 73.68% 2.40E-23 2.16E-22
Pool6 16 19 84.21% 1.84E-28 1.65E-27
Pool7 16 20 80.00% 9.10E-28 8.19E-27
Pool8 11 11 100.00% 1.89E-21 1.70E-20
Pool9 22 32 68.75% 2.92E-36 2.62E-35
total dbSNP total bases
39 2596
130
Figure 2.31. Supplementary Table 8
Variant Presence Method Measured Frequency SPLINTER Frequency
rs3050130 Y Sequenom 0,002 0,002
rs3918110 Y Sequenom 0,003 0,002
rs2070888 Y Sequenom 0,006 0,005
rs17884136 Y Sequenom 0,006 0,005
rs3093876 Y Sequenom 0,023 0,022
rs11573206 Y Sequenom 0,043 0,026
rs9658624 Y Sequenom 0,060 0,056
rs17885121 Y Sequenom 0,074 0,093
rs8177888 Y Sequenom 0,090 0,116
rs10305888 Y Sequenom 0,041 0,116
rs15561 Y Sequenom 0,359 0,502
INDEL18 32 Y Sequenom 0,020 0,034
INDEL4 96 Y Sequenom 0,048 0,039
INDEL1 59 Y Sanger / 0,413
Figure 2.32. Supplementary Table 9
Amplicon Forward Primer Reverse Primer Product size Annealing Temperature
M13/ Negative Control TCCGAAATAGGCAGGGGGCATTAA GCTGATGCAAATCCAATCGCAAGA 1934 56
Synthetic library/Positive Control CGCCAGGGTTTTCCCAGTCACGACG CAGGAAACAGCTATGAC 335 56
INDEL1 GCATCTCCTGCCCAGTCTGACCTC ATAGGGCGGAGGGAAGCTCATCAGT 187 59
INDEL2 AAAGAGAGGGAGGGAAGCCATCCAG GGGCCATGGTACTCACTCTTGGTTCC 153 59
INDEL4 CGGGTCTCCCATTCTCTGCCTCTTT GCCATTGAGAGTGGCTGGGGAGTAG 191 59
INDEL5 TGACGACCTATCATGTATCTTCTGTACCC TCCAAGATAACCACAGGCCATCTTTA 197 59
INDEL6 TGGAGCTAGGTTTGACAAATAAGGTGGG TGGATCAAAAGTGGTTTCTGGTGCG 172 59
INDEL8 CACCTCCTCTTAGGCCCAGGGAAAA CCCGTTAGGCACTACGAGGACCAAAT 173 59
INDEL9 CAGGACTGCTGTGTTGACTCTCTTCTGC CACTTTGGCTGACTGCATCCTCGAC 177 59
INDEL10 ACATTACCAGCAGTTCCCTCCTGCC TGCACAAAGGCACGTACGGAAACTAAG 178 59
INDEL11 GGCCCACCCCTAACCTGAATCAGAA TAAGGCCGACTTTAGGGGCTTGTCC 174 59
INDEL12 AATGTGCTGCTTCTGACATGCTGCC CCCTGGTACAGAGGACACAAAGAAGGG 166 59
INDEL13 GGGGTCTTTTGTTCTTGTGTGGCCT ACTGTGGGCCAGCGAAGAGAGAATC 159 59
INDEL16 TGACACTCAGCCTTTCCTGGAGGG GGCTGAAGGTCAGGGAGGAGTCAGA 160 59
INDEL17 AGTTTCAGATTTTTGGAGTATTTCAGGGA TATGGTACAGCCTTTGCTCCTGGGC 170 59
INDEL18 CTGTCCTGGGAAGCAGGGTCTGAAC CACATTGTGTCTGACGCCCCCTG 171 59
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3. High-throughput dissection of genetic factors underlying DNA
methylation.
3.1 Foreword
This chapter describes the development of a reporter system to dissect the genetic cis ar-
chitecture underlying DNA methylation patterns across the genome, with a specific focus on
neuronal differentiation. This project involves experimental work as well as computational
modeling aimed at inferring such elements from large scale DNA methylation datasets. This
project was conceived by me and supervised by Robi D Mitra, PhD. I designed, prototyped,
and tested the reporter system as well as the probabilistic models for the analysis of differ-
entially methylated regions. Rob and I discussed and designed the experiments. Sumithra
Sankararan, PhD and Zongtai Qi performed transposon-based experiments critical for the
correct implementation of the experimental assay. This work is in collaboration with Barak
A Cohen, PhD, who provided guidance and experimental reagents. This work is currently
in progress and has not yet been published.
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3.2 Introduction/Results
3.2.1 Experimental design and construction of a reporter system for DNA
methylation
Understanding how DNA methylation patterns across the genome are established remains
a major question in the fields of epigenetics and chromatin biology. A significant factor
hindering our efforts toward answering that question is the lack of a high-throughput system
to dissect the DNA sequence contribution to DNA methylation. The purpose of such system
is to provide a DNA backbone where a DNA fragment of interest could be inserted in
isolation from its endogenous locus of origin. Doing so would allow us to determine whether
such fragment contains all the sufficient sequence elements to determine its own methylation
pattern. Here we present the design and construction of a methylation reporter system
based on the piggyBAC DNA transposon [167] and its application to the dissection of the
establishment of DNA methylation across the regulatory regions of the gene Oct4 [62].
Design and testing of a high-throughput reporter system for DNA methylation
We first started by designing and testing our reporter system for DNA methylation. The
system that we adopted for our experiments is a derivation of piggyBAC, a type II DNA
transposon [167]. PiggyBAC is a two-component system consisting of a ”donor” vector,
i.e. the transposon, characterized by inverted repeats sequences, and a ”helper” vector,
encoding for the ”transposase” (Figure 3.1). Once co-transfected inside a particular cell
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type of interest, the piggyBAC transposase will integrate multiple copies of the donor vector
inside the host genome. Integration events will occur at the presence of a TTAA recognition
site in the host genome, but will otherwise be specified randomly. By inserting a DNA
fragment of interest inside the piggyBAC donor, it is therefore possible to integrate multiple
copies across the genome. Finally, after transient transfection, individual clones containing
one or multiple insertions can be selected by drug screening using an integrated resistance
cassette present in the inserted donor constructs. This setup can allow us to read out the
methylation of the inserted fragment by averaging out the methylation across all the insertion
events that occurred across the genome of all the transfected cells. This feature provides
several advantages. Firstly, by integrating our signal across many insertion events in different
genomic locations, site-specific position effects [168] can be averaged out, resulting in a clear
picture of the endogenous methylation pattern specified by the inserted DNA fragment.
Secondly, integration of the DNA fragment will ensure its persistence during the process of
differentiation without loss of signal due to dilution of the reporter during cell replication.
In order to determine the efficiency of the reporter, we started by inserting a DNA frag-
ment that had been previously identified as being sufficient to establish its own methylation
pattern outside of its endogenous locus. The control region that we chose consists of the
proximal promoter of the Trf gene, which is unmethylated in ES cells and acquires methy-
lation during differentiation into neural progenitors [70]. Using the RW4 mouse embryonic
stem cell line as a model system for neural differentiation (see Materials and methods), we
proceeded with the experiment as described in Figure 3.2. Briefly, the Trf promoter was first
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Figure 3.1. Overview of the piggyBAC DNA transposon system
H Wang*, D Mayhew* et al Genetics 2012
Pros Cons












This figure is adapted from [76] and describes the piggyBAC transposon system.
cloned into the donor plasmid (piggyBAC∼Trf ) and then co-transfected with the transposase
inside RW4 cell lines. After ransfection, cells containing copies of piggyBAC∼Trf will be
selected using a puromycin [169] resistance cassette inside the donor. After a one-week se-
lection, the ES cells (ESCs) will be differentiated into Neural Progenitor cells (NPCs). DNA
collected before and after differentiation is then harvested, processed and then sequenced in
order to read out methylation of the Trf fragment inside the piggyBAC donor (for details
see Materials and methods).
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Figure 3.2. Schematic representation of the piggyBAC methylation reporter assay
differentiate 
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This figure depicts a schematic representation of the piggyBAC methylation reporter assay: the DNA frag-
ment of interest is inserted inside the piggyBAC transposon plasmid, which is subsequently co-transfected in
the mouse RW4 embryonic stem cell line. After selection, the cells containing piggyBAC insertions in their
genome will be differentiated into neural progenitor cells. DNA is collected before and after differentiation
and processed for methylation readout.
The piggyBAC methylation reporter faithfully recapitulates the endogenous pat-
terns of DNA methylation
After performing the experiment and sequencing all samples, we then compared the level
of methylation of piggyBAC∼Trf between ESC and NPC across 2 biological replicates. As
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expected, we observed almost no methylation in ESC but, on the other hand, piggyBAC∼Trf
displayed intermediate levels of methylation in NPCs (Figure 3.3), in concordance to the
endogenous pattern of Trf. This result suggests that the piggyBAC reporter system can
recapitulate the endogenous patterns of DNA methylation. Interestingly, individual CpGs
displayed a unique and distinct pattern of DNA methylation, which appeared strikingly
similar between biological replicates, suggesting that specific methylation of individual CpGs
is a highly controlled process.
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This figure shows the levels of methylation of the Trf promoter in ES cells and NP cells. Each column
represents a cell type and each row is an individual biological replicate. In each barplot, the x-axis represents
the position in the Trf sequence, with each blue bar representing the position of every single CpG. The red
bar overlaying the blue bar is the fraction that CpG that appears methylated following the methylation scale
present on the left y-axis. The green line represents sequencing coverage in log10 scale, following the scale
present on the right y-axis.
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We then asked whether the patterns of single CpG methylation in piggyBAC∼Trf would
also recapitulate those of the endogenous copy of Trf. A comparison between the level of
single CpG methylation of endogenous Trf to the inserted copy in NP cells revealed a strong
correlation (r = 0.885, p-value = 1.137 ∗ 10−5, Figure 3.4). This result indicates not only
that the piggyBAC reporter system recapitulates methylation patterns down to a single
CpG level, but also that methylation is a highly controlled process down to a single CpG
resolution. A surprise result from our analysis was that the level of methylation from our
insert was dramatically lower than the one from the endogenous locus (compare 22% vs
70% in Figure 3.4). While this may produce potential shortcomings in the fine dissection of
smaller changes in DNA methylation, the data suggests that the system is still quantitatively
accurate on a relative scale even down to a single CpG level.
Since we compared the level of methylation of the same construct with different cell
types, a potential explanation underlying our result could derive from undirected global
methylation of the piggyBAC reporter in one cell type versus the other rather than sequence
specific effects. To rule out this scenario and assess whether the Trf insert specifically
acquired methylation independently of the context, we profiled two different regions of the
piggyBAC transposon (named CR1 and CR2). As these regions belong to the backbone of
the piggyBAC transpose, we would expect them to display a methylation pattern different
from the Trf. In contrast, if methylation levels were largely specified by the location of
insertion in the host genome and cell type, we would expect to observe the pattern of DNA
methylation displayed by Trf across the whole transposon. As shown in Figure 3.5, unlike
139
Figure 3.4. piggyBAC methylation reporter recapitulates endogenous patterns
at a single CpG level
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This figure compares levels of methylation at single CpG level between the Trf insert (x-axis) and the
endogenous copy (y-axis)
Trf, CR1 and CR2 display monotonic patterns of DNA methylation, suggesting that the
pattern observed in Trf is largely dependent on its sequence.
To assess the robustness of the piggyBAC reporter system in recapitulating endogenous
patterns of methylation, we generated 4 additional constructs with inserts deriving from
the promoters of OrmI,Mrap,Zic3, and Syt1 [70]. Unlike Trf, these promoters displayed
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This figure shows level of methylation of the Trf construct and 2 control regions of the piggyBAC reporter
(CR1 and CR2) respectively (structure of the reporter system is represented in the bottom panel of the
figure). Each barplot is interpreted analogously to the ones depicted in Figure 3.3. Arbitrary methylation
calls are shown underneath each panel.
monotonic patterns of DNA methylation across ES cells and NP cells (the first two being
methylated and the latter two being unmethylated respectively). We then asked whether each
construct displayed the same pattern of methylation of the endogenous locus, i.e. increase
in methylation or stationary methylation. To compare the changes in methylation between






where T1 and T2 are indicative of ES cells and NP cells respectively. When we compared
all the constructs to one another (Figure 3.6), we observed a large gain of methylation in Trf
(∼5-fold), whereas, in contrast, we observed a small increase (up to 1-fold) of methylation in
the other constructs. This result is concordant with the endogenous pattern of these regions
(Figure 3.6, bottom panel) and suggests that the piggyBAC reporter system can faithfully
recapitulate the endogenous dynamics in DNA methylation.
Finally we asked whether the results obtained with this system held true across biological
replicates. In Figure 3.7, levels of methylation at single CpGs across OrmI,Mrap,Zic3 and
Syt1 were correlated between two biological replicates. We observed high concordance (r =
0.97, p-value < 2.2 ∗ 10−16) indicating that the assay is highly reproducible. These results
indicate that the piggyBAC methylation reporter system can faithfully recapitulate endoge-
nous methylation patterns down to single CpGs and is highly reproducible across biological
replicates.
3.2.2 Dissection of the Oct4 regulatory elements as a proof of concept experi-
ment
Oct4 is a master regulator of stem cell fate [58]. As Oct4 is completely un-methylated
in ESC and acquires methylation upon differentiation [62], we asked which parts of the
regulatory sequence of Oct4 determined the establishment of its methylation pattern. The
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Figure 3.6. piggyBAC methylation reporter recapitulates endogenous patterns
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This figure shows the gain in DNA methylation in the analyzed control regions by comparing methylation
in ES cells versus NP cells. On the lower panel, the expected methylation pattern of the endogenous locus
is shown.
expression of Oct4 is controlled by a distal enhancer, a proximal enhancer, and its promoter
sequence spanning ∼2Kb [61].
Despite extensive molecular dissection and differentiation experiments, the cis-acting
elements regulating the methylation patterns observed in Oct4 are still largely unknown. To
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p-value < 2.2 e-16
This figure shows a correlation plot of methylation levels at single CpGs across the across OrmI,Mrap,Zic3
and Syt1 constructs.
dissect their role to the DNA methylation of Oct4, I generated 14 PCR-amplicons spanning
across its regulatory region covering at least one CpG (Figure 3.8) and tested their potential
in establishing methylation by inserting them into the piggyBAC methylation reporter. To
facilitate the construction of this library, the technique adopted for this experiment was
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based on assembly PCR. This protocol generated linear transposons compared to circular
molecules generated in the previous experiment (see Materials and methods for details).
After construction, I then transfected the Oct4 linear mini-library inside RW4 ESCs, put
them under selection for one week, and then differentiated them to NPCs. I then harvested
and processed the DNA before and after differentiation, sequenced it and measured the level
of methylation (details described in Materials and methods). Additionally, I added a set
of samples consisting of RW4 stem cells frozen and thawed after being transfected with the
library to test whether their storage could have an effect on methylation. For each sample,
two biological replicates were generated.


































This figure represents a snapshot of the Oct4 regulatory regions seen from the UCSC genome browser [170].
The amplicons generated for the mini-library are labeled MMOct4dpp and are represented as black bars in
the lower side of the figure. Also included are regions representing the distal enhancer, the proximal enhancer,
and the promoter. Mammalian conservation and DNAseI hypersensitivity tracks are also displayed.
Different inserts reproducibly display different levels of DNA methylation
I first asked whether the constructs showed different patterns of DNA methylation and
whether those patterns changed comparing the different samples. As seen in Figure 3.9,
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each construct showed distinct and specific levels of DNA methylation. Level of methylation
across the constructs were highly reproducible across biological replicates (r = 0.94∼0.97,
Figure 3.9). Reproducibility was also high at the level of single CpGs (r = 0.87∼0.98,
Figure 3.10). Because of the linear nature of this library, I expected a 10-fold decrease in
integration efficiency (see Materials and methods) and in the resulting number of insertions.
This translates to an average of 179 insertions per construct, compared to 25000 expected
insertions per construct in the previous experiments. These results further confirm the
robustness in reproducibility of this assay and its amenability to a multiplexed library.
By comparing fresh RW4 versus frozen and thawed (Figure 3.9), we did not observe any
substantial difference between the two conditions, indicative of the robustness of the process
of methylation establishment.Contrary to our expectations, the level of methylation of these
constructs was also similar when ESCs and NPSc where compared (Figure 3.9), whereas
in contrast the full Oct4 region acquired methylation during differentiation. There are
multiple explanations for this result. One possibility is that the regulatory elements driving
DNA methylation act cooperatively over a larger sequence region. As a result, breaking
the promoter in smaller fragments could potentially destroy their effect. Alternatively, the
regulatory region controlling methylation in Oct4 could have also potentially been missed
. As shown in Figure 3.8, by selecting only regions containing at least a single CpG, a
conserved (and therefore potentially functional) region between positions -1412 and -1290
from the TSS was excluded. Currently I am working to test these hypotheses.
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r =  0.94
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This figure indicates methylation levels across the Oct4 methylation library inside the piggyBAC methylation
reporter system. Barplots indicate methylation levels across the 14 Oct4 constructs. Each plot consists of
two biological replicates in a given condition/cell type. On the right, correlation plots of the methylation
between the two biological replicates for each set are displayed. The corresponding Pearson’s correlation
coefficient of each correlation is shown at the bottom right of each plot.
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Figure 3.10. Single CpG methylation reproducibility in the Oct4 library
...CTAATGATCGATCGATC ACGGCACGTACGAG GATCGATCGATCAAAAA...
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This figure shows the correlation of single CpG methylation levels across biological replicates in the piggyBAC
methylation reporter system for the Oct4 mini-library. Each column indicates a particular condition/cell
type. The first row, characterized by blue dots, consists of correlation plots of methylation levels for single
CpGs across the bisulfite PCR product of the piggyBAC reporter constructs. The second row, characterized
by red dots, is only limited to CpGs belonging to the variable DNA insert inside the piggyBAC reporter
(indicated by the light grey sequence above). The third row, characterized by green dots, is instead limited to
CpGs belonging to the fixed region of the piggyBAC reporter (indicated by the dark grey). The corresponding
Pearson’s correlation coefficient of each correlation is shown at the bottom right of each plot.
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Sequence elements in the inserts explain its levels of DNA methylation
Given that each insert displayed reproducible levels of DNA methylation, I then asked
whether the sequence of the insert could explain its methylation pattern. I performed this
analysis in two different ways. First, I asked whether the sequences contained any statistical
signature that was correlated with DNA methylation and that could be used to build a
predictive model. The advantage of this strategy is that it does not rely on any prior
knowledge and is therefore completely unbiased. Because of the limited size and number of
regions that I have profiled in this library I limited this analysis to short words of fixed size,
or ”k-mers”. I chose to perform my analysis looking at k-mers with k equal to 2, i.e. all
the possible dinucleotides as every dinucleotide was indeed observed at least once across the
sequences (by taking into account reverse complements as well). Each dinucleotide showed a
distinct correlation strength with respect to DNA methylation (Figure 3.11) with extremes
ranging from 0.4 to -0.4. To assess whether the dinucleotides contained enough information
to recapitulate the observed methylation patterns, I built a linear regression model that used
dinucleotide frequencies as features and predicted methylation in output (Figure 3.11, right).
Using forward regression as a feature selection strategy [171], I trained the models on
one dataset and computed the explained methylation variance (r2) on the remaining 5 (Fig-
ure 3.11, right panel, blue line). Because of limited sample size, to test for over-fitting,
I performed permutation tests where the methylation-dinucleotide pairs were shuffled and
the models were retrained 100 times (Figure 3.11, right panel, grey line). Using only 4
dinucleotides (GC,CA,AC, and TA) I was able to explain ∼70% of the variance in DNA
149





































GC CA AC TA AG CC AA CG
Oct4 dpp library
permutation tests
This figure shows correlations between DNA dinucleotide frequencies and DNA methylation (left panel) and
the results of linear regression models aimed at explaining DNA methylation as a function of dinucleotide
frequencies (right panel).
methylation, 50% more than what could expected by chance based on the permeation tests.
Interestingly and unexpectedly, CpG frequency was poorly correlated with levels of methyla-
tion. This result suggests that CpG density per se may not have any role in specifying DNA
methylation. Instead specific motifs or sequence elements that contain CpGs may instead
specify DNA methylation. This result suggests that the insert sequence contains information
that can be used to predict the insert methylation.
Previous evidence has implicated TFs in mediating establishment [63, 71, 82] and removal
[67, 68, 69] of DNA methylation. Using Positional Weight Matrices (PWMs) from Jaspar
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Figure 3.12. in silico occupancy of transcription factors predicts methylation of
the Oct4 inserts
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This figure shows the methylation levels predicted by the in silico occupancy of SP1 and SP1 with CREBB.
[172] and TRANSFAC [173], I calculated the in silico occupancy of each TF modeled in
the database and asked whether their occupancy correlated positively or negatively with








where i represents each base in a sequence of length n, the model is the PWM and the
background distribution assumes equiprobable nucleotide frequencies. Because SP1 has been
previously involved in removing and blocking DNA methylation [67, 77], I decided to start
by asking whether predicted occupancy of SP1 was negatively correlated with methylation
levels. I found that all the constructs with the exception of one outlier showed strong negative
correlation between their methylation levels and SP1 occupancy (r = -0.78, Figure 3.12, left
panel, blue dots, r = -0.39 including all points). This result suggests that the levels of
methylation of the constructs are indeed mediated by SP1 with the exception of construct
4, where other potential interactions might be taking place. I then asked which other PWM
together with SP1 could explain most of the variation in the data. The result was the
PWM for CREBB, a transcription factor previously linked in the up-regulation of several
neuropeptides and neuron-specific genes [174]. A simple linear regression model using the
PWMs for both SP1 and CREBB indeed improves the predictions for DNA methylation (r
= 0.69 Figure 3.12 right panel), suggesting that the regulation of the methylation patterns
of these fragments might indeed depend on the interplay between these factors. Follow-up
experiments with targeted mutagenesis are currently planned for dissecting the role of these
sites. These results suggests that methylation levels across the Oct4 mini-library can be
explained by the presence of regulatory elements in the DNA sequence.
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The variable insert region affects the methylation of the methylation reporter
system
A fundamental question in the establishment of DNA methylation is whether the signals
specifying the pattern of a single CpG originate from the same region or whether methylation
can be spread from one CpG to adjacent ones. The motivation underlying this question has
a practical basis as well: if a region contains the information necessary to specify its own
methylation pattern, can this region be used to modify/affect the methylation of nearby
regions? To answer this question, I engineered two CpGs in the piggyBAC reporter backbone
on the 5’ and 3’ regions flanking the insert. As these CpGs are fixed across all the construct,
they can act as a ”reporter” to read out the effects of the insert sequence.
First, I asked whether the methylation of the CpGs of the reporter sequence was estab-
lished randomly or whether it was indeed specified by the reporter system. To answer this
question, I correlated the level of methylation of the CpGs of the reporter from two biological
replicates and compared it to the correlation of the methylation levels of the CpGs belonging
to the insert sequence (Figure 3.10, green and red dots respectively). The high correlation
observed between biological replicates indicates that the methylation of the reporter is not
established randomly but rather suggests that each CpG is highly regulated. Then, I asked
whether methylation of the insert sequences was correlated with the methylation of the re-
porter CpGs. For all the analyzed experiments, I was able to observe good correlations
between insert and reporter methylation (Figure 3.13). Furthermore this correlation persists
between single CpGs of the reporter and the most proximal CpG in the insert sequence
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(Figure 3.14). These results indicate that the CpGs in the reporter system can be used as a
readout for the methylation patterns specified by the sequence of the insert.
3.2.3 Future directions:
The experiments that have been presented so far describe the creation and the testing of
a methylation reporter system. The goal of this project is ultimately to ask very specific and
detailed questions on the contribution of DNA sequence elements to DNA methylation. A
key advantage of the piggyBAC methylation reporter system is that it can easily be scaled
up to perform large scale genome-wide analysis. We are currently designing and testing a
large scale oligo library spanning several differentially methylated regions between mouse
ESC and NPCs.
3.3 Materials and methods
3.3.1 Construction of piggyBAC methylation reporter
We used the piggyBAC donor as the backbone from [76]. Circular donor plasmids were
built for the Trf,OrmI,Syt1,Zic3, and Mrap constructs by cloning them using the restriction
sites XhoI and ClaI. Restriction sites were engineered on the inserts by PCR. The sequence
of the inserts were obtained from [70]. For the construction of libraries, we adopted a strat-
egy based on linear assembly. Briefly, a linear donor vector was generated by assembling 4
linear DNA fragments or building blocks via PCR [175]. Each building block was generated
by PCR and required to have approximately 20bp of overlapping sequence with the adjacent
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Figure 3.13. Methylation of the insert affects the methylation of the reporter
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This figure shows the correlation between the methylation of the variable insert region and the fixed reporter
region in the piggyBAC methylation reporter system for the Oct4 mini-library (diagram on the left side). For
each experiment, methylation level of the insert region of a single construct is plotted against the methylation
level of the reporter region for the same construct. Each column represents a distinct biological replicate
of the same condition/cell type. The corresponding Pearson’s correlation coefficient of each correlation is
shown at the bottom right of each plot.
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Figure 3.14. Methylation of the insert affects the methylation of the reporter at
a single CpG level
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Analogous to Figure 3.13, this figure shows the correlation between the methylation level of the CpGs of
the fixed reporter region most proximal to the insert and the corresponding nearest CpG in the variable
insert region (diagram on the left side). Each column represents a distinct biological replicate of the same
condition/cell type. The corresponding Pearson’s correlation coefficient of each correlation is shown at the
bottom right of each plot.
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block. The first and the fourth building blocks contain the Inverted repeats necessary for
the integration of the transposon, the second building block contains a puromycin resistance
cassette and the third building block consists of a library of sequences to be tested. Each
fragment contains overlapping ends. The primers used for the construction are shown below:
Building Block F R
Building Block 1 gttttcccagtcacgacgtt ggctgcaggaattcgataaa
Building Block 2 tttatcgaattcctgcagccagcccaattctgtggaatgt ggaatcgaaatctcgtagca
Building Block 3 tgctacgagatttcgattccaagtgtaaagcctggggtgcctaat atattttcttgttatagataaaggatcttcttgagatccttttt
Building Block 4 atctataacaagaaaatat catcctcggcaaactctttc
The colored primer sequence indicates the overlapping region between construct necessary
for the assembly protocol.Each block was generated using piggyBAC donor as template. The
reaction was performed by using 12.5µl of 2X Phusion HF master mix (NEB), 1M Betaine,
0.4uM primers, and 42ng of piggyBAC donor in a final volume of 25 µl. For BB1 and BB4
we used the following protocol: 98C for 3’, 29 cycles of 98C for 10”, 50C for 30”,72C for
30”, followed by 72C for 10’. For BB2 we used the following protocol instead: 98C for 3’, 6
cycles of 98C for 10”, 56C for 30”,72C for 1’, followed by 29 cycles of 98C for 10”, 65C for
30”,72C for 1’, followed by 72C for 10’.
Libraries were assembled using the following PCR protocol: The reaction was performed
by using 12.5µl of 2X Phusion HF master mix (NEB), 1M Betaine, 0.4uM primers, and 0.1
pmoles of the required building blocks in a final volume of 25 µl. We then used the following
157
protocol: 98C for 3’, 6 cycles of 98C for 10”, 63C for 30”, 72C for 1’, 29 cycles of 98C for
10”, 72C for 30”, 72C for 1’, followed by 72C for 10’. The assembly protocol was executed
as follows: first BB1,BB2, and BB3 were assembled in a single reaction. The BB1∼ 2 ∼ 3
product was then assembled to BB4 in a second PCR reaction.
3.3.2 Construction of the Oct4 minilibrary
We built the Oct4 mini-library using the linear library construction strategy. The fol-































These fragments were then pooled together at a final concentration of 100nM and used
as templates to generate BB3. The library was then assembled as described above.
3.3.3 Cell culture protocols and differentiation
Experiments were carried out using the RW4 cell line. Cells were grown on gelatin
coated plates with High Glucose DMEM with L-Glutamine (DMEM 5796) (Sigma-Aldrich)
supplemented with 10% FBS, 10% NCBS, 1% nucleosides, 0.1% Leukemia Inhibiting Factor,
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and 0.2% β-mercaptoethanol (working medium). Differentiation from ESC to NPC was
performed as described in [176]. Briefly, undifferentiated cells were grown in DFK5 medium
[176] for 2 days in low-adhesion plates. At this stage, cells will turn in Embrioid Bodies
(EBs). After 2 days, EBs were plated in gelatin coated plates with DFK5 supplemented
with 2µM retinoic acid (Sigma) and 30 nM of Shh agonist Hh-Ag 1.4 (Curis) for 4 days.
3.3.4 Transfection and selection
Transfection experiments were performed on single wells of a 6-well plate(Cornig) using
Lipofectamine 2000 (Invitrogen). Briefly, a well was seeded with 500,000 cells in 2ml of
working medium 24hrs before transfection. Transfection was performed using 2µg of donor
and helper vectors with 10ul of Lipofectamine in 500ul of DMEM 5796 as described by the
manufacturer. Between 9 and 24hrs after transfection, the medium of each well was replaced
with working medium supplemented with 2.5ug/ml Puromycin (Sigma-Aldrich). Selection
is maintained for at least 3 days. After selection cells were passaged and grown in working
media for at least 2 days.
3.3.5 DNA extraction and bisulfite conversion
Genomic DNA was harvested from the cells using standard phenol/clorophorm extraction
followed by isopropanol purification [177]. Between 250ng to 1µg of DNA were then bisulfite-
converted using the Epitect Bisulfite Conversion kit (Qiagen) following standard protocol.
Bisulfite treated DNA was then amplified with bisulfite-specific primers (Forward: AAGTG-
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TAAAGTTTGGGGTGTTTAAT, Reverse: AAAAAATCTTCTTAAAATCCTTTTT) us-
ing 0.5 units of Jumpstart TAQ (Sigma), 1M Betaine, 0.4uM primers, 40µM dNTPs, and
5 µl of bisulfite converted DNA in a final volume of 25ul. The protocol was 95C for 10’,
followed by 5 cycles of 95C for 30”, 55C for 30”, 72C for 1’, 5 cycles of 95C for 30”, 50C for
30”, 72C for 1’, 40 cycles of 95C for 30”, 45C for 30”, 72C for 1’, followed finally by 10’ at
72C.
3.3.6 Next generation sequencing library preparation
DNA from long constructs (over 200bp) was prepped for next generation sequencing on
an Illumina miSEQ (Illumina) as previously described [121]. DNA from the Oct4 minilibrary
was prepped by adding sequencing adapters and indices by PCR (Forward adapter primer:
ACACTCTTTCCCTACACGACGCTCTTCCGATCT AAGTGTAAAGTTTGGGGTGTT-
TAAT, Reverse adapter primer: TGACTGGAGTTCAGACGTGTGCTCTTCCGATCT
AAAAAATCTTCTTAAAATCCTTTTT). The reaction was performed by using 12.5µl of
2X Phusion HF master mix (NEB), 1M Betaine, 0.4uM primers, and 1µ of bisulfite PCR
product in a total volume of 25µl. The protocol was 98C for 3’, followed by 6 cycles at
98C for 10”, 63C for 30”, 72C for 15”, and 12 cycles of 98C for 10”, 72C for 30”, 72C
for 15”. Indexed primers were added to the adapter PCR products using the same PCR
protocol (Forward index primer: ATGATACGGCGACCACCGAGATCTACACTCTTTCC-
CTACACGAC GCTCTTCCGATCT, Reverse index primer: CAAGCAGAAGACGGCAT-
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ACGAGAT [7bp index sequence] GTGACTGGAG TTCAGACGTGTGCTCTTCCGA). Li-
braries were then sequenced on an Illumina miSEQ machine (Illumina).
3.3.7 Computational analysis and methylation calls
Bisulfite reads were aligned to their reference using a custom bisulfite aligner that ac-
counts for C/T transitions in the context of CpGs. Once aligned, methylation levels were
called by estimating the frequency of C/T variants for each CpG dinucleotide using the
SPLINTER algorithm [14]. Positional weigth matrix analysis was performed as described in
the main text. Briefly Positional Weight Matrices (PWMs) from Jaspar [172] and TRANS-
FAC [173] were scanned on the sequence of the Oct4 mini-library as previously described







where i represents each base in a sequence of length n, the model is the PWM and
the background distribution assumes equiprobable nucleotide frequencies. Linear regression
model fits, permutation tests, and correlation analysis were performed using the statistical
programming language R.
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4. Origin and consequences of the relationship between protein
mean and variance
4.1 Foreword
This chapter describes the biophysical modeling of the relationship between single-cell
protein variance and its corresponding mean levels. The focus of this modeling effort is to
use this relationship to interpret the mechanism through which different biological process
increase protein variance through mean levels. Furthermore, we were able to recapitulate
this relationship and consequently predict single-cell protein variance at a genome-wide scale
by integrating information from empirically derived biophysical parameters. This work was
conceived by Robi D Mitra, PhD, Ilaria Mogno, PhD, and myself. Robi D Mitra, Marc Sher-
man, Barak A Cohen, PhD, designed the analysis. I performed the analysis in collaboration
with Marc Sherman, Zane Goodwin, and Robi D Mitra. Finally I performed the validation
experiments. This work is adapted from a draft of a corresponding manuscript in the process
of being submitted for publication.
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4.2 Abstract
Cell-to-cell variance in gene expression (noise) is a ubiquitous phenomenon that can in-
crease fitness by generating phenotypic differences within clonal populations of cells. An
important challenge is to identify the specific molecular events that control noise. This task
is complicated by the strong dependence of a proteins cell-to-cell variance on its mean ex-
pression level through a power-law like relationship (σ2 ∝ µ1.69). Here, we dissect the nature
of this relationship using a stochastic model parameterized with experimentally measured
values. This framework naturally recapitulates the power-law like relationship (σ2 ∝ µ1.6)
and accurately predicts protein variance across the yeast proteome. Using this model we
identified two distinct mechanisms by which protein variance can be increased. Variables
that affect promoter activation, such as nucleosome positioning, increase protein variance
by changing the exponent of the power-law relationship. In contrast, variables that affect
processes downstream of promoter activation, such as mRNA and protein synthesis, increase
protein variance in a mean-dependent manner following the power-law. We verified our
findings experimentally using an inducible gene expression system in yeast. We conclude
that the power-law-like relationship between noise and protein mean is due to the kinetics
of promoter activation. Our results provide a framework for understanding how molecular
processes shape stochastic variation across the genome.
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4.3 Introduction
Stochastic fluctuations in the biochemical processes that underlie gene expression produce
cell-to-cell variation in protein levels, or noise [89, 97, 105]. Noise performs several biolog-
ical functions. In unicellular organisms, noise improves fitness by generating phenotypic
differences within clonal populations of cells, thus enabling a rapid response to fluctuating
environments [88, 92, 179]. In multi-cellular organisms, noise plays a role in development,
allowing identical progenitor cells to acquire distinct fates [91, 93, 180]. Because of its func-
tional importance, a fundamental goal is to identify and dissect the molecular mechanisms
that generate and control noise. Single-cell studies have connected pathway-specific (extrin-
sic) and gene-specific (intrinsic) factors to changes in noise [89, 110, 181]. These factors
include the rate of transcript elongation12, the presence of a TATA-box [89, 112, 119, 179],
nucleosome positioning at the promoter sequence[89, 113, 114, 115, 182], fluctuating mRNA
levels [111], translation rate [86, 87], pathway-dependent fluctuations [111, 181], and asym-
metric partitioning at cell division [183]. Determining the relative contribution of these
factors to the noisiness of any given gene remains an important challenge. Understanding
the contribution of any particular molecular process to noise is complicated by the strong
dependence of a proteins cell-to-cell variance on its mean expression level [86, 94, 111, 181].
Several studies have revealed that a proteins cell-to-cell variance is related to its mean expres-
sion level by a power-law-like relationship (σ2 ∝ µj) [94, 111, 120, 184]. Any investigation
into the mechanistic origins of noise must account for this power-law-like relationship, as
any process that increases the mean expression level of a protein will necessarily increase its
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cell-to-cell variance. Only by accounting for the power-law-like relationship is it possible to
identify processes that increase noise beyond what is expected given the processes effects on
mean protein levels. Despite empirical observations, the biophysical origin of the power-law-
like relationship between the variance in protein levels and mean protein levels is not yet
clear. To address this problem, we analyzed noise using a stochastic model of gene expres-
sion parameterized with experimentally measured kinetic rates. This model recapitulated
the precise relationship (σ2 ∝ µ1.6) between mean and variance and accurately predicted
protein variance on a proteome-wide scale (r2 = 0.935). By further analyzing this model, we
identified two distinct classes of processes that influence noise. First, variables that affect
the rate of promoter activation, such as the presence of promoter-positioned nucleosomes or
TATA boxes, increase noise in a mean-independent fashion. In contrast, variables that influ-
ence processes downstream of promoter activation, such as the synthesis and degradation of
mRNA and protein, increase noise in a mean-dependent manner. Our results suggest that
the kinetics of promoter activation determine the power-law-like relationship between mean
protein levels and variance in protein levels. In support of this claim, we found that changing
the rate of promoter activation modulates the exponent of the power-law and consequently
the scaling between variance and mean. By providing a mechanistic interpretation of the
power-law-like relationship, our work provides the framework to achieve a better understand-
ing of the molecular processes that lead to cell-to-cell variation in gene expression.
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4.4 Results
4.4.1 Protein mean and variance are connected by a power-law-like relationship
We started by characterizing the relationship between mean protein levels and cell-to-cell
protein variance across the yeast genome. We analyzed data consisting of ∼2200 S. cerevisiae
GFP fusion strains for which protein levels had been measured at a single-cell resolution by
flow-cytometry [112]. We performed a log-log regression analysis of cell-to-cell protein vari-
ance as a function of the mean protein levels and observed a power-law-like relationship with
an exponent of 1.69 (Figure 4.1), in agreement with previous findings [94, 120]. Ninety-
seven percent of protein variance across the proteome can be explained solely by mean levels
through this relationship, indicating that highly expressed genes naturally exhibit high cell-
to-cell variation whereas genes expressed at low levels are more uniformly expressed across
different cells. Although the mean-independent component of protein variance accounts for
only 3% of the total variation, we found that, for certain genes, mean-independent contribu-
tions increased protein variance up to 20-fold higher than expected (Figure 4.2). In contrast,
very few genes displayed smaller protein variances than expected given mean levels. In fact,
we observed, at most, a 2-fold reduction (see Figure 4.2). Taken together, these results indi-
cate that for most genes, protein variance is largely explained by the protein mean through
a power-law-like relationship, except for a few notable cases in which protein variances are
increased substantially beyond their expected values.
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Figure 1
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Protein mean and variance values in S. cerevisiae plotted against each other in log-scale in arbitrary fluores-
cence, with corresponding Pearson’s correlation coefficient.
4.4.2 A stochastic model of gene expression recapitulates the power-law-like
relationship between mean and variance
We next sought to understand the molecular origin of the relationship between protein
mean and variance. One hypothesis is that this relationship originates purely as a conse-
quence of stochasticity in the steps of gene expression. Alternatively, this relationship could
result from mechanisms that are independent of expression, such as asymmetric partitioning
of protein and RNA molecules at cell division [183] or pathway-dependent fluctuations in
trans-acting factors [181]. To distinguish between these two hypotheses, we tested whether a
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Figure 1
Z   score   2
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Distribution of residual variance values across the S. cerevisiae dataset. Red bars indicate residual variance
value with Z-scores over 2 standard deviations from the mean
stochastic model based only on the processes involved in gene expression could recapitulate
the observed power-law relationship. We applied a model [117] that describes cell-to-cell
protein variance at steady-state as a function of kinetic parameters for promoter activa-
tion/inactivation events and mRNA and protein production/degradation (Figure 4.3, Figure
4.9). For most parameter values, we used empirical measurements (see supplementary meth-
ods). This was not possible, however, for the rates of promoter activation and inactivation,
which have only been measured in a few genes [185]. Since no high-throughput methods exist
for measuring rates of promoter activation and inactivation, we assumed that the promoter
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kinetics would be similar across the genome and fit their values from the data (supplementary
methods). The model converged to a regime in which promoter activation is an infrequent
event that is quickly followed by promoter inactivation, a result supported by published
experimental data [120] (supplementary information, and Figure 4.9). We obtained a rate
of promoter activation (Kon) of 0.59 min
−1, a value that agrees with empirically measured
activation rate for the GLT1 gene in yeast (1.3 ± 0.72 min−1) [185]. Using this value for
Kon, the model naturally generates a power-law-like relationship between mean and variance
that is similar to the one observed empirically (modeled relationship: σ2 ∝ µ1.60, observed
relationship: σ2 ∝ µ1.69). Furthermore, our framework correctly predicts protein variance
across the genome (log space r = 0.962, p < 2.2∗10−16; linear space r = 0.839, p < 2.2∗10−16,
Figure 4.4). We tested for over-fitting by performing 2-fold cross-validation 100 times and
again found good agreement (r = 0.957 ± 0.018, p < 2.2 ∗ 10−16 ). Taken together, these
results support the validity of our model and suggest that the power-law relationship be-
tween mean and variance depends solely on the kinetics of the processes that underlie gene
expression.
4.4.3 The power-law-like relationship between protein variance and mean de-
pends on promoter kinetics
Our analysis indicates that the power-law-like relationship between mean and variance is
a consequence of the steps that lead to gene expression. We next sought to determine which of
these processes specify the exponent of the power-law-like relationship. Using our biophysical
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Figure 4.3. Stochastic model of gene expression
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{ {PolII Promoter OnOff mRNA Protein   KpKm Dm DpKonKoff PolIISm { {
Schematic representation of the model. Each step transition is determined by a rate constant. Promoter
activation and inactivation occur at Kon and Koff rates respectively. When active, a promoter is transcribed
at Km rate into an mRNA molecule. The mRNA molecule can then be either degraded at Dm rate or
translated at Kp rate into a protein. The protein molecule can then be degraded at rate Dp. Kon, Koff , and
Km determine the synthesis rate of mRNA, or Sm. Blue indicates that the parameter has been empirically
measured or calculated across the dataset, red indicates that the parameter has been simplified or fit across
the dataset
model, we randomly sampled transcription and translation rates, as well as degradation rates
of mRNA and protein, while maintaining the same promoter activation regime we identified
above (Kon = 0.59 min
−1, Kon << Koff ). Virtually all permutations resulted in a power-
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Figure 4.4. Model prediction of genome-wide protein variance in S. cerevisiae
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{ {PolII Promoter OnOff mRNA Protein   KpKm Dm DpKonKoff PolIISm { {
Model performance in predicting protein variance in S. cerevisiae. Each point represents a single GFP fusion
strain. Data is displayed in log-scale (linear scale r = 0.836)
law relationship between mean and variance that was nearly identical to the one observed
experimentally (exponent = 1.612± 5.9 ∗ 10−3, 1000 permutations, Figure 4.5). This result
indicates that, when Kon << Koff , the exact form of the power-law-like relationship between
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mean and variance is independent of the rates of transcription, translation, and protein
and mRNA degradation. In contrast, we found that the exponent of the power law was
strongly dependent on promoter kinetics. Using the same modeling framework, we changed
the parameters governing promoter transitions to enforce a slow kinetics regime (Kon and
Koff << Km, Dm, Kp, Dp). We found that protein mean and variance followed a quadratic
relationship (exponent = 1.97, Figure 4.5), which differs substantially from our previous
results and the observed power-law. Taken together these results suggest that the power-law
relationship between protein mean and cell-to-cell variance is dictated by the kinetics of
promoter activation, and is largely insensitive to downstream steps.
4.4.4 The relationship between protein mean and variance separates mean-
dependent from mean-independent sources of variance
A strong prediction of our model is that perturbations which affect the kinetics of pro-
moter activation should increase noise in a mean-independent manner, whereas perturba-
tions that affect processes downstream of promoter activation should increase noise in a
mean-dependent fashion. Several variables have previously been correlated with increases in
noise including changes in transcription13 and translation rates [86, 87, 89], the presence of a
TATA box [87, 89, 112], and promoter positioned nucleosomes [89, 113, 114, 182]. Our model
suggested that only variables involved in promoter activation should increase protein vari-
ance independently of mean levels, in contrast to variables affecting downstream processes.
To test this hypothesis, we correlated the power-law residuals with variables that reflect
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Figure 4.5. Promoter kinetics but not mRNA and protein synthesis and degra-
dation rates modulate the relationship between mean and variance
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Predicted relationship between mean and variance using original model with original parameter set (grey
squares), original model with permuted sets of kinetic rates for mRNA/protein synthesis and degradation
(purple), and slow promoter kinetics model with original parameter set (orange).
changes in promoter activation, and with variables that affect downstream processes. Genes
with TATA boxes or promoter-positioned nucleosomes, factors which influence promoter ac-
tivation, had high values of residual variance (Figure 4.6), indicating that they increase noise
independently of the mean. In contrast, differences in measured rates of mRNA synthesis and
degradation [186], rates of protein degradation [187], measures of ribosomal occupancy[188],
and the Codon Adaptation Index [189] showed little or no correlation with residual variance
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(Figure 4.6). This result demonstrates that these variables, which affect processes down-
stream of promoter activation, influence cell-to-cell protein variance almost exclusively by
changing mean levels of gene expression. Taken together, the results support our hypothesis
and point to positioned nucleosomes in particular as a potent source of mean-independent
noise.
Figure 4.6. Promoter-associated factors modulate protein variance independently
of the mean
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Fraction of residual variance explained (r2) by sources of noise operating at the promoter/initiation level
(orange) or at a post-initiation level (purple).
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4.4.5 Experimental confirmation of the relationship between promoter-positioned
nucleosomes and mean-independent variance
To obtain additional support for these findings, we experimentally tested whether changes
in nucleosome occupancy could produce an increase in the mean-independent component of
gene expression. Using in vivo nucleosome positioning data [190], we selected a set of S.
cerevisiae TATA-containing genes whose promoters are nucleosome free in glucose but which
acquire a positioned nucleosome in ethanol. A prediction of our analysis is that such genes
would display increased residual variance when switched from glucose-containing medium to
ethanol-containing medium. We measured the distribution of fluorescence of GFP-tagged
fusion strains [187] in both glucose and ethanol by flow-cytometry, and computed the resid-
ual variance above what is expected from the mean-variance relationship. We observed a
significant increase in residual variance as cells were shifted from glucose to ethanol relative
to a control set of genes in which nucleosomes do not change between the two conditions
(p-value < 0.05, T-test across 3 biological replicates, Figure 4.7). Using this same gene
set, we examined whether changes in protein translation rate affected the mean-independent
component of the variance. Our model predicts that translation rate should not correlate
with residual variance, and we did not observe any significant difference (p-value > 0.4,
T-test across 3 biological replicates, Figure 4.7).These results support our hypothesis that
positioned nucleosomes are the major source of mean independent noise. We conclude that
nucleosome bound promoters showed higher protein variance as a result of slowed promoter
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activation kinetics, which increases the exponent of the power-law-like relationship between
protein mean and variance.
Figure 4.7. Changes in nucleosome occupancy but not in translation rate induce
changes in mean-independent variance
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Increment in residual variance from glucose to ethanol in genes that show increased occupancy in ethanol
(orange set: test) and genes with unaltered occupancy (orange set: control) compared to the same genes
ranked by high (purple set: test) or low (purple set: test) increase in translation rate (purple set) (* indicates
p < 0.05, t-test).
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4.4.6 Promoter-positioned nucleosomes increase variance by slowing promoter
activation kinetics
Our model suggests that the increase in residual variance caused by positioned nucleo-
somes is the result of slower promoter activation in these genes. To test this hypothesis,
we examined single-cell mRNA measurements performed for different genes in S. cerevisiae
[191], since the relationship between mRNA mean and variance can be used to distinguish
groups of genes with different promoter kinetics [120] (see materials and methods). Our pre-
diction is that genes without promoter-positioned nucleosomes (Figure 4.8b) will have fast
promoter activation kinetics and thus display an approximately linear relationship between
mean and variance (Figure 4.8a, blue line, see supplementary methods). Indeed, this was
observed in the single-cell mRNA data (see Figure 4a, red dots). In contrast, our model pre-
dicts that genes with promoter-positioned nucleosomes (Figure 4.8c) will have slow promoter
activation kinetics and will therefore display a quadratic scaling between mean and variance
(Figure 4.8a, red line, see supplementary methods). This was again confirmed – genes lacking
a nucleosome-free region (NFR) displayed the predicted mean-variance relationship (Figure
4.8a, red dots).
4.5 Discussion
A fundamental property of protein variance is its dependence on mean protein lev-
els through a power-law-like relationship. This power-law-like relationship holds in yeast
(σ2 ∝ µ1.6 , bacteria (σ2 ∝ µ1.5)[184], and human T-cells (σ2 ∝ µ1.7)[94], suggesting the
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Figure 4.8. Single-cell mRNA variance connects underlying promoter kinetics to
nucleosome occupancy
Figure 4
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a) mRNA mean and variance in S. cerevisiae plotted against each other in log-scale. Blue dashed line
indicates the expected relationship between mean and variance in a regime of slow activation and fast
inactivation rate (σ2 = µ), red dashed line indicates expected relationship at slow promoter kinetics (σ2 =
µ + µ2). Circles represent experimental values of mRNA mean and variance (color matches best fit to
promoter kinetics regime) b) Average nucleosome occupancy between -600 to +1000 relative to the TSS of
S. cerevisiae genes exhibiting linear mRNA mean-variance scaling. The position of the canonical nucleosome
free region is indicated by the black arrow. c) Same as b) but with respect to S. cerevisiae genes exhibiting
quadratic mRNA mean-variance scaling.
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processes that determine the power-law are common across species. Our work supports
this conclusion. We found that the power-law is a natural consequence of the kinetics of
transcription and translation, fundamental mechanisms shared between the three organ-
isms. Molecular processes that differ significantly between these species, such as chromatin
structure, nuclear export, or unequal partitioning during the cell cycle, were not required to
explain the power-law. Our work suggests that the power-law is a universal feature of gene
expression whose particular shape is determined by the rates at which promoters transition
between their active and inactive states. We therefore expect to observe this power-law in
all cell types, with an exponent that reflects the particular promoter kinetics regime of the
cell. One practical application of understanding the power law is that the mean-independent
component of noise can be measured. Surprisingly, we found that, in yeast, there are few
genes with a significant mean-independent variance. In fact, 97% of all protein variance
across the genome is explained solely by mean protein levels, a result that only becomes
obvious after using the power-law to remove intrinsic mean effects. The 3% of genes with
excess variance (up to twenty-fold over what is expected) is consistent with the occurrence of
slow promoter kinetics, which our data suggest is caused by positioned nucleosomes on their
promoters. Finally, we did not observe any genes with variances significantly below that
expected from the power-law. Reducing protein variance may be difficult for the cell due to
physical constraints that render this process energetically dis-advantageous. A theoretical
analysis on the limits of suppression of molecular fluctuations [192] supports this observa-
tion. Alternatively, it is possible that cells have evolved regulatory networks with intrinsic
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robustness to molecular fluctuations [193], suggesting that even if achievable, noise reduction
may not be necessary. Identifying the sources of noise and their underlying mechanisms is an
important step in determining their role in increasing fitness. The work presented here pro-
vides a way to isolate mean-independent effects from protein variance and to connect them
to their biophysical origins. A long-standing question regarding stochastic gene expression
is its role in fitness [179]. Through this framework, it will be possible to decouple the role
of protein variance from the mean, allowing a better understanding of the functional and
evolutionary constraints that shape gene expression variance.
4.6 Methods
4.6.1 Data Sources
We used single-cell protein mean and variance values from flow-cytometry measurements
on S. cerevisae GFP-fusion strains grown in YPD for ∼2000 genes from Newman et al.
[112]. mRNA level measurements in YPD and YPEtOH were obtained from Gasch et al
[194].We acquired mRNA synthesis and degradation rates from Miller et al. [186]. mRNA
single-cell measurement data were obtained from Gandhi et al. [191]. Nucleosome occupancy
was assessed from mnase-seq datasets in YPD and YPEtOH from Kaplan et al. [190]. We
used protein mean and variance from synthetic promoter libraries from the work of Mogno
et al. [119]. Definition of TATA-containing and TATA-less were obtained from Basehoar
et al. [195] . We obtained in vivo ribosome occupancy profiles for each mRNA species
measured in YPD from Ingolia et al. [188]. Data and source code generated and used in
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this work can be found at http://cgs.wustl.edu/~fvallania/5_noise_2011/5_noise_
website/NOISE_Project_supporting_materials.html.
4.6.2 Analysis of the relationship between protein mean and variance
Using single-cell protein mean and variance values in S. cerevisiae, we assumed that the
underlying relationship between mean and variance could be non-linear and exponential in
nature. This formulation can be generally expressed as
σ2 = kµj (4.1)
where k is a scaling factor and J is the exponential index. In log-space, this equation
transforms into
log(σ2) = J ∗ log(µ) + log(k) (4.2)
where J can now be directly calculated as the slope of a linear regression. We estimated the
fraction of variance explained by the mean as the r2 of the regression. Variance residuals
originated from this fit were defined as mean-independent variance. Regression analysis was
performed using the R programming language.
4.6.3 Stochastic modeling of protein and mRNA variance
To model mRNA and protein variance in S. cerevisae, we used analytical stochastic
models derived from the solution of a system of stochastic differential equations as previously
described [117]. This model describes the steady-state value of mRNA and protein variance
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as a function of the kinetic rates for protein activation and inactivation (Kon and Koff ),
mRNA synthesis and degradation (Km and Dm), and protein translation and degradation
(Kp and Dp). The model for mRNA variance is described in equation (4.3), whereas the
model for protein variance in equation (4.4). In order to predict genome-wide protein variance
in S. cerevisiae, we assumed Kon and Koff to be uniform across the genome and fit their
values. Fitting, prediction and cross-validation were computed in Perl. Analysis of the fit
was performed in R. (for complete explanation see Supplementary Information).
4.6.4 Correlation analysis between mean-independent variance and molecular
properties
We compared mean-independent variance to mRNA synthesis rate, mRNA degradation
rate, ribosomal occupancy and CAI (Codon Adaptation Index). CAI was computed as
previously described [189]. To determine the amount of variation of noise explained explained
by each property, we correlated mean-independent variance with the log of the measure of
each property and calculated the Pearson’s correlation coefficient. We used a linear regression
in log scale to avoid any non-linear effects. Regression analysis was performed in R.
4.6.5 Regression model between mean-independent variance and nucleosome
occupancy
We computed the Pearson’s correlation coefficient between mean-independent variance
and nucleosome occupancy at a single base resolution for each base ranging from -1000 to
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+600 relative to the transcription start site of each gene in S. cerevisae for which we had
both nucleosome data and residual mean-independent variance. For each base, we obtained
a correlation value, which was plotted as a function of its position relative to the TSS. We
repeated this analysis focusing on TATA-containing and TATA-less genes only. In order to
estimate the amount of variation explained by nucleosome occupancy on TATA-containing
genes, we applied a linear model to predict residual mean-independent variance as a function
of nucleosome occupancy. We performed a forward-regression strategy to determine the
positions in the promoter sequence to be used as predictive features for our model followed by
leave-one-out cross-validation to assess over-fitting (supplementary information for details).
Regression analysis was performed in R.
4.6.6 Experimental measurement of mean-independent variance as a function
of nucleosome occupancy
We selected 15 yeast genes that acquired a nucleosome when grown in YPEtOH com-
pared to YPD using genome-wide nucleosome occupancy data [190] YAL054C, YBL015W,
YBL075C, YBR139W, YBR145W, YDL097C, YER081W, YFL021W, YGL040C, YGL197W,
YLR042C, YMR315W, YNL241C, YOL143C, YOR084W, YPR127W). We constructed a
second set (control set) of 15 genes either stable nucleosome-bound or nucleosome-free pro-
moters (YBR066C, YBR092C, YER056C-A, YJL200C, YKL071W, YLR177W, YNL112W,
YOR355W, YAL060W, YDR055W, YDR495C, YDR533C, YDL222C, YER054C). For each
gene in each set, we grew a corresponding GFP-fusion S. cerevisiae strain [187] in YPD
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and YPEtOH to log phase and measured single-cell protein levels using a Beckmann-Coulter
Cytomics FC500 MPL flow-cytometer (Beckmann Coulter, Fullerton, CA) as previously
described previously [112]. We calculated residual variance from mean and variance as de-
scribed above and, for each gene we computed differential residual mean independent vari-
ance between YPEtOH and YPD. For each gene we computed the translation rate in both
conditions as described above and computed the differential translation rate (∆Kp) between
conditions. We tested for increase in residual variance between the test and control set and
between the top and the bottom half of all strains ranked by decreasing ∆Kp using one-sided
t-test. Statistics were performed in R.
4.7 Supplementary methods
4.7.1 Stochastic Modeling of mRNA and Protein Variance in S.cerevisiae
Description of the Model
We used a stochastic model describing the expression of a single gene though the process of
its promoter activation, inactivation, transcription at the active promoter state, degradation
of the transcribed mRNA, translation of the transcribed mRNA, and degradation of the
protein. A visualization of the model is described in Figure 4.3. Each step is associated with
a rate constant:
• Kon = promoter activation rate
• Koff = promoter inactivation rate
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• Km = mRNA transcription rate of active promoter
• Dm = mRNA degradation rate
• Kp = mRNA translation rate
• Dp = protein degradation rate
The model that we used is the analytical solution of a chemical master equation describ-
ing σ2 for mRNA and protein at steady-state. This solution and its derivation have been
previously described [117]. The value of σ2 for mRNA levels at steady-state corresponds to:
σ2mRNA = µmRNA[1 +
KoffKm
(Kon +Koff )(Dm +Kon +Koff )
] (4.3)
whereas σ2 for protein levels at steady-state is defined as:




(KoffKm)(Dm +Dp +Kon +Koff )
(Kon +Koff )(Dm +Kon +Koff )(Dp +Kon +Koff )
]} (4.4)
µmRNA and µp are the mean mRNA and protein levels respectively and are defined as
µmRNA =














Description of input datasets and calculation of Kp
We applied the model to a single-cell protein measurement dataset in S. cerevisiae [112]
in order to predict σ2p. The dataset provides values of σ
2
p and µp for ∼2200 genes. Our
experimentally derived parameters were obtained from the following sources:
Parameter Source
Sm Miller et al MSB 2011
Dm Miller et al MSB 2011
Kp Computed from Newman et al Nature 2006
Dp assumed to be constant (1/90 min
−1)
Sm is defined as the product of Km with the probability of the promoter being active,
which is specified by Kon and Koff as
Sm =< Pon > Km (4.8)
and, unlike Km, can be experimentally measured. Because all genes were tagged with
GFP, we assumed the fusion proteins to be stable and degraded at a rate equivalent to the
dilution rate, i.e. 1/90 min−1 (reported in http://www.yeastgenome.org/). This value
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represents the lower limit of protein degradation as active degradation events will result in
higher observed degradation rates. Although Kp was not readily available at a genome-wide





Fitting Kon and Koff across the entire S. cerevisiae genome
By applying (4.8) to (4.4), we removed Km from the model by replacing it with Sm
resulting in :






Koff (Dm +Dp +Kon +Koff )
(Dm +Kon +Koff )(Dp +Kon +Koff )
]} (4.10)
which can be parameterized using the data described above. We estimated Kon and Koff
on Newman’s dataset using a gradient descent non-linear fit strategy implemented in Perl
(this strategy is described in detail in [14]. We obtained a value of Kon = 0.59 min
−1 whereas
Koff always converged to the maximum allowed value, therefore becoming negligible. This
result indicates a regime of slow promoter activation (Kon) followed by fast inactivation
(Koff ). We derived an expression for protein variance under this regimen.
Starting from (4.10), and by assuming that Koff dominates over the other parameters,
as determined by the fit, the equation simplifies to
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We applied (4.11) to estimate σ2p in S.cerevisiae using the estimated value of Kon and
empirically measured values for the remaining parameters. We obtained a real scale corre-
lation of r = 0.839 and a log scale correlation of r = 0.962 between predicted and measured
σ2p. The results of this prediction are plotted in Figure 4.4.
To check for over-fitting, we performed cross-validation by randomly sampling 50% of the
dataset as training set and the second 50% as a validation set 100 times. For each round,
we estimated Kon and Koff from the training set and evaluated the goodness of fit on the
validation set (r = 0.957± 0.018, p < 2.2 ∗ 10−16).
Validating the assumption of a global invariant activation rate across the S.
cerevisiae genome
The results of our fit indicated a fast inactivation rate and suggested a slow and general
value of Kon across the S.cerevisiae genome. Previous experiments [94] suggest that in
mammalian cells it is the case, as mean and variance are affected by changes in burst size
( Km
Koff
) rather than changes in burst frequency (Kon).
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In order to test whether this assumption applied to our system, we analyzed a promoter
dataset described above [119]. In this dataset, a library of different promoters was cloned
upstream the same reporter gene. As a result, Kp,Dm,and Dp can be assumed as constants
in the system. We asked whether changes in promoter activity in the libraries were due to
changes in burst frequency Kon or burst size (
Km
Koff
). To do so, we analyzed the relationship
between the VMR (
σ2p
µp
) and CV 2 (
σ2p
µ2p


























where the parameters represented in blue indicate constants. Changes in Kon will result
in a inverse relationship between both mean and VMR and mean and CV 2 (Figure 4.9a).
In contrast, changes in burst size (by either Km or Koff ) with constant burst frequency
would result in a linear relationship between VMR and µp and an asymptotically constant
relationship between CV 2 and µp (Figure 4.9b). The experimental data from [119] follows
the second model which assumes changes in burst size with constant Kon, thereby validating
our assumption (Figure 4.9c).
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Figure 4.9. Changes in gene expressions are driven by changes in Koff or Km
whereas Kon remains largely constant.
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Changes in gene expressions are driven by changes in Koff or Km whereas Kon remains largely constant.
(a) Expected relationship of the VMR (
σ2p
µp
) (upper half, blue line) and the CV (
σ2p
µ2p
) (lower half, red line)
with protein mean levels (µp) assuming constant Koff and Km and variable Kon. (b) Same as in (a) but
assuming instead constant Kon and variable Koff or Km. Equations indicate the slope of the line for the
VMR-mean relationship (upper half) and the equation of the asymptotic line for the CV-mean relationship.




To estimate the exponent of the power-law relationship generated between protein mean
levels (µp) and predicted protein variance (σ
2
p)in the Newman et al dataset we performed
log-log regression between σ2p and µp which is defined as
log(σ2p) = j ∗ log(µp) + log(k) (4.15)
corresponding to
σ2p = k ∗ µjp (4.16)
in real space, where j is the exponent of the power-law.
Power-law relationship under slow promoter kinetics
We performed the same power-law analysis described above for a promoter regime char-
acterized by slow activation and inactivation kinetics. Under this regimen Kon, Koff <<
Km, Dm, Kp, Dp and the promoter contributes to σ
2
p following a Bernoulli/Binomial process
(Paulsson 2005). As described above, in this context the variance of the active promoter
(σ2prom), can be expressed as





which will reach it’s maximum value when < Pon > and 1− < Pon > will be equivalent.
As Kon and Koff are small in this regimen, by assuming maximum promoter variance, we
derived an expression of mRNA variance under bursty kinetics. As Kon and Koff are small
in this regimen, we can re-write (4.4) as






]} ≈ µp + µp Kp
Dm +Dp
+ µ2p (4.18)
We then estimated σ2p in this regime by computing its values using the same set of
parameters used above and again computed the exponent of the power-law relationship
between predicted σ2p and µp using (4.15).
Power-law relationship: Randomization analysis of molecular parameters
We developed a Monte-Carlo simulation in which each parameter in the parameter set
(Kon, Koff , Km,Kp, Dm, Dp) is randomly selected according to the known physiological
distribution and range. The physiological ranges used for this simulation were as follows:
193
Parameter Minimum Maximum Distribution/Source
Kon 0.5 0.6 Uniform in log-space
Koff 0.003 50 Measured by JR Chubb et al Current Biology 2006 and
DM Suter et al Science 2011
Km 0.05892 12.1 Computed from Sm (measured by Miller et al MSB
2011)
Dm 0.0054301 3.013683 Measured by Miller et al MSB 2011
Kp 0.05892 52.8 Computed from Newman et al Nature 2006
Dp 0.000042 0.3465736 measured by Ghaemmaghami S et al Nature 2003
Kon was defined by using our fitted value of 0.59 min
−1 and determining a small range
around it. Koff was defined from [196] and [197]. Km was computed from Kon,Koff and
Sm using (4.8). Kp was computed from the dataset using (4.9). Each round of Monte-Carlo
simulation randomly produced 2400 parameter sets (as large as the dataset from Newman
etal.). For each set, a protein mean and variance were computed using the previous equations.
A linear regression between the log values of mean and variance for the whole dataset was
then computed. We repeated this procedure 1,000 times and finally we computed the average
slope resulting from each linear regression.
Derivation of stochastic models for σ2mRNA
We derived expressions for mRNA variance under different promoter kinetics regimens.
We started by expressing equation (4.3) as a function of Sm, resulting in
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σ2mRNA = µmRNA[1 + Sm
Koff
Kon(Dm +Kon +Koff )
] (4.19)
Under a regimen of fast Koff and slowKon, this equation converges to




We found that in our dataset, the average burst size Sm
Kon
corresponds to 0.1042561.
σ2mRNA ≈ µmRNA (4.21)
Under a regimen of slow promoter kinetics, we expressed equation (4.3) as described
above for (4.18), resulting in:
σ2mRNA ≈ µmRNA[1 +
KoffKm
(Kon +Koff )Dm
] = µmRNA[1 + (1− < Pon >)Km
Dm
] (4.22)
if we assume that the promoter variance term is at its maximum, implying that < Pon >
is equal to (1− < Pon >), then the expression simplifies to
σ2mRNA ≈ µmRNA + µ2mRNA (4.23)
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4.7.2 Analysis of residual protein variance
Linear regression model between mean-independent variance and nucleosome
occupancy
To determine the amount of variation in mean-independent variance explained by nucle-




Ni ∗ αi (4.24)
where miv represents mean-independent variance, Ni represents the value of nucleosome
occupancy of the ith descriptive position used in the model, where n is the number of single-
base positions in the promoter sequence that are used as input features for the model. We
chose a linear model because of its simplicity and because we lacked detailed information on
the promoter architecture of each analyzed gene, making a physically motivated sequence
based model difficult to apply. Because the number of potential features (positions in the
promoter sequence) is large, we selected the number of features to be used by the model
by applying a forward regression strategy (for details see [171]). For each subset of features
incorporated in the model, we computed a set of Monte Carlo simulations where we ran-
domized nucleosome positions and MIV pairing 100 times. We computed the average r2 of
the Monte Carlo simulations and compared it to the real r2 of the model using the same
set of features. We chose the set of features that maximized the increment of r2 of the real
set from the average Monte Carlo simulations. Our final set includes 149 features, namely
positions in the promoter sequence with associated values of nucleosome occupancy across
196
the dataset. To test for over-fitting, we performed a leave-one-out cross-validation strategy,
where we predicted the results of 1 data-point after training the parameters on the rest of
the dataset. This procedure was repeated for each data point and overall correlation was
then computed. This strategy was implemented in the R programming language.
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5. Concluding remarks and future implications
The advent of the post-genomic era started with promises and doubts. Twelve years after
its incipit, we still are plagued with important biological questions that the pure genomic
approach has failed to address. However, one important factor has changed in recent years.
During the progression of my thesis, I have witnessed the establishment of massive paral-
lelized high-throughput sequencing as an everyday tool in the research community. What
this meant, on a practical, everyday level, is the ability to sequence someone’s genome in
the course of a single day in a single reaction, something that even one year before the start
of my PhD was considered to be unthinkable.
What, however, I find most important about this revolution is not just its technological
nature but its deep implication in changing everyone’s perspective on science. Because the
accessibility of such technology is now widespread to the whole scientific community, the
genomic approach can now be carefully directed to answer specific biological questions. In
a way, next-generation sequencing has become the 21st century analogous of PCR, with
the best results yet to come. Because of such untapped power at our disposal, these few
years have seen a tremendous explosion of scientific creativity where new tools, methods,
and protocols were created at a rapid pace. Over the course of my research in Rob’s lab, I
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have been lucky enough to contribute to the creation of tools and protocols to leverage its
potential in answering biological questions.
My first project involving the creation of SNPseeker and SPLINTER has given me a lot
of rewards on both a personal and professional level. Although pooled DNA sequencing is no
longer a necessity due to the declining costs of sequencing and the increased automation of
library creation, there are still useful and important application of this technology. Pooling
groups is still faster and more convenient for large screenings, but there are also many
scenarios where samples are naturally heterogenous and therefore behave as pools. One
important application is the problem of accurate detection of somatic mutations in cancer
samples. As cancer undergoes phases of evolution and selection through interaction with
the host immune response and chemotherapy, early mutation events initially occurring at
low frequency can inform clinicians for an adequate tailored therapeutic regimen. Although
different groups are now exploring single-molecule labeling strategies, detecting rare somatic
mutations can be optimally done using appropriate computational strategies. As of now, I
am currently involved in an effort to test SPLINTER as a potential tool for the detection of
such mutations in the clinic. Another important application of this technology is monitoring
of changes in viral populations in a single individual during the course of an infection.
Notable examples of viruses that exist as populations or quasispecies are HCV and HIV.
Understanding how their diversity can impact the host phenotype can lead to tremendous
benefits in the design of vaccines and understanding of viral biology.
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My second project (chronologically the last) involved the creation of a methylation re-
porter system. This project was the most challenging and more than any other has taught
me invaluable lessons. The first is the value of persistence, as without it no important
discoveries or breakthroughs will ever be made. Secondly, but not less importantly, the
ability to be flexible and creative in order to reach the desired goal. Sometimes a specific
approach may look great on paper but in reality it will not work, and the converse is also
true. Finally, any step in the development of something novel always feeds on the passion
and drive of realizing a vision of promise and potential. The potential for this project is in
my opinion the highest compared to everything else I have ever made as it provides a tool
that can be readily used to crack untapped biological knowledge. Importantly, it provides a
experimental mean to decode the regulatory function of the genome in the context of DNA
methylation, a biological process whose study has greatly benefited in recent times from the
advent of high-throughput sequencing. While basic biology questions of DNA methylation
can be readily dissected using this tool, more clinically relevant applications come in the
context of cancer and tumorigenesis. Despite the fact that a significant fraction of cancers
shows hyper-methylation of tumor suppressor genes, little is known of how this process is
generated, and consequently pharmaceutical therapies targeting this phenomenon are still
very a-specific. I believe in the potential application of this method to discover drivers of
cancer hyper-methylation.
My third project involved a deep modeling effort in order to connect a large scale dataset
to its biophysical roots. This project has challenged me in many ways and the most valuable
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lesson that I have gathered from its completion was quite rewarding: any question or problem
will always look difficult and unapproachable if faced from the wrong angle. However, if we
take the time and the mental effort to look at the same issues from a different and novel
perspective, new discoveries can be made but also difficult problems may in fact be very
easy and interpretable. This project differs significantly from the previous ones also because
it embodies the final steps in high-throughput biology and the next challenge in the post-
genomic world. Once a large dataset is generated, the next step is to analyze it correctly
and really understand the underlying biology. This requires not only computational prowess
but also a clear understanding of how to mathematically model biological processes. The
results of our work have important implications in the field of noise but also in single-cell
biology. With the increases in resolution of our experimental assays, many groups have now
been able to profile individual cells, showing their underlying and unexpected heterogeneity.
Through the analysis of the relationship between mean and variance, we can understand
what processes regulate the gene and speculate on their downstream implications in the
context of phenotype.
I would like to conclude my thesis by stating an important realization that occurred over
the course of my PhD. In my experience, many approach biology in two different ways: one
group operates by focusing on a well-define, well-characterized model system and dissect
it using well known and established approaches. The second group on the other hand,
much smaller than the first, operates at the technical side by breaking new ground and new
frontiers with new approaches and algorithms, but lacks focus and clarity as no biology is
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necessarily learnt directly from their endeavors. I came to realize that the best possible
work lies in between these two poles. The ability of attacking specific unsolved questions by
creating novel algorithms, models, and novel tools, tailored for the problem, can be quite
powerful and lead to great progress. Only by framing the right question in the right way,
one can bring the theory into practice and create ways and change the perspective of the
problem. But again, only by knowing all aspects of each step, especially the most technical
ones, one can take a perfectly framed question and attack it in the real world. The interface
between biological theory and the development of new technologies has the potential to turn
dreams and thoughts into reality because it can bring a fresh unbiased perspective to attack
established hard problems. I think this is by far one of the most important lessons learnt
during my journey. It is not so much a path toward specialization but rather a path toward
balance in connecting polar opposites.
I hope this thesis will delight you, interest you, or instigate new curiosity in you, dear
reader. After all, curiosity is what got it written in the first place.
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